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Abstract 
Escherichia coli and Klebsiella spp. are important pathogens, responsible for several 
infectious diseases. These members of Enterobacteriaceae family are of particularly 
concerning due to a high increase in their resistance to antimicrobials. The detection 
of more resistant strains brings into question if this enhancement of resistance may 
be accompanied by an increase in virulence. If so, extremely pathogenic strains 
would start to emerge, and no antibiotic therapy would be available to fight them, 
leading to serious public health problems. Thus, the main objective of this research 
was to understand the relation between virulence and resistance among E. coli 
collected from different origins and Klebsiella spp.. 
The interplay between resistance and virulence was studied among 
Uropathogenic E. coli (UPEC). E. coli strains are classified into four main 
phylogenetic groups. More virulent strains belong mainly to phylogroup B2 and, to a 
lesser extent, to group D, and most of the commensal strains belong to groups A and 
B1. During the characterization of strains, a new genotype was discovered in the 
Clermont method, which is used to assess phylogenetic groups. This yjaA/ tspE4.C2 
genotype was assigned to phylogroup B2. 
Pathogenicity islands (PAIs) are mobile genetic elements that carry virulence 
genes and may increase the virulence of bacteria. PAI I536, PAI II536, PAI III536 and 
PAI IIJ96 were found to be associated to phylogroup B2. A trade-off between virulence 
and resistance was observed for these islands, as they were generally found among 
susceptible strains. The same was observed for the majority of individual virulence 
genes including adhesins, toxins and siderophore systems. Contrarily, a correlation 
was observed for the PAI IV536, PAI ICFT073 and PAI IICFT073 and resistance to 
amoxicillin-clavulanic acid, cephalothin, cefotaxime, ceftazidime and gentamicin. This 
combination of PAIs, along with IncF plasmid, blaCTX-M-15 and aac(6’)-lb-cr genes, was 
also found to be prevalent among the UPEC CTX-M-15 producers assigned to the 
sequence type ST131. 
It was observed that strains with a higher number of identified plasmids carried 
less PAIs. It was hypothesised that the biological cost of the carriage of a resistance 
plasmid was higher to the cell, according to the number of PAIs carried. Conjugation 
assays and fitness studies were performed, and the latter indicated that the carriage 
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of a higher number of PAIs did not implicate a direct rise in the fitness cost of the 
acquisition of the resistance plasmid, at least in strains harbouring until three PAIs. 
Participation on an international study with E. coli isolates from Nigeria, 
allowed comparing the characteristics of these isolates with the Portuguese ones. 
Even though regional differences were observed, clone ST131, IncF plasmids and 
blaCTX-M-15 were common in the two countries. This supports the fact that clone ST131 
and the referred resistance determinant are widely and successfully disseminated 
worldwide.  
The same E. coli  ST131 clone, carrying resistance determinants blaCTX-M-15, 
blaTEM-type, qnrS and aac(6’)-lb-cr; IncF and IncP plasmids, and virulence factors PAI 
IV536, PAI ICFT073, PAI IICFT073, iutA, sfa/foc and papAH, was also identified at the 
effluent of a hospital wastewater treatment plant (WWTP). This shows that WWTPs 
may be contributing to the dissemination of virulent and resistant bacteria into water 
ecosystems, constituting, thus, an environmental and public health risk. 
The interplay between resistance and virulence was also assessed for K. 
pneumoniae and K. oxytoca. PAI IV536 was statistically associated to resistance to 
gentamicin and sulfamethoxazole-trimethoprim among K. pneumoniae. The presence 
of PAI IICFT073 was firstly identified among K. oxytoca in this study. It was significantly 
associated with resistance to cephalothin, cefotaxime, ceftazidime, ciprofloxacin, and 
gentamicin. Contrarily to the observed in E. coli, the trade-off between resistance and 
virulence did not seem to exist. In fact, among K. pneumoniae, higher prevalence of 
virulence factors was detected among isolates resistant to ciprofloxacin and 
gentamicin and at a lesser extent to cefotaxime and sulfamethoxazole- trimethoprim. 
Furthermore, higher prevalence of virulence genes was observed in K. oxytoca 
resistant to sulfamethoxazole-trimethoprim. 
Multidrug resistant K. pneumoniae isolates from an outbreak in a renal 
transplant unit were studied and characterized for virulence factors, resistance 
determinants and genetic relatedness. Two main genetic lineages were detected 
excluding the hypothesis of an outbreak caused by a single internal clone. PAI III536 
and PAI IICFT073 were detected for the first time in K. pneumoniae during this study.  
Overall, the results presented in this dissertation indicated that, although it was 
detected a general trade-off between resistance and virulence among E. coli, the 
same was not usually verified for Klebsiella spp. isolates. Nonetheless, despite of the 
trade-off verified in E. coli, clone ST131, found among Portuguese and Nigerian 
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isolates in this study, is an example that in this species, virulence and resistance 
features may co-exist.  The interplay between resistance and virulence seems to be, 
therefore, influenced by the genus and species, the virulence factor, and the 
resistance phenotype and genotype. 
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Resumo 
Escherichia coli e Klebsiella spp. são importantes agentes patogénicos, 
responsáveis por diversas doenças infecciosas. Estas bactérias da familia 
Enterobacteriaceae são particularmente preocupantes, devido ao crescente aumento 
da sua resistência aos antimicrobianos. A detecção de estirpes mais resistentes leva 
a ponderar sobre um eventual aumento simultâneo da virulência. Caso isto se 
verifique, a emergência de estirpes extremamente patogénicas, para as quais não 
haverá alternativas terapêuticas, levaria a sérios problemas de Saúde Pública. Desta 
forma, o principal objectivo desta investigação foi compreender a relação entre 
virulência e resistência em E. coli de diferentes origens e em isolados do género 
Klebsiella. 
 A relação entre resistência e virulência foi estudada em E. coli 
uropatogénicas. As estirpes de E. coli podem ser classificadas em quatro grupos 
filogenéticos principais. As estirpes mais virulentas pertencem maioritariamente ao 
grupo B2, seguido do D, enquanto que a maioria das comensais pertencem aos 
grupos A e B1. Durante a caracterização das estirpes, foi descoberto um novo 
genótipo usando o método de Clermont, utilizado para identificar os filogrupos. Este 
genótipo yjaA/ tscpE4.C2 foi atribuído ao grupo filogenético B2. 
As ilhas de patogenicidade (PAIs) são elementos genéticos móveis que 
transportam genes de virulência e, consequentemente, aumentam a virulência 
bacteriana. Neste trabalho, as ilhas PAI I536, PAI II536, PAI III536 e PAI IIJ96 foram 
associadas ao filogrupo B2. Relativamente a estas ilhas, observou-se uma relação 
inversa entre resistência e virulência, uma vez que foram geralmente encontradas 
em estirpes susceptíveis. O mesmo foi observado para a maioria dos genes 
individuais de virulência, nomeadamente de adesinas, toxinas e sideróforos. 
Contrariamente, observou-se uma correlação entre a PAI IV536, PAI ICFT073  e PAI 
IICFT073 e as resistências à amoxicilina-ácido clavulânico, cefalotina, cefotaxima, 
ceftazidima e gentamicina. Esta combinação de PAIs juntamente com um plasmídeo 
IncF, e os genes blaCTX-M-15 e aac(6’)-lb-cr, foram também mais prevalentes nos 
isolados de E. coli uropatogénicas produtoras de CTX-M-15, identificadas como 
pertencendo ao clone ST131. 
Observou-se que as estirpes com maior número de plasmídeos identificados 
tinham menor número de PAIs. Colocou-se então a hipótese de que a presença de 
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um plasmídeo de resistência e um maior número de PAIs levaria a um custo 
biológico para a célula. Assim, efectuaram-se ensaios de conjugação e estudos de 
fitness, tendo sido concluído que a presença de maior número de ilhas não implicava 
um aumento directo no custo biológico da aquisição do plasmídeo de resistência, 
pelo menos em estirpes com três ou menos PAIs.  
A participação num estudo internacional com estirpes de E. coli isoladas na 
Nigéria permitiu comparar as características destes isolados com os isolados 
portugueses. Apesar de se terem observado diferenças regionais, o clone ST131, 
plasmídeo IncF e o gene blaCTX-M-15 foram comuns nestes dois paises, suportando o 
facto que este clone, e os respectivos determinantes de resistência, se encontrarem 
disseminados mundialmente.  
O mesmo clone ST131, contendo os determinantes de resistência blaCTX-M-15, 
blaTEM-type, qnrS e aac(6’)-lb-cr; plasmídeos IncF e IncP, e os factores de virulência 
PAI IV536, PAI ICFT073, PAI IICFT073, iutA, sfa/foc e papAH foi detectado no efluente de 
uma Estação de Tratamento de Águas Residuais (ETAR) hospitalar, demonstrando-
se que as ETARs podem estar a contribuir para a disseminação de bactérias 
resistentes e virulentas para os ecossistemas naturais, constituindo assim, um risco 
para a saúde pública e ambiental.  
A relação entre resistência e virulência foi também estudada para estirpes de 
K. pneumoniae e K. oxytoca. Em K. pneumoniae, a PAI IV536 foi estatisticamente 
associada com a resistência à gentamicina e ao sulfametoxazole-trimetoprim (SXT). 
Neste estudo, a PAI IICFT073 foi descrita pela primeira vez em K. oxytoca, 
encontrando-se estatisticamente associada com a resistência à cefalotina, 
cefotaxima, ceftazidima, ciprofloxacina e gentamicina. Contrariamente ao observado 
em E. coli, não foi detectada uma relação inversa entre virulência e resistência. De 
facto, em K. pneumoniae, detectaram-se maiores prevalências de factores de 
virulência em isolados resistentes à ciprofloxacina e à gentamicina, e em menor 
escala à cefotaxima, e ao SXT. Além disso, também foi observado em K. oxytoca 
uma maior prevalência de genes de virulência em isolados resistentes ao SXT.  
Finalmente, foram estudados isolados de um surto de K. pneumoniae 
multiresistente numa unidade de transplantes renais. Investigaram-se os factores de 
virulência, determinantes de resistência e a relação clonal. Foram detectadas duas 
linhagens genéticas principais, o que permitiu excluir a hipótese da ocorrência de um 
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surto provocado por apenas um clone interno. Neste estudo, as ilhas PAI III536 e PAI 
IICFT073 foram detectadas, pela primeira vez, em K. pneumoniae.  
Assim, os resultados apresentados nesta tese indicaram que, apesar de se ter 
verificado uma relação inversa entre virulência e resistência em E. coli, o mesmo não 
se verificou na generalidade dos isolados do género Klebsiella. Apesar da relação 
inversa verificada em E. coli, o clone ST131, detectado neste estudo entre isolados 
portugueses e nigerianos, é um exemplo de como, nesta espécie, podem co-existir 
traços de virulência e resistência. A relação entre resistência e virulência parece 
assim ser influênciada pelo género e espécie, factor de virulência em causa e 
fenótipo e genótipo de resistência.  
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Thesis Outline 
With the increase of resistance among E. coli and K. pneumoniae, concernings about 
the possible emergence of strains simultaneously resistant and virulent start to 
emerge. The studies presented in this PhD dissertation are focused on the relation 
between resistance and virulence among these Enterobacteriaceae. 
Chapter 1 consists in a general introduction. 
Chapter 2 presents a new genotype in the Clermont method, used to identify 
the phylogenetic group of E. coli. 
Chapter 3 describes the relation between resistance and virulence among a 
collection of uropathogenic E. coli. 
Chapter 4 focuses on the genetic relatedness of CTX-M-15 producers among 
E. coli, and identifies a prevalent combination of virulence factors and resistance 
determinants in ST131 isolates. 
Chapter 5 presents the resistance phenotype and genotype of E. coli from a 
Nigerian collection of bovine and clinical isolates. 
Chapter 6 characterizes the virulence and resistance profile of E. coli from 
wastewater treatment plants. 
Chapter 7 describes the relation between virulence and resistance among K. 
pneumoniae and K. oxytoca from several clinical origins. 
Chapter 8 characterizes the virulence and resistance profile and clonal 
relatedness of K. pneumoniae isolates from an outbreak in a Renal Transplant Unit. 
Chapter 9 presents a general discussion of all the results from this study, as 
well as the main concluding remarks. 
Chapters 2, 4, 5, and 8 were published, chapter 6 has been accepted for 
publication and chapters 3 and 7 are submitted for publication.  
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Abbreviations 
bla β-Lactamase encoding gene 
CLSI Clinical and Laboratory Standards Institute 
DAEC Diffusely Adherent E. coli 
EAEC Enteroaggregative E. coli 
EHEC Enterohemorrhagic E. coli,  
EIEC Enteroinvasive E. coli 
EPEC Enteropathogenic E. coli  
ETEC Enterotoxigenic E. coli   
ESBL Extended-Spectrum β-Lactamase 
ExPEC Extraintestinal Pathogenic E. coli 
Is Insertion sequence 
ISCR Insertion Sequence Common Region 
MNEC Meningitis-associated E. coli 
MIC Minimal Inhibitory Concentration 
PCR Polymerase Chain Reaction 
PFGE Pulsed-Field Gel Electrophoresis 
PLA Pyogenic liver abscess 
PMQR Plasmid mediated quinolone resistance 
SEPE Sepsis-causing E. coli 
SXT Sulfamethoxazole- trimethoprim 
UPEC Uropathogenic E. coli 
UTI Urinary tract infection 

Table of Contents 
xv 
 
Table of Contents 
Acknowledgements .................................................................................................................................i 
Abstract ..................................................................................................................................................iii 
Resumo ................................................................................................................................................ vii 
Thesis Outline ....................................................................................................................................... xi 
Abbreviations...................................................................................................................................... xiii 
Table of Contents ................................................................................................................................ xv 
List of Tables ..................................................................................................................................... xvii 
List of Figures ..................................................................................................................................... xix 
 .................................................................................................................... 1 Chapter 1
1. Escherichia coli and Klebsiella spp. as human pathogens ...........................................................2 
1.1. Escherichia coli .............................................................................................................................2 
1.1.1. Escherichia coli clinical importance .......................................................................................3 
1.1.2. Uropathogenic Escherichia coli and urinary tract infections ..................................................3 
1.2. Klebsiella spp. ...............................................................................................................................4 
1.2.1. Klebsiella spp. clinical importance .........................................................................................5 
2. Antimicrobial resistance ....................................................................................................................6 
2.1. Resistance to beta-lactams ...........................................................................................................7 
2.1.1. Naturally occurring resistance ...............................................................................................8 
2.1.2. Extended spectrum β-lactamases ...................................................................................... 10 
2.2. Resistance to Quinolones .......................................................................................................... 13 
2.2.1. Target mediated Quinolone resistance............................................................................... 13 
2.2.2. Plasmid-mediated quinolone resistance (PMQR) .............................................................. 14 
2.3. Resistance to aminoglycosides .................................................................................................. 16 
2.4. Antimicrobial resistance dissemination ...................................................................................... 16 
2.4.1. Mechanisms of horizontal gene transfer ............................................................................ 17 
2.4.2. Plasmids and the dissemination of resistance ................................................................... 18 
3. Virulence characterization .............................................................................................................. 19 
3.1. Escherichia coli virulence factors ............................................................................................... 19 
3.1.1. Fimbriae and other adhesins .............................................................................................. 19 
3.1.2. Siderophore systems .......................................................................................................... 22 
3.1.3. Toxins ................................................................................................................................. 23 
Table of Contents 
xvi 
 
3.1.4. Group 2 capsules ................................................................................................................ 24 
3.1.5. Virulence factors associated with Shiga toxin-producing E. coli ......................................... 25 
3.1.6. Pathogenicity Islands .......................................................................................................... 26 
3.2. Klebsiella virulence factors ......................................................................................................... 30 
3.2.1. Adhesins ............................................................................................................................. 30 
3.2.2. Capsule ............................................................................................................................... 32 
3.2.3. Other virulence factors ........................................................................................................ 33 
4. Virulence versus resistance ........................................................................................................... 36 
4.1. Resistance to beta-lactams versus virulence ............................................................................. 36 
4.2. Resistance to quinolones versus virulence ................................................................................ 39 
4.2.1. Resistance to quinolones and phylogroups ........................................................................ 39 
4.2.2. Resistance to quinolones and virulence genes .................................................................. 40 
4.3. Resistance to sulfamethoxazole-trimethoprim and to aminoglycosides .................................... 44 
5. Objectives ......................................................................................................................................... 45 
 ................................................................................................................. 47 Chapter 2
 ................................................................................................................. 51 Chapter 3
 ................................................................................................................. 67 Chapter 4
 ................................................................................................................. 75 Chapter 5
 ................................................................................................................. 85 Chapter 6
 ................................................................................................................. 97 Chapter 7
 ............................................................................................................... 105 Chapter 8
 ............................................................................................................... 111 Chapter 9
1. General Discussion ....................................................................................................................... 112 
2. Concluding Remarks ..................................................................................................................... 119 
References ............................................................................................................ 121 
List of Tables 
xvii 
 
List of Tables 
Table 1.1 – Annual percentage (%) of antimicrobial resistance reported between 2003 and 2012 in 
Portugal for Escherichia coli and Klebsiella pneumoniae. ....................................................6 
Table 1.2 – Classification schemes for β-lactamases. .............................................................................9 
Table 1.3 – Main groups of CTX-M enzymes according to amino acid sequences and corresponding 
elements. ........................................................................................................................... 12 
Table 1.4 – Members of the family of Dr adhesins. ............................................................................... 22 
Table 1.5 – General features of the main Uropathogenic Escherichia coli Pathogenicity islands. ....... 28 
Table 3.1 – Prevalence of Pathogenicity Islands, virulence genes and plasmid groups in the different 
phylogroups. ...................................................................................................................... 57 
Table 3.2 – Distribution of phylogroups, PAIs and virulence genes among susceptible and resistant 
strains. ............................................................................................................................... 60 
Table 3.3 – Distribution of isolates according to the number of PAIs and number of identified plasmids.
 ........................................................................................................................................... 62 
Table 5.1 – Antibiotic susceptibility pattern of the human and bovine E. coli isolates. ......................... 79 
Table 5.2 – Origin, antimicrobial resistance pattern, and genetic characteristics of human and bovine 
E. coli isolates. ................................................................................................................... 81 
Table 6.1 – Distribution of strains and characterization of phylogeny, virulence and resistance 
determinants and plasmid incompatibility groups. ............................................................. 92 
Table 7.1 – Distribution of virulence genes among Klebsiella pneumoniae according to the 
antimicrobial susceptibility profile. ................................................................................... 101 
Table 7.2 – Distribution of virulence genes in Klebsiella oxytoca according to the antimicrobial 
susceptibility profile. ......................................................................................................... 102 
Table 8.1 – Antimicrobial resistance and virulence determinants of the main genetic clusters. ......... 110 
 

List of Figures 
xix 
 
List of Figures 
Figure 1.1 – General mechanisms of antimicrobial resistance. ...............................................................7 
Figure 1.2 – Global distribution of CTX-M enzymes. ............................................................................ 13 
Figure 1.3 – Global dissemination net of antimicrobial resistance. ....................................................... 17 
Figure 2.1 – Triplex PCR profiles specific for E. coli phylogenetic groups.. ......................................... 49 
Figure 4.1 – Clonal relatedness of strains and characterization of phylogeny, virulence and resistance 
determinants, and plasmid incompatibility groups. ............................................................ 72 
Figure 8.1 – Dendrogram based on the band-based coefficient of similarity of PFGE profiles. ......... 108 
 
 
 

  Chapter 1
General Introduction 
  
Chapter 1 
2 
 
1. Escherichia coli and Klebsiella spp. as human 
pathogens 
Escherichia coli and Klebsiella species are important human pathogens, responsible 
for a growing number of nosocomial and community infections. Nowadays, the 
growing resistance among these pathogens is considered a concerning threat to 
public health. It is responsible not only for the failure of empirical treatment, delaying 
the administration of the adequate antimicrobial treatment, but also to the reduction 
of therapeutic options leading to higher morbidity and mortality rates.  
It is therefore important to understand if more resistant bacteria from these 
species, may also be simultaneously more virulent. This will allow the better 
acknowledging of the real danger that these bacteria may constitute to public health 
and to the environment. 
1.1. Escherichia coli 
Escherichia coli is the most common Gram-negative, non-sporulating facultative 
anaerobe in the human intestinal tract (Dworkin et al., 2006b).  
This member of Enterobacteriaceae family generally inhabits the terminal part 
of the small intestine, as well as the large intestine of mammals. The presence of this 
bacilli in the environment is attributed to fecal contamination, rather than to 
presenting the capacity to replicate outside of the intestine (Dworkin et al., 2006b). 
Nonetheless it has been suggested that E. coli is capable of replicating in tropical 
fresh water (Bermúdez & Hazen, 1988).  
E. coli was firstly identified by Theodore Escherich in 1886, in the feces of a 
child (Escherich, 1886) and designated Bacterium coli commune (common colon 
bacterium). Afterwards, Alphonse Lesage inferred that this species was composed by 
innocuous elements, as well as strains with variable pathogenic potential (Lesage, 
1897). It is known that commensal E. coli are part of the normal intestinal flora, while 
other E. coli strains developed their pathogenic potential, becoming capable of 
causing disease in humans and animals (Clements, Young, Constantinou, & Frankel, 
2012).   
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1.1.1. Escherichia coli clinical importance 
E. coli pathogenic strains can cause enteric or extraintestinal infections in humans. 
Enteric infections are generally divided in six pathotypes: Enterohemorrhagic E. coli 
(EHEC), Enteroaggregative E. coli (EAEC) Enteropathogenic E. coli (EPEC), 
Enteroinvasive E. coli (EIEC, including Shigella sp), Diffusely Adherent E. coli 
(DAEC) and Enterotoxigenic E. coli (ETEC). This classification is based in their 
pathogenicity characteristics including virulence factors, phylogenetic background 
and clinical pathology (Kaper, Nataro, & Mobley, 2004). Furthermore, E. coli strains 
responsible for infections outside of the gastrointestinal tracts, including 
uropathogenic strains isolated from the urinary tract (UPEC), sepsis-causing E. coli 
(SEPEC), as well as meningitis-associated E. coli (MNEC) have been grouped as 
extraintestinal pathogenic E. coli (ExPEC) (Johnson & Russo, 2002b; Russo & 
Johnson, 2000). ExPEC are the most common cause of urinary tract infections (UTI), 
sepsis, community-acquired bacteremia, neonatal sepsis and neonatal meningitis. 
They can also be pathogenic agents in nosocomial pneumonia, intra-abdominal 
infections, and less frequently, can be implicated in other infections such as cellulitis, 
wound infections and osteomyelitis (Johnson & Russo, 2002a). 
E. coli strains are classically classified into four main phylogenetic groups (A, 
B1, B2, and D). This classification scheme is based in the simple and rapid detection 
of two genes (chuA and yjaA) and a DNA fragment TspE4C2 (Clermont, Bonacorsi, & 
Bingen, 2000). According to this classification, virulent extra-intestinal strains belong 
mainly to group B2 and, to a lesser extent, to group D, while the majority of 
commensal strains belong to group A.  
1.1.2. Uropathogenic Escherichia coli and urinary tract infections 
UPEC are the most frequent pathotype of ExPEC. They are a heterogeneous group 
of clones responsible for urinary tract infections (UTIs). UPEC are responsible for 70-
90% of community UTIs, as well as 50% of nosocomial urinary infections (Kucheria, 
Dasgupta, Sacks, Khan, & Sheerin, 2005). It has been estimated that, more than 
50% of women will experience an UTI during their lifetime, 25% will be affected for a 
second urinary infection and, in addition, 3% will suffer a third UTI during the next six 
months after the primo-infection (Smith, Fratamico, & Gunther, 2007). 
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According to the site of infection, UTIs may be classified as cystitis (bladder), 
prostatitis (prostate), pyelonephritis (kidney), or asymptomatic bacteriuria (urine). 
While in immunocompetent individuals, cystitis is generally resolved without further 
problems, pyelonephritis cases can be responsible for increased morbidity and can 
be fatal. In addition, some persons may present asymptomatic bacteriuria, 
characterized by high concentrations of bacteria in the urine, without having any 
clinical symptoms (Smith et al., 2007). 
Several factors that may predispose to the development of UTIs have been 
identified. These include: age (infants and elderly); pregnancy; diabetes; multiple 
sclerosis; persons with spinal cord damages; urinary catheters; HIV infection and 
abnormal urologic apparatus (Foxman, 2002). 
E. coli infections affecting the urinary tract are thought to begin with an UPEC 
strain harboring several virulence factors colonizing the bowel, and further 
contaminating the periurethral space. Afterwards, the bacteria ascend throughout the 
urinary apparatus, up to the urethra and posteriorly to the bladder, using flagella. 
Once in the bladder, UPEC uses a set of adhesins for colonization, toxins to escape 
from the host innate immune system, and iron acquisition mechanisms to promote 
growth. Afterwards, some E. coli can detach and ascend to the kidneys, causing 
pyelonephritis  (Bien, Sokolova, & Bozko, 2012).  
1.2. Klebsiella spp. 
Klebsiella genus belongs to Enterobacteriaceae family, and is composed by gram-
negative rod-shaped bacteria, generally encapsulated, lysine decarboxylase but not 
ornithine decarboxylase producers, and commonly positive in the Voges-Proskauer 
test (Dworkin et al., 2006a).  
Klebsiella spp. are ubiquitous in the environment, and are often detected in a 
variety of environmental sources including water, soil, vegetation and sewage 
(Podschun & Ullmann, 1998). In addition, Klebsiella spp. have also been detected in 
insects (Dillon, Vennard, & Charnley, 2002) and several mammals (Gordon & 
FitzGibbon, 1999). In humans, Klebsiella spp. may be a commensal colonizing the 
nasopharynx and gastrointestinal tract, or may act as an opportunistic human 
pathogen (Podschun & Ullmann, 1998).  
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1.2.1. Klebsiella spp. clinical importance 
 K. pneumoniae is the most relevant pathogen within genus Klebsiella, being 
responsible for 75% to 86% of Klebsiella spp infections. Additionally, K. oxytoca is 
the second most prevalent Klebsiella species, being responsible for 13% to 25% of 
infections (Broberg, Palacios, & Miller, 2014).  
   Klebsiella spp., as human pathogens, may be responsible for both community 
and nosocomial infections. In the community set, K. pneumoniae is associated to 
several infections. It is responsible for Friedländers pneumoniae, a community-
acquired pulmonary infection, which affects chronic alcoholics, and whose incidence 
has been decreasing over the years (Carpenter, 1990; Dworkin et al., 2006a). 
Additionally, three new severe clinical syndromes have been emerging in Asia. First 
of all, community-acquired primary pyogenic liver abscess (PLA), a K. pneumoniae 
infection that as emerged in the past 20 years and may or may not be associated to 
septic metastatic complications (Keynan & Rubinstein, 2007). The majorities of PLA 
cases are generally associated with K1 serotype and have been detected mainly in 
Taiwan (Chuang, Fang, Lai, Chang, & Wang, 2006).  Another clinical manifestation is 
K. pneumoniae endophtalmitis, which may be a secondary complication of PLA and 
is similarly mainly detected in Asia (Connell, Thomas, Sabharwal, & Gelbard, 2007; 
Liu, Cheng, & Lin, 1986). Finally, in Taiwan, K. pneumoniae is also responsible for 
community-acquired bacterial meningitis in adults, without having connection to 
infections in other body locations (Keynan & Rubinstein, 2007; Tang, Chen, Hsu, & 
Chen, 1997).  
Considering nosocomial infections, Klebsiellae are considered important 
opportunistic pathogenic agents, being responsible for infections mainly located in 
the urinary and respiratory tracts, but which may also affect soft tissues and wounds 
and  cause septicemia (Dworkin et al., 2006a). Several host characteristics such as 
diabetes mellitus, extremes of age, renal, cardiac or pulmonary chronic diseases, as 
well as oncologic problems, may predispose to Klebsiella spp. infections (Feldman et 
al., 1990; Hansen, Gottschau, & Kolmos, 1998).  
In the hospital setting, Klebsiella spp. colonization rates increase in a direct 
proportion to the duration of the hospitalization, and also seem to be associated with 
antibiotic therapy (Podschun & Ullmann, 1998). 
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2. Antimicrobial resistance 
Bacteria can present different resistance phenotypes, in which multidrug resistant is 
defined if bacteria present resistance to at least one agent in three or more 
antimicrobial categories (Magiorakos et al., 2012). Thus, considering the progressive 
risk of occurrence of untreatable infections due to multidrug resistant bacteria, 
antimicrobial resistance has become a central problem worldwide. 
Multidrug resistance in Gram-negative bacteria, particularly 
Enterobacteriaceae such as E. coli and K. pneumoniae, has become one of the 
biggest global concerns. Infections with these bacteria lead to prolonged hospital 
admissions and higher mortality rates (Munoz-Price et al., 2013). 
In Portugal, increasing rates of resistance to important antibiotics such as beta-
lactams, fluoroquinolones and aminoglycosides have been reported for both E. coli 
and K. pneumoniae. Data on resistance reported by the European Antimicrobial 
Resistance Surveillance System (EARSS) for these microorganisms in Portugal 
between 2003 and 2012 are shown in Table 1.1 (EARSS, 2013).    
Table 1.1 – Annual percentage (%) of antimicrobial resistance reported between 2003 and 2012 in 
Portugal for Escherichia coli and Klebsiella pneumoniae (adapted from EARSS 2013). 
 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
E. coli           
Aminopenicillins 53 58 58 59 59 58 58 56 57 59 
Third generation 
Cephalosporins 7 8 12 10 10 10 9 10 11 14 
Fluoroquinolones 26 27 29 28 30 29 28 27 27 30 
Amynoglycosides 9 13 12 12 12 14 11 12 16 16 
K. pneumoniae           
Third generation 
Cephalosporins - - - 21 17 26 28 28 35 39 
Fluoroquinolones - - <1 20 18 22 28 31 36 36 
Amynoglycosides - - <1 13 11 19 20 27 32 32 
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In general, resistance mechanisms are mainly due to increased efflux of the 
antibiotic, decreased wall penetration, target modification, or enzymatic alteration or 
inactivation of the antimicrobial agent (Figure 1.1). 
 
Figure 1.1 – General mechanisms of antimicrobial resistance. 
2.1. Resistance to beta-lactams 
Resistance   to   β-lactams may be a result of several mechanisms including 
modification of penicillin-binding  proteins,   loss  of  porins,  production  of  β-lactamases 
or overexpression of efflux pumps (Talbot, 2013). Nonetheless, in Gram-negative 
bacteria, β-lactams resistance is mainly due to the hydrolytic  action  of  β-lactamases. 
These enzymes inactivate beta-lactam antibiotics by hydrolyzing the peptide bond of 
the four-membered beta-lactam ring (Majiduddin, Materon, & Palzkill, 2002). 
Classification   of   β-lactamases has been conventionally made using two 
different approaches, one based on the primary structure of the enzymes (Ambler, 
1980) an other on their functional characteristics (Bush, Jacoby, & Medeiros, 1995; 
Richmond & Sykes, 1973).  
The  Ambler   scheme  classifies  β-lactamases into four major classes (A to D) 
according to their protein homology, not considering their phenotypic characteristics. 
DECREASED PENETRATION
ENZYMATIC INACTIVATION OR MODIFICATION
INCREASED EFFLUX
TARGET MODIFICATION
ANTIBIOTIC
ENZYME
EFFLUX PUMP
DRUG TARGET
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In   this   scheme,   β-lactamases from classes   A,   C,   and   D   are   serine   β-lactamases, 
while the class B enzymes are metallo- β-lactamases (Paterson & Bonomo, 2005). 
The functional classification is based in functional similarities such as substrate 
and inhibitor profile. Recently an updated functional classification scheme was 
published by Bush and Jacoby (Bush & Jacoby, 2010). The main classification 
schemes   for   β-lactamases and the new updated classification are represented in 
Table 1.2. 
Four  major  groups  of  β-lactamases can be identified considering the substrate 
characteristics: penicillinases, AmpC-type cephalosporinases, Extended-Spectrum  β-
lactamases (ESBLs) and carbapenemases, with ESBLs being the largest group 
(Bush, 2010). 
2.1.1. Naturally occurring resistance 
Several gram-negative bacteria have an intrinsic chromosomally mediated β-
lactamase (Bush & Fisher, 2011). E. coli naturally present insignificant levels of a 
non-inducible chromosomal AmpC β-lactamase. Due to its limited capacity, this 
AmpC is only responsible for resistance to agents which have a poor capacity of 
penetration like isoxazolyl penicillins and benzylpenicillin, and to cefsulodin. E. coli 
carrying only this non-inducible AmpC are characteristically susceptible to ampicillin 
and the narrow-spectrum cephalosporins, including cephalothin and cephalexin 
(Livermore, 1995).  
Klebsiella spp. also presents one chromosomal intrinsic gene belonging to the 
blaSHV, blaOKP or blaLEN family in K. pneumoniae, and blaOXY in K. oxytoca. Among K. 
pneumoniae, these β-lactamases confer natural resistance to ampicillin and 
amoxicillin (aminopenicillins); carbenicillin and ticarcillin (carboxypenicillins) and other 
penicillins, but are unable to confer resistance to the majority   of   the   remaining   β-
lactam antibiotics (Dworkin et al., 2006a).  
Despite of the occurrence of these chromosomally encoded β-lactamases 
among E. coli and K. pneumoniae,  the  transferable  β-lactamases including plasmidic 
ESBLs are of much more concern, and constitute a major threat in antimicrobial 
resistance. 
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Table 1.2 – Classification schemes for β-lactamases, adapted from Bush and Jacoby 2010. 
 
Bush-
Jacoby 
group 
(2009) 
 
Molecular 
class 
(subclass) 
 
Distinctive 
substrate(s) 
 
Inhibited by 
 
 
Defining characteristic(s) 
 
Representative 
enzyme(s) 
CA or 
TZB 
EDT
A 
1 C Cephalosporins 
 
No No Greater hydrolysis of cephalosporins 
than benzylpenicillin; hydrolyzes 
cephamycins 
E. coli AmpC, 
P99, ACT-1, 
CMY-2, FOX-1, 
MIR-1 
1e C Cephalosporins 
 
No No Increased hydrolysis of ceftazidime and 
often other oxyimino-β- lactams 
GC1, CMY-37 
2a A Penicillins Yes No Greater hydrolysis of benzylpenicillin 
than cephalosporins 
PC1 
2b A Penicillins, 
early 
cephalosporins 
Yes No Similar hydrolysis of benzylpenicillin and 
cephalosporins 
TEM-1, TEM-2, 
SHV-1 
2be A Extended-
spectrum 
cephalosporins, 
monobactams 
Yes No Increased hydrolysis of oxyimino-β- 
lactams (cefotaxime, ceftazidime, 
ceftriaxone, cefepime, aztreonam) 
TEM-3, SHV-2, 
CTX-M-15, PER-
1, VEB-1 
2br A Penicillins No No Resistance to clavulanic acid, sulbactam, 
and tazobactam 
TEM-30, SHV-10 
2ber A Extended-
spectrum 
cephalosporins, 
monobactams 
No No Increased hydrolysis of oxyimino-β- 
lactams combined with resistance to 
clavulanic acid, sulbactam, and 
tazobactam 
TEM-50 
2c A Carbenicillin Yes No Increased hydrolysis of carbenicillin PSE-1, CARB-3 
2ce A Carbenicillin, 
cefepime 
Yes No Increased hydrolysis of carbenicillin, 
cefepime, and cefpirome 
RTG-4 
2d D Cloxacillin Variable No Increased hydrolysis of cloxacillin or 
oxacillin 
OXA-1, OXA-10 
2de D Extended-
spectrum 
cephalosporins 
Variable No Hydrolyzes cloxacillin or oxacillin 
and oxyimino-β-lactams 
OXA-11, OXA-15 
2df D Carbapenems Variable No Hydrolyzes cloxacillin or oxacillin 
and carbapenems 
OXA-23, OXA-48 
2e A Extended-
spectrum 
cephalosporins 
Yes No Hydrolyzes cephalosporins. 
Inhibited by clavulanic acid but 
not aztreonam 
CepA 
2f A Carbapenems Variable No Increased hydrolysis of 
carbapenems, oxyimino-β- lactams, 
cephamycins 
KPC-2, IMI-1, 
SME-1 
3a B (B1) Carbapenems No Yes Broad-spectrum hydrolysis including 
carbapenems but not monobactams 
IMP-1, VIM-1, 
CcrA, IND-1 
 B (B3)     L1, CAU-1, GOB- 
1, FEZ-1 
3b B (B2) Carbapenems No Yes Preferential hydrolysis of carbapenems CphA, Sfh-1 
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2.1.2. Extended spectrum β-lactamases 
The  designation  ESBL  was  used   to   define  β-lactamases with a broad spectrum of 
hydrolysis, resulting from the occurrence of amino acid substitutions in the structure 
of the enzymes (Livermore, 2008).  ESBLs  belong  to  Class  A  according   to  Ambler’s  
classification, and  group  2be  functional  group  of  Bush’s  classification   (Ambler et al., 
1991; Bush & Jacoby, 2010). These  β-lactamases are active against broad-spectrum 
cephalosporins (such as ceftazidime, cefotaxime and ceftriaxone) but are inhibited by 
β-lactamases inhibitors like tazobactam, sulbactam and clavulanic acid (Poirel, 
Bonnin, & Nordmann, 2012).  
The majority of the ESBLs detected among Enterobacteriaceae belong to 
three main families: TEM, SHV and CTX-M. 
2.1.2.1. TEM  β-lactamases 
The  TEM   (for  Temoneira   patient’s   name)  β-lactamase family is composed of more 
than 219 variants according to the database of the Lahey Clinic 
(http://lahey.org/studies/temtable.asp last access on 22 of September 2014). 
The first enzyme of this family described, the native TEM-1   β-lactamase is 
capable of hydrolyzing ampicillin at a greater rate than carbenicillin, oxacillin, or 
cephalothin, and has insignificant activity against extended-spectrum cephalosporins. 
In addition, it is inhibited by clavulanic acid. TEM-2, was the first variant identified, but 
it is not considered an ESBL as the hydrolitic profile is identical to TEM-1. Besides an 
amino acid substitution (Q39K), TEM-2 differs from TEM-1 because it presents a 
more active promoter and has a different isoelectric point (Paterson & Bonomo, 
2005). 
The TEM-type ESBLs are derivates of TEM-1 and TEM-2. Amino acid 
substitutions acting alone or with additional other structural gene mutations, have 
been detected in over than 90 described TEM-1-or TEM-2-derived enzymes, 
according to internet site of the Lahey Clinic. Each TEM-derived slightly differs in the 
hydrolytic profile, and therefore one ESBL may hydrolyze a specific extended-
spectrum cephalosporin in a more efficient way than another ESBL (Rupp and Fey 
2003). 
The most disseminated TEM-type ESBLs among Enterobacteriaceae in  
Europe in the clinical setting are TEM-24, TEM-4 and TEM-52, while in isolates from 
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animals TEM-52, TEM-106 and TEM-116 are the most common (Coque, Baquero, & 
Cantón, 2008a). 
2.1.2.2. SHV  β-lactamases 
The SHV (for Sulfhydryl reagent Variable) β-lactamase family comprises 185 variants 
according to the internet site of the Lahey Clinic.  
The native SHV-1 β-lactamase is an enzyme which may be chromosomally or 
plasmid encoded, and is responsible for resistance to penicillins (Livermore, 1995).  
SHV-type ESBLs are point mutants of both narrow-spectrum   β-lactamases 
SHV-1 or SHV-11 that had origin in the K. pneumoniae chromosome (Poirel et al., 
2012). The hydrolytic spectrum of SHV-type ESBLs includes activity against 
oxyimino-β- lactams such as cefotaxime, ceftazidime, ceftriaxone and aztreonam 
(Bush & Jacoby, 2010).  
According to internet site of the Lahey Clinic, more than 45 SHV-type ESBLs 
have been described so far. In Europe, SHV-5 is widespread in the clinical setting, 
while SHV-12 has been reported in both human and animal strains (Coque et al., 
2008a). 
2.1.2.3. CTX-M  β-lactamases 
CTX-M-type (for Cefotaximase firstly identified in Munich) β-lactamases are a family 
of ESBLs which comprise 157 elements, according to the internet site of the Lahey 
Clinic.  
These β-lactamases confer resistance to penicillins and expanded-spectrum 
cephalosporins, and the majority of the variants present higher  rates of hydrolysis to 
cefotaxime than to ceftazidime (Bonnet, 2004). Nonetheless, some of these 
enzymes, including CTX-M-15, -16,- 25, -27, -28, -29 and- 32 have an Asp240Gly 
substitution which enhances  the catalytic activity against ceftazidime (Woodford & 
Ellington, 2007).  
CTX-M enzymes are also susceptible to clavulanate and tazobactam β-
lactamase  inhibitor combinations, with tazobactam presenting greater inhibitory 
activity compared to clavulanic acid (Bonnet, 2004). 
Chapter 1 
12 
 
The main CTX-M enzymes may be classified into five clusters according to the 
amino acid sequences (Bonnet, 2004). Table 1.3 presents the five main groups and 
corresponding enzymes (Poirel et al., 2012). 
Table 1.3 – Main groups of CTX-M enzymes according to amino acid sequences and corresponding 
elements. 
CTX-M group Enzymes 
CTX-M-1 CTX-M-1,3,10,11, 12, 15, 22, 23, 28-30, 32-34, 36, 37, 42, 52-54, 57, 58, 60,61 
CTX-M-2 CTX-M-2, 4-7, 20, 31, 35, 43, 44 
CTX-M-8 CTX-M-8, 40, 63 
CTX-M-9 CTX-M-9, 13, 14, 16, 17-19, 21, 24, 27, 38, 46-51, 55, 65 
CTX-M-25 CTX-M-25, 26, 39, 41 
 
The blaCTX-M genes had origin from the chromossome of different Kluyvera 
species. Kluyvera georgiana is though to be the progenitor of blaCTX-M-8-like and blaCTX-
M-9-like genes, while Kluyvera ascorbata and Kluyvera cryocrescens the progenitors of  
blaCTX-M-1-like and blaCTX-M-2- like genes respectively (Bonnet 2004). 
The dissemination of blaCTX-M genes is now a global concern, as they are 
worldwide disseminated in both nosocomial and community-aquired pathogens 
(Hawkey & Jones, 2009; Poirel et al., 2012). The main CTX-M-types identified 
worldwide are represented in Figure 1.2.  
The  epidemiology of CTX-M β-lactamases is associated to plasmid 
dissemination on one hand, and clonal success on the other. The most prevalent 
enzyme, CTX-M-15, is mainly carried by IncF conjugative plasmids (Carattoli, 2009). 
In K. pneumoniae, these plasmids are associated with diverse strains, none of them 
being a wide case of success (Livermore, 2012). Contrarily, in E. coli, IncF plasmids 
carrying blaCTX-M-15 are strongly associated with sequence type (ST)131 (Livermore, 
2012). This is a highly successful clone, which is, nowadays, worldwide disseminated 
and, also, the predominant E. coli lineage among ExPEC (Nicolas-Chanoine, 
Bertrand, & Madec, 2014).  
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Figure 1.2 – Global distribution of CTX-M enzymes (adapted from Hawkey & Jones, 2009). 
2.2. Resistance to Quinolones 
The main and most clinically relevant mechanism of resistance to quinolones is 
specific amino acid substitutions in the quinolones targets. In addition, other 
chromosomal mechanisms including under expression of porins or overexpression of 
efflux pumps have also been described (Aldred, Kerns, & Osheroff, 2014). Several 
transferable plasmid-mediated mechanisms can also occur, being responsible for 
different levels of resistance.   
2.2.1. Target mediated Quinolone resistance 
The main mechanism leading to high-levels of fluoroquinolone resistance is the 
acquisition of mutations, in one or more genes, that encode the targets of these 
antibiotics, the type II topoisomerases (Redgrave, Sutton, Webber, & Piddock, 2014). 
The target genes are DNA gyrase subunits gyrA and gyrB, and DNA topoisomerase 
IV subunits parC and parE. The region in which the mutations occur, is a small DNA 
sequence denominated quinolone resistance determining region (QRDR) (Piddock, 
1999). Mutations in this region, lead to amino acid substitutions, and consequent 
changes of the target protein structure. This alters the fluoroquinolone-binding affinity 
of the enzyme and causes resistance (Piddock, 1999). The most common mutation in 
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Gram-negatives involves a substitution at a serine 83 within the gyrA (Redgrave et 
al., 2014). Alterations in the primary target site may be further followed by secondary 
mutations in lower affinity binding sites. In fact, highly resistant Gram-negative 
bacteria characteristically carry a combination of mutations within gyrA and parC 
genes (Everett, Jin, Ricci, & Piddock, 1996).     
2.2.2. Plasmid-mediated quinolone resistance (PMQR) 
The PMQR mechanisms include proteins that avoid quinolone-enzyme interaction 
(Qnr), increase antibiotic efflux by efflux pumps (QepA or OqxAB) or enzymes that 
alter  the  drug  [AAC  (6’)-lb-cr]. Nonetheless, these mechanisms only slightly increase 
the minimum inhibitory concentration (MIC) of quinolones (Ruiz, Pons, & Gomes, 
2012).   
2.2.2.1. QNR proteins 
Qnr proteins are encoded by the qnr genes and belong to the pentapeptide repeat 
protein family (Aldred et al., 2014). These proteins interact with DNA gyrase and 
topoisomerase IV, physically preventing the interaction between the antibiotic and the 
target enzymes. This lack of contact avoids the action of quinolones, and 
consequently reduces their inhibitory effect (Ruiz et al., 2012). 
Qnr proteins are grouped in five main families according to their DNA 
homology, each of them composed of one or more alleles: QnrA (seven alleles), 
QnrB (48 alleles); QnrS (six alleles), QnrC (one allele) and QnrD (one allele) (Ruiz et 
al., 2012).  
The qnr genes commonly confer modest protection against fluoroquinolones. 
The transfer of the original qnrA plasmid into a receptor increased in the MIC of 
ciprofloxacin from 0.008µg/ml to 0.25 µg/ml (Martínez-Martínez, Pascual, & Jacoby, 
1998). Plasmids carrying qnrS or qnrB genes also confer levels of quinolone 
resistance similar to the ones conferred by qnrA1 (Strahilevitz, Jacoby, Hooper, & 
Robicsek, 2009). 
2.2.2.2. AAC  (6’)-lb-cr 
AAC  (6’)-lb-cr is a variant of an aminoglycoside acetyltransferase which confers low 
levels of resistance to quinolones, and maintains its ability to inactivate 
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aminoglycosides. It acts by acetylating the amino nitrogen on the piperazinyl 
substituent in ciprofloxacin and norfloxacin, not affecting other quinolones that lack 
non-substituted piperazinyl nitrogen. This enzyme increases the MICs of ciprofloxacin 
and norfloxacin in approximately three to fourfold (Robicsek et al., 2006b). 
This variant contains two specific point mutations, D179Y which seems to be 
responsible for increasing the affinity of this enzyme for fluoroquinolones, and 
W102R which is thought to play a role in stabilizing the interactions, or in interacting 
with the fluoroquinolone carboxylate (Maurice et al., 2008; Ruiz et al., 2012). 
AAC-(6’)-lb-cr, which is either carried by plasmids or chromosomally encoded, 
has a huge dissemination potential. lt has been described worldwide, including in 
strains from farm animals and environmental bacteria (Ruiz et al., 2012).  
2.2.2.3. Efflux pumps 
There are different families of efflux pumps with the capacity to pump out quinolones. 
They present different affinities and affect the MICs in different manners.  Three 
quinolones efflux pumps have been described so far, QepA1, QepA2 and OqxAB. 
Nonetheless, while QepA efflux pumps have been found mainly in human infections, 
OqxAB is almost exclusively detected in animal infections (Aldred et al., 2014).  
 The qepA1 gene encodes a proton-dependent efflux pump. The substrates  for 
this pump are hydrophilic quinolones such as ciprofloxacin and norfloxacin,  
nonetheless,  it has reduced or no effect on more hydrophobic quinolones including 
nalidixic acid, levofloxacin or  moxifloxacin (Ruiz et al., 2012).  It increases the MICs 
of nalidixic acid, ciprofloxacin and norfloxacin in 2-, 32- and 64- fold, respectively 
(Yamane et al., 2007).  
QepA2 is another QepA-like efflux pump which presents a spectrum of 
substrates similar to QepA1, and only differs from this pump in two of the 511 amino 
acids and in the genetic environment (Ruiz et al., 2012). 
Despite of the fact that QepA-like efflux pumps may act as a factor in favoring 
the development of full resistance either to ciprofloxacin or norfloxacin, the 
prevalence of these pumps seems to be very low, with reported frequencies between 
0.3- 0.8% (Ruiz et al., 2012). 
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2.3. Resistance to aminoglycosides 
Resistance to aminoglycosides may be mediated by different mechanisms: 
modification of the 16S RNA of bacterial 30S ribosomal subunit by mutation or 
methylation of the aminoglycoside binding site; decrease of the intracellular 
concentration of the antibiotic resulting from the occurrence of modifications in the 
bacterial outer membrane; increase of the activity of active efflux systems; decrease 
of the drug transport into the cell; and by enzymatic deactivation of aminoglycosides 
(Houghton, Green, Chen, & Garneau-Tsodikova, 2010). 
The aminoglycosides modifying enzymes are N-acetyltransferases (AAC), 
which deactivate the aminoglycosides by N-acetylation in positions 3, 29, and 69; O-
phosphotransferases (APH) that modify the antibiotic in positions 39 and 20 by O-
phosphorylation; and O-nucleotidyltransferases (ANT) which cause aminoglycosides 
deactivation at positions 49 and 20 by O-nucleotidylation (Shakil, Khan, Zarrilli, & 
Khan, 2008). 
2.4. Antimicrobial resistance dissemination  
Antimicrobial resistance dissemination has been associated to the elevated use of 
antimicrobial agents in both human and veterinary medicine, agriculture, higher 
movement of people and increased industrialization (Figure 1.3) (Cantas et al., 
2013).  
In addition, wastewater treatment plants (WWTPs) are important reservoirs of 
antimicrobial resistant bacteria and resistance genes (Figure 1.3), as they contain 
wastewaters from human and animal origins. The concomitant presence of 
commensal and pathogenic resistant bacteria,  with antibiotics which are not fully 
degraded in the untreated waters, may favor and select these microorganisms 
(Cantas et al., 2013). Although the wastewater treatment reduces the concentration 
of resistant bacteria, treated water still contains antimicrobial resistant bacteria and 
this may therefore contribute to the selection and further dissemination of multidrug 
resistant microorganisms (Czekalski, Berthold, Caucci, Egli, & Bürgmann, 2012).  
The interaction between bacteria from different backgrounds, may contribute to 
the dissemination of different resistance traits by horizontal gene transfer, thus 
contributing to the aggravation of this worldwide concern. 
Chapter 1 
17 
 
 
Figure 1.3 – Global dissemination net of antimicrobial resistance (adapted from Cantas, Shah et al. 
2013). 
2.4.1. Mechanisms of horizontal gene transfer 
Horizontal gene transfer is the stable unidirectional transfer of genetic material from 
one organism (donor) into another (receptor) without reproduction (Syvanen, 1994). It 
is driven by three main mechanisms: bacterial transformation, bacterial transduction 
and bacterial conjugation. 
Natural transformation consists in the uptake of foreign extracellular DNA 
which may be released from living cells by excretion, or from decomposing or 
disrupted cells or viral particles; its integration and functional expression under 
natural bacterial growth conditions. It requires that naturally transformable bacteria 
develop a genetically programmed physiological state of competence, which is 
achieved as a response to specific environmental conditions, including starvation and 
changes in the nutrient access, growth conditions or cell density (Thomas & Nielsen, 
2005). After the uptake, the DNA can be integrated in the bacterial genome by 
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homologous recombination, homology-facilitated illegitimate recombination, or may 
form an autonomous self- replicating element (de Vries & Wackernagel, 2002). 
Transduction is another mechanism contributing to antibiotic resistance gene 
transfer. It occurs when a bacteriophage that has previously infected and replicated 
in another bacteria (donor), packages a part of the host genome into the phage head, 
and further transfers the genes to another bacteria (recipient) (Huddleston, 2014).  
Finally, conjugation is the process by which a DNA molecule is transferred 
from a donor to a recipient, mediated by cell-to-cell junctions and a pore through 
which DNA can pass (Thomas & Nielsen, 2005). This gene transfer mechanism 
involves cell-to-cell contact, mating pair formation, and finally transfer of plasmid DNA 
through a conjugative pilus (Huddleston, 2014).  
Some plasmids are conjugative as they harbor genes encoding the transfer 
machinery and thus are self-transmissible. On the other hand, other plasmids are 
non-conjugative, and thus, are only mobilized when a helper self-transmissible 
plasmid is present (Huddleston, 2014). 
2.4.2. Plasmids and the dissemination of resistance  
Plasmids constitute one of the most difficult issues to control, in order to avoid the 
spread of antimicrobial resistance, as these elements contribute to the dissemination 
of important resistance genes (Carattoli, 2013). They can acquire mobile genetic 
elements, including transposons and insertion sequences, which can lead to the 
mobilization of the antimicrobial resistance genes. Furthermore, they may promote 
the dissemination of these genes among bacteria from different species, genera or 
kingdoms, depending on their host range (Thomas & Nielsen, 2005).  
Plasmids may carry genes that can be responsible for conferring resistance to 
the   major   classes   of   antibiotics   including   β-lactams, quinolones, aminoglycosides, 
tetracyclines, sulfonamides, trimethoprim, macrolides and chloramphenicol (Carattoli, 
2009). In fact, regularly, multiple physically linked genetic determinants, conferring 
resistance to different classes of antibiotics, may be carried in the same plasmid. 
These plasmids may be responsible for the acquisition of a multidrug resistant 
phenotype, and thus,  may provide selective advantage to the bacteria which carries 
the plasmid (Carattoli, 2013).  
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Plasmid identification in Enterobacteriaceae, is standardly performed using 
PCR-based replicon typing, a method that targets the main families of replicons 
(Carattoli et al., 2005).  
In addition to the typical characterization of the resistance profile of bacteria, 
the necessity to characterize the bacterial virulence starts to emerge.  
3. Virulence characterization 
A better knowledge of the virulence factors carried by a strain may help to determine 
the real pathogenic potential of bacteria, and the possible evolution of an infectious 
disease. Strains that carry a great armory of virulence factors may be responsible for 
the development of serious health conditions in a short period of time.  
Several virulence factors have been described in bacteria. These include 
fimbriae and other adhesins, siderophore systems, toxins, capsule, pathogenicity 
islands and several putative virulence factors.  
3.1. Escherichia coli virulence factors 
3.1.1. Fimbriae and other adhesins 
In the pathogenesis of UTIs, the successful colonization of the urinary tract is a 
crucial step to the development of infection. The attachment to the host epithelium 
mediated by fimbriae and other adhesins, avoids that bacteria to be washed out 
during the urination process. Several adhesins have been described in UPEC. 
3.1.1.1. P fimbriae 
P fimbria was the first virulence factor of UPEC being described (Edén, Hanson, 
Jodal, Lindberg, & Akerlund, 1976). Edén and Hansson reported that E. coli involved 
in acute symptomatic pyelonephritis adhered more frequently to exfoliated 
uroepithelial cells, compared to E. coli from patients with asymptomatic bacteriuria. 
Later, the presence of fimbriae, was associated to the ability of UPEC to attach to 
human uroepithelial cells (Edén & Hansson, 1978). 
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P fimbria is encoded by the pap (pyelonephritis associated pili) operon, 
comprising 11 genes (Hull, Gill, Hsu, Minshew, & Falkow, 1981). It is considered an 
important virulence factors, being detected in more than 80% of pyelonephritogenic 
E. coli (Antão, Wieler, & Ewers, 2009). These adhesins are strongly associated with 
pyelonephritis, and are essential to adhesion to renal tissue, but are unnecessary for 
bladder colonization in cynomogus monkeys (Roberts et al., 1994). In addition, P pili 
have a significant role in initiating pyelonephritis in normal urinary tracts, but seem to 
be less important in the colonization of urinary tracts with obstructions or 
abnormalities (Tseng, Huang, Ko, Yan, & Wu, 2001). P- fimbriae are positively 
related to the severity of the infection (Spurbeck et al., 2011). These pili increase the 
severity of the UTI by allowing a strong attachment to the vascular endothelium as 
well as to the muscular layer and promoting weak adherence to bladder epithelium 
(Virkola et al., 1988).  It has also been proposed that P-fimbriae may enable UPEC to 
establish a reservoir in the intestine, allowing the UPEC persistence in the intestinal 
flora (Goetz et al., 1999). 
3.1.1.2. S and F1C fimbriae 
S fimbriae are a group of fimbriae discovered in pyelonephritogenic E. coli which 
have the capacity to recognize structures containing neuraminic acid (sialic acid), 
other than P antigens of human red blood cells or mannosides (Parkkinen, Finne, 
Achtman, Väisänen, & Korhonen, 1983).  
S pili are important adhesins and are frequently associated with E. coli causing 
meningitis, sepsis, ascending UTIs, including cystitis and pyelonephritis (Korhonen et 
al., 1985; Malagolini, Cavallone, Wu, & Serafini-Cessi, 2000; Parkkinen, Korhonen, 
Pere, Hacker, & Soinila, 1988). In fact, S fimbriae have been associated with several 
ExPEC strains, being present in 50% of UPEC, 24% of NMEC and 9.2% of APEC 
strains (Ewers et al., 2007). 
Other adhesins genetically homologous to S fimbriae have been described, 
including F1C; but despite of the genetic similarities, they exhibit differences in the 
receptors specificity (Ott, Hoschützky, Jann, Van Die, & Hacker, 1988).  The binding 
specificity of F1C pili allied with the fact that these structures are present in 
approximately 14% of UPEC, indicates that they may be important in the 
pathogenesis of UTI (Mulvey, 2002).  
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On E. coli Nissle 1917, a probiotic and colonizer of the human intestine, F1C 
fimbriae are necessary for biofilm formation on inert surfaces, adherence to epithelial 
cells, as well as persistence during the colonization of an infant mouse (Lasaro et al., 
2009).  
3.1.1.3. Dr/Afa Adhesins 
Vaisanen-Rhen firstly described a mannose– resistant P blood group- independent 
haemagglutinin, further named 075X, because it was detected in UPEC from 
serogroup 075 (Väisänen-Rhen, 1984). Later, 075X was termed Dr haemagglutinin 
(Nowicki, Moulds, Hull, & Hull, 1988). 
Dr adhesins are a family of adhesins from E. coli, which target the Dr blood 
group antigen (also known by decay-accelerating factor) as receptor (Nowicki et al., 
1988). This  antigen   is   present   in   the  Bowman’s   capsule  and   the   tubular   basement  
membrane of the kidney (Nowicki et al., 1988). Dr adhesin family elements, also have 
the capacity to bind to carcinoembryonic antigen (CD66e) (Guignot et al., 2000). 
Furthermore, Dr adhesin contrarily to other members of this family, can also bind to 
type IV collagen (Nowicki, Selvarangan, & Nowicki, 2001). 
The Dr family comprises fimbrial adhesins, such as Dr adhesins and F1845, as 
well as non-fimbrial adhesins, including AFA-I and AFA-III (Nowicki et al., 1990). The 
members of this family are referred in Table 1.4. 
Elements from Dr adhesins family are thought to have a role in the ascending 
colonization of the urinary tract, as well as in chronic interstitial infection (Mulvey, 
2002). In addition, E. coli expressing Dr fimbriae are able of causing tubulointerstitial 
nephritis and persist in the kidney tissue, thus contributing to recurrent UTIs 
(Goluszko et al., 1997a). 
The expression of Dr adhesins in E. coli causing infections in pregnant women 
may constitute a threat, because of the elevated invasive potential of these bacteria, 
associated to the up-regulation of the DAF receptor during pregnancy (Goluszko et 
al., 2001). 
Dr fimbriae also mediates cell invasion, which allows bacteria to hide in the 
intracellular space and, consequently, to escape from the humoral immune response 
(Das et al., 2005; Goluszko et al., 1997b). 
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Table 1.4 – Members of the family of Dr adhesins (adapted from Nowicki, Selvarangan at al. 2001). 
Adhesion factor Type Adhesin Disease 
Dr Fimbrial DraE Pyelonephritis and cystitis 
F1845 Fimbrial DaaE Diarrhea 
Afa-I Afimbrial AfaE1 Cystitis and diarrhea 
Afa-III Afimbrial AfaE3 Cystitis and diarrhea 
Dr-II Nonfimbrial DraE2 Gestational-pyelonephritis 
Nfa-Ia Nonfimbrial NfaA Cystitis 
Afa-V Afimbrial AfaE5 Diarrhea 
Afa-II Afimbrial AfaE2 Cystitis and diarrhea 
Afa-IV Afimbrial AfaE4 Cystitis and diarrhea 
Afa-VII Afimbrial AfaE7 Diarrhea 
Afa-VIII Afimbrial AfaE8 Septicemia 
Aaf-I Afimbrial AggA Diarrhea 
Aaf-II Afimbrial AafA Diarrhea 
 
3.1.2. Siderophore systems 
Iron is an essential element for bacterial growth. In E. coli, iron is required for several 
biological functions, including DNA replication, oxygen transport and storage, 
electron transport, as well as peroxides metabolism (Johnson, 1991). Considering the 
limited iron conditions in hosts, bacteria have mechanisms for scavenging this 
element, including the production of siderophores. Siderophores are high affinity 
ferric chelators that have the capacity to capture ferric iron from host sources (Skaar, 
2010). In E. coli, the siderophore aerobactin is considered the most effective iron 
chelating mechanism (Johnson, 1991). 
3.1.2.1. Aerobactin 
The aerobactin system is an important virulence factor, implicated in UTIs and other 
severe infections in humans and animals, possibly because it allows bacterial growth 
even under the limiting iron conditions which are found during the infection process 
(Johnson, 1991). 
Aerobactin is more prevalent among E. coli from patients suffering from 
pyelonephritis (73%) cystitis (49%) or bacteremia (58%), compared to strains causing 
asymptomatic bacteriuria (38%) or fecal isolates (41%), suggesting that aerobactin 
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pathofisiology is  important, not only inside, but also outside of the urinary tract 
(Johnson, 1991). 
The induction of a deficiency in the aerobactin system reduces the virulence of 
an APEC strain in a chicken systemic infection model (Dozois, Daigle, & Curtiss, 
2003). In addition, mutants of the iucD (gene from the aerobactin operon), present 
decreased capacity of colonization in several organs, suggesting that aerobactin 
system plays an important role both in APEC and UPEC strains (Gao et al., 2012). 
Furthermore, the expression of iutA, encoding aerobactin receptor, is higher during 
infection by ExPEC, or in conditions mimicking the infection (Chouikha, Bree, Moulin-
Schouleur, Gilot, & Germon, 2008). 
3.1.3. Toxins 
Several toxins may be produced by E. coli. Hemolysin and cytotoxic necrotizing 
factor are particularly important in ExPEC. Despite of their differences, they are both 
responsible for host cells destruction. 
3.1.3.1. Hemolysin 
Hemolysin (HlyA) is an extracellular pore-forming cytolysin that was originally 
identified by its ability to lyse erythrocytes, and is considered the prototype of the 
RTX (Repeats in ToXin) family of bacterial toxins (Cavalieri & Snyder, 1982; 
Jorgensen, Short, kurtz, Mussen, & Wu, 1976; Mackman & Holland, 1984).   
The synthesis, maturation and export of hemolysin are determined by a four-
gene operon termed hlyCABD (Felmlee, Pellett, & Welch, 1985; Koronakis & 
Hughes, 1996). This operon may be integrated in the chromosome of E. coli or 
located in large plasmids. Chromosomal hemolysin operons are located within 
pathogenicity islands in UPEC isolates (Hacker et al., 1990), and may present 
several differences in 5' flanking region, as well as in the levels of toxin expression 
(Hacker et al., 1990; Nagy et al., 2006). On the other hand, plasmidic HlyA genes 
were found associated with EPEC strains, (Burgos, Pries, Pestana de Castro, & 
Beutin, 2009), and with ETEC and STEC strains (Prada et al., 1991; Wu et al., 2007). 
Hemolysin containing plasmids of E. coli are different in size, conjugation capacity, as 
well as incompatibility groups (Burgos et al., 2009; Knapp et al., 1985; Prada et al., 
1991).  
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Considering the environments colonized by E. coli, some of them with elevated 
nutrient depletion, hemolysin is thought to be important in destroying the host cells, 
with the objective of acquiring their nutrients to support bacterial growth (Wiles, 
Kulesus, & Mulvey, 2008).  
3.1.3.2. Cytotoxic Necrotizing Factor 1 
Cytotoxic necrotizing factor 1 is a bacterial toxin firstly described by Caprioli and 
colleagues. It was described as a cytotoxic toxin, because of its capacity to cause 
multinucleation in cultured cells, and necrotizing because of its ability to originate 
necrosis in rabbit skin (Caprioli, Falbo, Roda, Ruggeri, & Zona, 1983). 
This toxin is chromosomally encoded by cnf1, a single open reading frame, 
comprising 3042-bp (Falbo, Pace, Picci, Pizzi, & Caprioli, 1993). 
CNF1 production has been detected in strains causing UTIs, including 
prostatitis (Andreu et al., 1997), and pyelonephritis (Jacobson, Katouli, Tullus, & 
Brauner, 1990); bacteremia (Blanco, Alonso, Gonzalez, Blanco, & Garabal, 1990) 
and meningitis (Wang & Kim, 2013). 
3.1.4. Group 2 capsules 
Bacterial capsule is an important virulence factor of pathogenic bacteria responsible 
for invasive infections. It allows the bacteria to evade the immunological defenses of 
the host, permitting the survival and establishment of infection in sites which are 
generally sterile and hostile, including lungs, blood, kidney and meninges (Moxon & 
Kroll, 1990).  
E. coli can express more than 80 different capsular polysaccharides, which 
consist of linear polymers of repeating carbohydrate subunits, and may include an 
amino acid or a lipid element (Johnson, 1991).   
Epidemiological studies associate group 2 capsules to several pathologies. 
Some of group 2 capsular antigens, including K1, K2, K3, K5, K12, K13, K20 and 
K51 are more common among E. coli of patients with cystitis and pyelonephritis than 
in isolates from fecal samples (Johnson, 1991). Capsular antigens K1 and K5 are 
present in 63% of women suffering from pyelonephritis, and in addition, K1, K2, K3, 
K12 and K13 are detected in 70% of isolates from pyelonephritis affecting girls 
(Johnson, 1991). K1 capsule is prevalently associated to meningitis, being detected 
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in more than 79% of E. coli isolates from neonatal meningitis, as well as most of the 
isolates from neonatal sepsis (Johnson, 1991). In addition, K2 capsule is necessary 
for serum resistance and in competitive colonization experiments in a murine model 
of ascending UTI, a mutant lacking the capacity to synthesize K2 capsule was 
outcompeted by the wild type strain. This indicates that expression of the K2 capsule 
is relevant in the pathogenesis of UTI (Buckles et al., 2009).    
3.1.5. Virulence factors associated with Shiga toxin-producing E. 
coli 
The crescent identification of food borne ExPEC infections, namely UTIs (Bélanger et 
al., 2011; Manges & Johnson, 2012; Vincent et al., 2010), raises the necessity of 
studying the presence of virulence traits generally associated to animal and food 
backgrounds. This knowledge will allow understanding the possible capacity of other 
E. coli pathotypes, including STEC, to cause extraintestinal disease.  
STEC are responsible for hemorrhagic colitis, characterized by bloody 
diarrhea, as well as hemolytic uremic syndrome (HUS), potentially fatal in children, 
and responsible for  acute renal failure, microangiopatic hemolytic anemia and 
thrombocytopenia (Bergan, Dyve Lingelem, Simm, Skotland, & Sandvig, 2012). 
In the pathophysiology of STEC infections, there are two main classes of 
virulence factors: toxins, including Shiga-like toxins, and adhesins, such as intimin 
(Serna & Boedeker, 2008).  
3.1.5.1. Shiga toxins 
Shiga toxins are proteins which belong to the family of AB5 toxins. These toxins 
contain one subunit A, enzymatically active, and 5 subunits B, that bind to the  
glycosphingolipid globotriosylceramide, Gb3 receptor, expressed in various organs, 
including brain, kidney, liver and pancreas (Etcheverría & Padola, 2013).  
Two types of shiga-toxin have been identified in STEC, shiga toxin type 1 and 
shiga toxin type 2. These toxins are respectively encoded by stx1 and stx2 genes, 
inserted in the genome of defective or functional lambdoid bacteriophages, the Stx-
phages (Bergan et al., 2012; O'Brien et al., 1984). 
The toxic effects of Shiga toxins are exerted by catalytic inactivation of the 60S 
ribosomal subunit and consequent inhibition of protein synthesis in the target cells 
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(Bergan et al., 2012). In addition, these toxins are also able to induce apoptosis in 
several cellular types (Bergan et al., 2012).  
3.1.5.2. Intimin 
Intimin is an outer-membrane adhesion protein present in a group of pathogenic E. 
coli, called Attaching and Effacing Escherichia coli (AEEC). AEEC include EPEC, 
responsible for epidemic and sporadic infantile diarrhoea, and STEC that can cause 
acute gastroenteritis and haemorrhagic colitis. These pathogenic E. coli are capable 
of causing disease in animals and humans, by forming attaching and effacing (A/E) 
lesions in the intestine (Blanco et al., 2004; Frankel et al., 1998). These lesions lead 
to the destruction of microvillus border, by restructuring the underlying cytoskeleton 
through signal transduction mechanisms between bacteria and the host cells; 
intimate adherence to the intestinal epithelium, as well as aggregation of polymerized 
actin at the local and pedestal formation (Frankel et al., 1998).  Intimin is encoded by 
the eae gene, which is integrated in a 35-kb pathogenicity island designated LEE 
(locus of enterocyte effacement) (Jerse, Yu, Tall, & Kaper, 1990; McDaniel, Jarvis, 
Donnenberg, & Kaper, 1995). 
3.1.6. Pathogenicity Islands 
In the 1980s, Hacker and colleagues investigated the production of virulence factors 
in UPEC E. coli strains,  including  α-hemolysin (hly) (Hacker, Knapp, & Goebel, 1983; 
Knapp et al., 1985). Afterwards,   the   term   “hemolysin islands”  emerged to describe 
large chromosomal DNA regions in which hly genes were found to be located in 
(Knapp, Hacker, Jarchau, & Goebel, 1986). 
The designation pathogenicity islands (PAIs), was firstly introduced by Jörg 
Hacker and colleagues, while they were investigating the genetic base of the 
virulence of two uropathogenic E. coli strains, 536 and J96. They observed a close 
linkage between genes coding for P, P-related fimbriae and hemolysin; as well as the 
co-deletion of these linked gene clusters (Hacker et al., 1990). 
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PAIs were further defined by Hacker and colleagues (Hacker, Blum-Oehler, 
Mühldorfer, & Tschäpe, 1997) using a set of characteristics: 
a) PAIs carry genes coding for one or more virulence determinants, including 
toxins, adhesins, invasins, iron uptake systems, as well as protein secretion 
systems, among others. 
b) PAIs are present in pathogenic strains but absent or sporadically distributed in 
the genome of less pathogenic members of the same, or closely related 
species.  
c) PAIs occupy relatively extensive chromosomal regions, frequently with more 
than 30Kb. 
d) PAIs are frequently flanked by direct repeats (DR), small DNA sequences 
which may be generated during the integration of the PAI in the host genome 
through recombination. 
e) PAIs are frequently composed of DNA sequences which differ from the 
remaining genome of the host in both G+C content and in codon usage, 
indicating the possible foreign origin of the fragment. This feature will not be 
pronounced or may also be absent if the donor and receptor present similar 
G+C content. 
f) PAIs are usually associated with tRNA genes, which may act as target sites 
for the integration of external DNA, including pathogenicity islands. 
Furthermore,   the   3’   regions   of   the   tRNA   loci   are   usually   similar   to   the  
attachment sites of bacteriophages (Cheetham & Katz, 1995; Schmidt, 
Scheef, Janetzki-Mittmann, Datz, & Karch, 1997). The association of PAIs and 
tRNA genes and additionally the presence of even cryptic genes coding for 
phage integrases next to the tRNA loci, may point to the possibility that PAIs, 
or PAIs components, are bacteriophage-derived elements. 
g) PAIs are frequently unstable, and moreover may be deleted via the insertion 
sequences (IS) elements, DR sequences inserted at their ends, or throughout 
other homologous sequences from the PAIs.  
h) PAIs are usually carriers of cryptic or functional genes coding mobility 
elements, namely transposases, integrases or parts of insertion sequences.  
The main PAIs detected among uropathogenic E. coli and corresponding 
characteristics are presented in Table 1.5.  
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Pathogenicity islands are inserted in the host chromosome by a site-specific 
event. Although not fully understood, it is thought that tRNA genes are used as 
integration sites for PAIs. This hypothesis is consistent with the observation that the 
majority of the   islands   are   inserted   in   the   3’   end   of   the   loci   of   these   tRNA  genes. 
Furthermore, these are the regions in which phage attachments sites are usually 
positioned (Schmidt & Hensel, 2004).  
The loss of PAIs plays an important role in the bacterial genome plasticity and 
consequently in microbial evolution. In addition, it is important in the transition 
between the stages of acute and chronic infection (Blum et al., 1994).  
Excision of pathogenicity islands, mediated by site-specific recombination 
between the DRs flanking the islands, has been firstly described for PAI I536 and PAI 
II536 (Blum et al., 1994). The DRs associated to the pathogenicity islands are 
considered to correspond to the sequences located at the left and right end of 
prophages (attL and attR) (Hochhut et al., 2006).  
With the exception of PAI IV536, which has one degenerate DR, all other islands of 
strain 536 were found to have the capacity to excise from the chromosome, in 
frequencies from 10-6 to 10-5. In addition, the island PAI III536 was determined to be 
the most unstable (Middendorf et al., 2004). Two types of excision were identified for 
PAIs of strain 536: site-specific recombination between the flanking DRs for PAI I536, 
PAI II536, PAI III536 and PAI V536; and an additional partial deletion mechanism for PAI 
III536, involving homologous recombination between two incomplete IS100 copies, 
which was called type II deletion (Middendorf et al., 2004).  
With the exception of this referred deletion, excision mechanisms in E. coli strain 
536, are not RecA-dependent (Blum et al., 1994; Middendorf et al., 2004), but 
alternatively, appear to be mediated by the respective PAI-encoded integrases, 
similarly what happens in the bacteriophages (Hochhut et al., 2006). 
The excision of pathogenicity islands has been associated with several 
contributing factors, including environmental stimuli. Low temperature and high cell 
density were found to induce the excision of PAI II536. In contrast, growth in artificial 
urine, high temperature, depletion of nutrients, and salt stress, do not affect the 
excision rate of this island (Middendorf et al., 2001; Middendorf et al., 2004). PAI III536 
excision rate is not significantly changed by these environmental factors, but low 
temperature shifts the deletion types of this island to site specific recombination, the 
type 1 deletion. This also occurs under nutrient depletion, salt stress or at high 
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temperature, and is most potentiated in artificial urine. Contrarily to these referred 
islands, PAI I536 excision, is not affected by environmental factors. This is another 
indication that this island is reasonably stable in the bacterial host chromosome 
(Middendorf et al., 2004). 
In addition to environmental factors affecting the loss of pathogenicity islands, 
quinolones also increase the frequency of excision of some PAIs (Soto, Jimenez de 
Anta, & Vila, 2006). The exposure of strains to sub-inhibitory concentrations of 
quinolones induces total or partial loss of PAI I536, as well as PAI IIJ96. Contrarily, the 
excision of PAI III536 and PAI IV536 under sub-inhibitory concentrations of quinolones 
is not verified (Soto et al., 2006). 
3.2. Klebsiella virulence factors 
Although virulence has been more extensively studied in E. coli, several virulence 
factors have also been associated to the pathogenesis of Klebsiella spp. infections. 
Additionally to the common virulence factors, like adhesins and capsule, other 
virulence factors have been described among the genus Klebsiella. 
3.2.1. Adhesins 
In Klebsiella spp., adhesins like type 1 and type 3 fimbriae are important virulence 
factors, which contribute to the development of urinary and respiratory tract 
infections. 
3.2.1.1. Type 1 fimbriae 
Type 1 fimbriae are mannose- sensitive hemagglutinins that have the capacity to 
agglutinate guinea pig erythrocytes, and can be detected on virtually all 
Enterobacteriaceae members (Jones et al., 1995; Podschun & Ullmann, 1998).  They 
are composed of cylindrical pilus rods constituted by subunits of FimA pilin, as well 
as small tip fibrillum which integrates FimF, FimG and the adhesin FimH (Jones et 
al., 1995). FimC and FimD are not part of the final structure but are necessary for the 
type 1 assembly (Jones et al., 1995).   
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Similarly to E. coli, the expression of fim operon is phase variable. During 
colonization and infection in lungs and in the intestine the switch is “off” while when in 
the urinary tract it is on the  position  “on” (Struve, Bojer, & Krogfelt, 2008).  
The majority of studies focusing the role of type 1 pili in the UTI pathogenesis 
were performed using E. coli strains, in which this fimbriae has been associated with 
lower UTI, as well as pyelonephritis (Podschun & Ullmann, 1998). Nonetheless, the 
role of type 1 fimbriae in UTI has also been reported in K. pneumoniae using animal 
models (Fader & Davis, 1980, 1982; Maayan, Ofek, Medalia, & Aronson, 1985). In 
addition, type 1 pili also participates in the colonization of the urogenital and 
respiratory tracts, contributing not only to the development of UTI, but also for 
development of pneumonia (Podschun & Ullmann, 1998). Type 1 fimbriae are also 
expressed in biofilm-like intracellular bacterial communities both in UPEC and in K. 
pneumoniae strains (Rosen et al., 2008).  
3.2.1.2. Type 3 fimbriae 
Type 3 fimbriae belong to the fimbrial group of mannose-resistant hemagglutinins, 
and have the capacity to cause mannose-resistant agglutination of erythrocytes 
treated with tannic acid (Hornick, Allen, Horn, & Clegg, 1992).  
These hemagglutinins are adhesins which are expressed by the majority of the 
isolates associated to human infections, in both the respiratory and urinary tracts 
(Hornick, Thommandru, Smits, & Clegg, 1995; Huang, Liao, Wu, & Peng, 2009).  
Type 3 fimbriae mediate the connection to the type V collagen, basolateral 
surfaces of different types of cells, including trypsinized human buccal cells, renal 
tubular cells, bronchial cells, tracheal epithelial cells, extracellular matrix proteins, as 
well as basement membrane of lung tissue (Hornick et al., 1992; Hornick et al., 1995; 
Sebghati, Korhonen, Hornick, & Clegg, 1998). In addition, this adhesin has been 
shown to participate in biofilm formation on plastic surfaces (Jagnow & Clegg, 2003; 
Langstraat, Bohse, & Clegg, 2001). The formation of bacterial biofilms plays an 
important role in bacterial cells communication, escape from host defenses 
mechanisms, as well protection against antibiotics, thus contributing to bacterial 
virulence (Jagnow & Clegg, 2003). 
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3.2.1.3. Adhesin CF29K 
CF29K is a non fimbrial protein of 29kDa, from the K88 adhesin family. This adhesin 
is expressed in K. pneumoniae and is related to CS31A surface protein in E. coli (Di 
Martino et al., 1995). The gene encoding CF29K, termed cf29A, was found inserted 
on a 185-kb conjugative R plasmid, and is 100% homologue to the structural gene 
encoding CS31A. In fact, CF29K is considered an antigenic subtype of CS31A (Di 
Martino et al., 1995).   
Despite of the fact that no in vivo studies support the role of this adhesin in 
virulence, the presence of this determinant is more strongly associated to 
hipervirulent strains. Nonetheless, cf29A gene has also been detected in non- 
hipervirulent K. pneumoniae (Brisse et al., 2009; Di Martino et al., 1995; Shon, 
Bajwa, & Russo, 2013).  
3.2.2. Capsule 
Klebsiella spp. are covered by a hydrophilic polysaccharide capsule which confers 
the mucoid aspect of the colonies on agar plates (Dworkin et al., 2006a). There are 
as a minimum, 78 capsular polysaccharide distinct serotypes (Pan et al., 2008); eight 
of which are associated with hypervirulent strains (K1, K2, K5, K16, K20, K54, K57 
and KN1) (Shon et al., 2013).  
The capsule is an important virulence factor, as it protects bacteria against 
phagocytosis by polymorphonuclear leukocytes, and against serum killing (Dworkin 
et al., 2006a). In addition, the capsule was found to be an important virulence factor 
in several animal infection models. Strains from serogroups K1 and K2 were found to 
be particularly virulent in a mouse peritonitis model, compared to strains from other 
capsular antigens (Mizuta et al., 1983). In experimentally induced skin lesions in 
mice, strains from K1, K2, K4 and K5 were found to be more virulent than other 
capsular antigens types (Simoons-Smit, Verwey-van Vught, Kanis, & MacLaren, 
1984). Furthermore, in an experimental murine burn wound sepsis model, strains 
from K1 serotype were found to be extremely virulent (Cryz, Fürer, & Germanier, 
1984). Capsular polysaccharides were also found to be crucial for virulence in a 
murine model of pneumonia (Cortés et al., 2002). Additionally, capsule expression 
was shown to be an important virulence factor in UTI, but not in intestinal colonization 
in animal models (Struve & Krogfelt, 2003).   
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3.2.3. Other virulence factors 
3.2.3.1. Regulator of the mucoid phenotype A  
The regulator of the mucoid phenotype A (RmpA) is a mucoid factor which is 
responsible for the regulation of the capsular polysaccharide biosynthesis (Cheng et 
al., 2010).  RmpA protein is encoded by the rmpA gene which was first detected in a 
180 kb plasmid of a K2 strain (Nassif, Fournier, Arondel, & Sansonetti, 1989). Later, 
gene rmpA2 sharing 80% of identity with rmpA was also identified in a large plasmid 
(Wacharotayankun et al., 1993), and in addition a chromosomal gene, c-rmpA was 
also identified (Hsu, Lin, Chen, Chou, & Wang, 2011). 
The presence of rmpA gene has been associated with the 
hypermuscoviscosity phenotype in K. pneumoniae, and was found to be more 
prevalent in liver abscess strains than in bacteremia isolates (Yu et al., 2006). In 
addition, this gene is  more frequently detected among strains from K1/K2 serotypes 
(Cheng et al., 2010),  in which it has been linked to virulence in a mouse model of 
infection (Brisse et al., 2009). Contrarily, in another study, after intraperitoneal and 
intragastric inoculation and in vivo competition assays in a K1 isolate, rmpA was not 
responsible for enhancing the virulence, but the authors suggest that the effects of 
this gene in virulence may differ according to the strain (Hsu et al., 2011). Thus, it 
has been suggested that rmpA may be a marker of Klebsiella PLA rather than being 
directly related to virulence (Hsu et al., 2011).   
3.2.3.2. Activator of the allantoin regulon 
Some Enterobacteriaceae members have the capacity to use allantoin as a nitrogen 
source (Cusa, Obradors, Baldomà, Badía, & Aguilar, 1999). The allantoin regulon 
comprises several genes involved in the allantoin utilization, and in addition, it carries 
two regulator genes: allR, a repressor gene; and alls, an activator of the regulon 
(Rintoul et al., 2002). 
Contrarily to E. coli, which is only capable of using allantoin anaerobically as a 
sole nitrogen source but not as sole carbon source, K. pneumoniae can use allantoin 
as unique source of carbon, nitrogen and energy, under both aerobic and anaerobic 
conditions (Chou et al., 2004). Thus, the utilization of allantoin may be extremely 
useful for Klebsiella during competition for nitrogen supplies. 
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In K. pneumoniae, a 22kb region containing the allS gene has been associated 
to liver infection. Furthermore, in a mouse model of intragastric infection, the wild 
type strain showed increased virulence compared to a mutant without this region 
(Chou et al., 2004).  Considering that primary liver abscess is more prevalent in 
patients with diabetes mellitus, in whom allantoin levels are increased, the presence 
of this region may constitute an important benefit for bacteria (Chou et al., 2004).  
Epidemiological studies associate the presence of alls gene with K1 isolates 
from PLA (Brisse et al., 2009; Yu et al., 2008), although this determinant is not 
present within all K1 strains (Brisse et al., 2009). In addition, alls has also been 
detected in non-K1 isolates (Turton, Perry, Elgohari, & Hampton, 2010).  
3.2.3.3. Uridine phosphate galacturonate 4- epimerase 
In several members of the Enterobacteriaceae family, the lipopolysaccharide (LPS) 
core oligosaccharide backbone is altered by phosforyl groups, which  are known to 
be important in the maintenance of the barrier function provided by the outer 
membrane (Frirdich, Bouwman, Vinogradov, & Whitfield, 2005). These groups are 
absent in K. pneumoniae, in which this function is achieved by the presence of 
galacturanic acid (Frirdich et al., 2005).  
Uridine phosphate galacturonate 4- epimerase is an enzyme responsible  for 
the conversion of  the UDP - GlcUA to UDP-GalUA (UDP galacturanic acid), which is 
essential for the synthesis of the core oligosaccharide of LPS, a major virulence 
determinant in Enterobacteriaceae (Frirdich & Whitfield, 2005). This enzyme is 
encoded by uge gene, (Regué et al., 2004), further designated glaKP (Frirdich & 
Whitfield, 2005). 
3.2.3.4. Glucosyltransferase 
Glucosyltransferase is a protein responsible for the attachment   of   α-L-glycero-D-
manno-heptopyranose II (L,DHeppII) to the O-3   position   of   an   α-D-
galactopyranosyluronic acid  (α-D-GalAp) in the outer core lipopolysaccharides (LPS) 
(Izquierdo et al., 2003) . This enzyme is encoded by the gene wabG (Izquierdo et al., 
2003), inserted in the wa region of the K. pneumoniae chromosome, responsible for 
LPS core synthesis (Regué et al., 2001; Regué et al., 2005).  
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K. pneumoniae wabG mutants loose the capacity to synthetize the outer core 
LPS, including O-antigen, and thus totally lack the outer core LPS. Furthermore, 
mutants are also non- capsulated, consequently being more sensitive to polymyxinB 
as well as to SDS (Izquierdo et al., 2003). 
In experimental UTIs, the mutation of this gene reduces radically the 
colonization capacity of K. pneumoniae (Izquierdo et al., 2003) and in an 
experimental model of pneumonia, wabG mutants are totally avirulent (Fresno et al., 
2007). The reintroduction of the gene in the mutants recovers the pathogenic 
capacity of strains (Fresno et al., 2007; Izquierdo et al., 2003). 
3.2.3.5. Urease 
Urease is a metalloenzyme which contains nickel and has the capacity to catalyse 
the hydrolysis of urea, originating ammonia and carbamate. Furthermore, carbamate 
suffers spontaneous decomposition creating a second molecule of ammonia and 
carbonic acid (Pearson, Michel, Hausinger, & Karplus, 1997). Once released by the 
action of urease, the extremely alkaline agent ammonia may become protonated 
originating ammonium ion. Ammonium is responsible for alkalinizing the cytoplasm, 
as well as the extracellular environment (Maroncle, Rich, & Forestier, 2006). The 
release of ammonia leads to tissue damage, and in some circumstances it is also an 
important factor contributing for the persistence of pathogens (Burne & Chen, 2000). 
Urease is a recognized virulence factor in several animal and human 
pathogens, being associated to a variety of pathologies including pyelonephritis, 
urolithiasis and peptic ulcers (Mobley, Island, & Hausinger, 1995). Furthermore, the 
expression of urease is thought to be important to the infective capacity of bacteria, 
the severity of the disease, and in addition, to the persistence in the host (Maroncle 
et al., 2006).  
It has been shown that K. pneumoniae ΔureA mutants have an attenuated 
capacity to colonize the mouse intestine (Maroncle et al., 2006). Considering that 
nosocomial infections caused by K. pneumoniae, are generally preceded by 
gastrointestinal colonization despite of the infection localization (Maroncle et al., 
2006), the contribution of urease for enhancing the colonization capacity in this tract 
makes it an important virulence factor. 
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3.2.3.6. Klebsiella ferric iron uptake 
Klebsiella ferric iron uptake (kfu) is a virulence factor responsible for iron uptake. It 
allows bacteria to acquire iron, even under the limited iron conditions provided by the 
human host (Ma, Fang, Lee, Shun, & Wang, 2005). 
The kfu operon is present in the majority of the genomes of tissue-invasive K. 
pneumoniae and absent in noninvasive isolates, suggesting that this operon may be 
implicated in the modulation of in vivo virulence, and constitute a competitive 
advantage to strains that carry it (Ma et al., 2005). In addition, mutants lacking this 
operon showed decreased virulence in vivo, confirming the role of this system in 
virulence (Ma et al., 2005). 
In patients with PLA, kfu has been correlated with magA and alls. The 
association of these genes relates with the invasiveness capacity of bacteria (Ma et 
al., 2005). 
4. Virulence versus resistance 
Along with the global concern about the rise of resistance among human pathogens, 
fears about the simultaneously enhancement of the pathogenic capacity of bacteria 
started to emerge. The possibility of acquisition of both resistance and virulence traits 
via horizontal gene transfer could be responsible for the appearance of strains 
simultaneously virulent and resistant. Furthermore, it is also possible that 
antimicrobial agents may select strains with more virulence factors. This could lead to 
serious public health problems. Multidrug resistant and virulent strains could be 
responsible for severe infections and antibioterapy would be inefficient to treat these 
infections, increasing morbidity and mortality rates. Despite of the realization of some 
studies focusing on the relation between resistance and virulence, this interplay is still 
not completely elucidated.  
4.1.  Resistance to beta-lactams versus virulence 
Studies focusing on the interplay between resistance to beta-lactams and virulence 
are based either on phenotypic resistance profile or in the presence of specific beta-
lactamases. 
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Resistance to extended-spectrum cephalosporin plus cephamycin is 
associated to non- B2 groups, fewer virulence factors and, in addition, to depletion 
for hlyD, pap, sfa/foc and kpsM II in E. coli human isolates. It is also associated to 
lower prevalence of kpsM II and malX (marker for a pathogenicity island of strain 
CFT073) among ExPEC animal isolates (Johnson, Kuskowski, Owens, Gajewski, & 
Winokur, 2003). 
In a group of E. coli urinary isolates, few differences were found between the 
prevalence of virulence factors among ampicillin resistant and susceptible strains. 
Only K1 kpsM (group 2 capsule variant K1) was found to be more prevalent among 
isolates susceptible to ampicillin (Horcajada et al., 2005). 
A study among E. coli from women with acute uncomplicated cystitis revealed 
that the differences on the prevalence of virulence factors, aggregate virulence 
factors scores and phylogenetic distribution, according to susceptibility versus 
resistance to ampicillin were minimal. Exceptions were F12 papA allele (variant F12 
from papA), more prevalent among susceptible isolates, and traT (serum resistance 
associated) gene, often associated with plasmids, which was more prevalent among 
strains resistant to ampicillin (Johnson, Kuskowski, O'Bryan T, Colodner, & Raz, 
2005b).       
According to Branger et al. (2005), the production of SHV, and to a lesser 
extent, of TEM type beta-lactamases, are preferentially associated to the B2 
phylogenetic group, whose strains carry more VFs but are fluoroquinolone- 
susceptible. Contrarily, the CTX-M type is associated with the D phylogenetic group 
in which strains present less virulence factors but are fluoroquinolone-resistant 
(Branger et al., 2005). Nonetheless, other studies indicate that E. coli CTX-M-
producers generally belong to the virulent phylogenetic groups, especially the B2 
phylogroup (Carattoli et al., 2008; Karisik, Ellington, Livermore, & Woodford, 2008; 
Pitout, Laupland, Church, Menard, & Johnson, 2005). 
According to Lee et al. (2010), among commensal E. coli isolated from faeces 
of healthy individuals, and pathogenic strains from blood and urine isolates, the 
prevalence of nine virulence factors, except S fimbrial adhesin, was significantly 
higher in pathogenic strains compared with commensal strains. Phylogenetic group 
B2 presented more virulence genes, and the phylogenetic distribution among CTX-M-
producers was similar to that observed among the total pathogenic strains, with a 
higher prevalence of phylogroup B2. Nonetheless, blaCTX-M-1 group strains belonged 
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mainly to phylogenetic group B2 and A, while blaCTX-M-9 group strains belonged to 
phylogenetic group D and B2. No differences were found in aggregate virulence 
factor scores between CTX-M-producers and non-CTX-M- producers in the 
pathogenic strains. Despite of the similarities between the prevalence of each 
individual virulence factor regardless of CTX-M production, iutA and traT were 
significantly more frequent in blaCTX-M-1 group and in blaCTX-M-9 group, respectively, than in 
CTX-M-non-producers. These virulence genes, along   with   α-haemolysin and 
yersiniabactin receptor, were found to be predictors of pathogenicity (Lee et al., 
2010). The higher prevalence of phylogroup B2 among CTX-M-type producers 
reported by these authors, is in agreement with previous reports (Carattoli et al., 
2008; Karisik et al., 2008; Pitout et al., 2005), but contradicts the observations of 
Branger et al. (2005), which reported an association to phylogroup D (Branger et al., 
2005).  
Additionally, among a collection of ESBL producing E. coli isolates from North 
America, the majority of CTX-M-14 and SHV producers were from phylogroup D, 
while CTX-M-15 and TEM producers were mainly from group B2. Substantial 
prevalence differences were found between CTX-M producers and non-producers, 
for individual virulence factors. CTX-M producers were more commonly carriers of 
afa/dra, iha (putative adhesin-siderophore receptor), sat and kpsM II. Contrarily, 
among non-CTX-M producers, ireA (iron-regulated element) and cvaC (colicin 
[microcin] V) genes were more frequently found. The usp gene (uropathogenic-
specific protein) was detected in both CTX-M-15   β-lactamase producers and non 
CTX-M producers, but not among CTX-M-14 producers. Even so, aggregate 
virulence factor scores were similar (Pitout et al., 2005). 
According to a different study, the epidemic lineages from B2 group with CTX-
M-15 enzyme in United Kingdom, did not produce more virulence factors, neither 
appeared to be more virulent than the non-epidemic isolates of the same phylogroup, 
regardless of the ESBL produced. However, iutA and fyuA (yersiniabactin receptor) 
were significantly more prevalent among epidemic strains than in non-clonal isolates 
also belonging to phylogroup B2.  Similarly to the finding of Pitout et al. (2005), the 
afa/draBC gene pair was associated to the production of CTX-M β-lactamases 
(Karisik et al., 2008). 
The presence of PAIs from UPEC has also been reported among CTX-M 
producers. Among these ESBL producers, three PAIs were detected, with PAI IV536 
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being the most prevalent, as it was identified in all isolates. The majority of the strains 
were CTX-M-15 producers, from B2 phylogroup and carried PAI IV536, PAI ICFT073 and 
PAI IICFT073 (Carattoli et al., 2008).  
In a study with Caenorhabditis elegans infection assays, using susceptible and 
ESBL-producing E. coli, it was determined that the ability to kill these nematodes 
correlated with the presence of virulence factors. As susceptible strains presented 
higher prevalence of virulence factors than ESBL producers, they were more virulent 
than the resistant isolates. The number of virulence factors, contrarily to the reported 
by Lee et al. (2010) was found to be higher among TEM-type producers than in CTX-
M-type, and thus, CTX-M-producing isolates had lower virulence in vivo than TEM-
producers. As it was previously reported, traT and iutA were also more prevalent 
among ESBL producers than in susceptible strains (Lavigne et al., 2006).  
4.2.  Resistance to quinolones versus virulence 
An inverted relation between virulence and resistance to quinolones has been 
documented in several studies. Generally, quinolones and fluoroquinolones resistant 
strains show reduced virulence and invade immunocompromised hosts, while on the 
contrary, susceptible strains are more virulent, and affect uncompromised patients 
(Piatti, Mannini et al. 2008).  The investigations that leaded to this observation 
generally have taken in account the phylogroup of the strains, number of virulence 
factors carried, and the presence or absence of specific virulence factors, as well as 
their expression. 
4.2.1. Resistance to quinolones and phylogroups 
Resistance to quinolones and particularly to fluoroquinolones has been associated to 
shifts in the phylogenetic groups towards phylogenetic groups A, B1 and D, and 
away from phylogroups B2.   
In a study performed in E. coli mainly from extraintestinal human infections, 
cattle and swine isolates, differences were found between the human and animal 
isolates, considering the relation between resistance to fluoroquinolones and 
phylogroups (Johnson, Kuskowski et al. 2003). Among human isolates, despite of the 
general higher prevalence of phylogenetic B2 group, it was observed that the 
resistant isolates, in comparison with the susceptible counterparts, were considerably 
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depleted for phylogroup B2, and presented higher prevalence of group D. In contrast 
with human isolates, the resistant animal isolates did not presented significant shifts 
in overall virulence.  
Moreno et al. reported that among UPEC, resistance to quinolones or 
fluoroquinolones was also associated with shifts away from phylogenetic group B2 to 
phylogroups A, B1 or D. The magnitude of this shift depended on antimicrobial 
resistance profile, being greater for resistance to fluoroquinolones in comparison with 
resistance to quinolones or trimethoprim-sulfamethoxazole. In addition, it changed 
among fluoroquinolone-resistant isolates according to the trimethoprim-
sulfamethoxazole phenotype (Moreno, Prats et al. 2006). 
Other studies, within strains from urinary origin (Piatti, Mannini et al. 2008) and 
strains causing acute uncomplicated cystitis (Johnson, Kuskowski et al. 2005, Kim, 
Kim et al. 2010), also reported that ciprofloxacin resistance was associated to shifts 
away from phylogroup B2. This observation was also verified for urosepsis isolates 
but concerning resistance to nalidixic acid (Houdouin, Bonacorsi et al. 2006). In 
addition, the shift towards non-B2 phylogroups was also reported among isolates 
from human and animal wastewaters (Sabaté, Prats et al. 2008). 
In opposition to the referred studies, Kawamura-Sato et al. reported that 
among a collection of UPEC from Japan, the shift of quinolone and fluoroquinolone 
resistant strains to non-B2 groups of was not observed, as this group was the most 
prevalent among either susceptible and resistant isolates  (Kawamura-Sato, Yoshida 
et al. 2010). Therefore, despite of the apparent link between phylogenetic 
background and resistance to quinolones and fluoroquinolones reported by the 
majority of studies, some contradictory results may indicate that this relationship is 
more complex. 
4.2.2. Resistance to quinolones and virulence genes 
Resistance to quinolones and fluoroquinolones also seems to be associated to the 
presence of less virulence genes. Several studies reported that among human UPEC 
and ExPEC, resistance to nalidixic acid or ciprofloxacin was accompanied by 
reduced virulence scores (Graziani et al., 2009; Johnson et al., 2006; Johnson et al., 
2005b; Johnson et al., 2003; Moreno et al., 2006). 
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Furthermore, another study reported that there was no correlation between the 
number of virulence factors carried, and the number of agents to which the isolates 
were resistant to, among fluoroquinolone resistant E. coli from urinary origin (Grude 
et al., 2008).    
Among E. coli strains from animal origin, studies seem to be more 
contradictory. A study performed with cattle and swine intestinal E. coli, reported that 
aggregate virulence factor scores differed minimally between resistant and 
susceptible isolates (Johnson et al., 2003). Nonetheless, studies performed in E. coli 
from chickens indicate that similarly to the human strains, resistance to quinolones 
and fluoroquinolones is associated to lower virulence scores (Graziani et al., 2009; 
Johnson et al., 2006). 
In addition to the connection between resistance to quinolones and the number 
of virulence factors carried, the presence and expression of specific virulence factors 
and their relation to resistance has also been studied. However, this question seems 
to be more complex and depend on the specific virulence factor. 
Vila et al. (2002) investigated if quinolone resistant UPEC were less virulent 
than susceptible isolates. They suggested that resistance to quinolones may be 
associated to a diminishing in the carriage or expression of virulence factors (Vila et 
al., 2002). They reported that the expression of type1-fimbriae and hemolysin, and, in 
addition, the carriage of genes hlyA, cnf1 and sat, was significantly lower among 
nalidixic acid- resistant isolates compared to susceptible isolates. At a lesser extent, 
genes fimA and papC were also less prevalent among resistant isolates. Considering 
these findings, they first hypothesised that these observations were a result of the 
acquisition of resistance to quinolone and further spread in a clonal fashion, among 
strains that naturally do not carry these virulence factors. However, clonality was not 
demonstrated in the genetic relationship studies they performed, and they suggested 
two other hypotheses which do not exclude each other. The first theory is based on 
the detection of a mutation at the codon 83 of the gyrA gene, which may be 
responsible for the reduction of the degree of DNA supercoiling catalyzed by DNA 
gyrase, and consequently affect some gene expression. This may explain the 
reduced expression of type-1-fimbriae. The second hypothesis relies on the fact that 
the genes which were significantly depleted among resistant strains may be carried 
by pathogenicity islands. Therefore, during the development of quinolone resistance, 
possibly aided by quinolone exposure, these antimicrobial agents can lead to the 
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excision of these elements mediated by SOS response (Vila et al., 2002). Contrarily 
to the observed for the remaining genes, iucD (a gene from aerobactin operon) was 
found to be more prevalent among resistant isolates, but the authors were unable to 
explain this observation. 
A set of 35 virulence markers was studied by Johnson and colleagues  in a 
Dutch collection of fluoroquinolone resistant E. coli, and was compared to 
fluoroquinolone susceptible E. coli isolates (Johnson, van der Schee, Kuskowski, 
Goessens, & van Belkum, 2002). The fluoroquinolone resistant E. coli were found to 
be extremely depleted in virulence factors, and the classic ExPEC virulence 
determinants pap, sfa/foc, hly and cnf were remarkably absent in these isolates. The 
fluoroquinolone susceptible E. coli presented higher prevalence for 25 of the 35 
genes analysed, being that, for fuyA, kpsMT II and ompT the differences observed 
were statistically significant. On the opposite, iutA, ibeA and traT were found to be 
more prevalent among fluoroquinolone resistant E. coli, although this was not 
statistically significant. According to the authors, the phylogenetic background and 
virulence profiles of fluoroquinolone resistant E. coli are more similar to animal 
isolates. This observation gives strength to previous suggestions according to which 
fluoroquinolone resistant E. coli are derived from animal sources and may be 
transmitted to humans by foodborne transmission (Garau et al., 1999). 
Another study was performed by Horcajada et al, comparing the prevalence of 
31 virulence genes among phylogroup B2 E. coli isolates susceptible or resistant to 
nalidixic acid (Horcajada et al., 2005). The findings were similar to the reports by 
Johnson et al. and Vila et al. (Johnson et al., 2002; Vila et al., 2002), but added the 
information that there was a significant increase in the prevalence of bmaE (M 
fimbriae) and gafD (G fimbriae) among nalidixic acid resistant strains from 
phylogroup B2. 
Regarding studies from animal origin, Johnson et al. reported that among 
swine and cattle E. coli isolates, the five genes which are used to define an ExPEC 
and hlyD exhibited minimal shifts according to the resistance profile. With the 
exception of iutA, papA and papC, which were more prevalent among 
fluoroquinolone resistant isolates, the remaining virulence genes were more 
prevalent among fluoroquinolone susceptible isolates. Nonetheless, only for kpsMTII 
the differences were considered statistically significant, as fluoroquinolone resistant 
isolates were totally depleted of this virulence factor (Johnson et al., 2003). Contrarily 
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to the observed in this study, among E. coli isolated from chicken, kpsMTII was found 
to be more prevalent among fluoroquinolone resistant E. coli than in fluoroquinolone 
susceptible isolates. Nonetheless, this was not statistically relevant, as the only data 
with statistical significance was the higher prevalence of ireA and iutA among 
fluoroquinolone resistant E. coli (Johnson et al., 2006). 
As it was demonstrated by the referred studies, although controversial, 
quinolone- and fluoroquinolone-resistant E. coli isolates typically seem to be less 
virulent than their susceptible counterparts. Quinolone and fluoroquinolone resistant 
isolates generally lack characteristic ExPEC virulence genes, such as pap and hly, 
which may indicate that mutation to quinolone or fluoroquinolone resistance may be 
accompanied by the loss of virulence genes (Vila et al., 2002). Reports indicating that 
exposition to sub-inhibitory concentrations of quinolones, leaded to the loss of 
virulence genes in a small subset of the studied population support this theory (Soto 
et al., 2006). Nonetheless, the reported absence of detectable alterations on the 
virulence factors profile in two wild-type E. coli strains, after experimental selection 
for quinolone resistance contradicts this theory (Johnson et al., 2005b; Martínez-
Martínez, Fernández, & Perea, 1999). Also opposing to this theory, is the consistent 
epidemiological observation that quinolone  and fluoroquinolone-resistant human 
clinical isolates present a clearly distinct  phylogenetic group distribution, compared 
to their susceptible counterparts (Houdouin et al., 2006; Johnson et al., 2005b; 
Johnson et al., 2003; Moreno et al., 2006; Piatti, Mannini, Balistreri, & Schito, 2008). 
A possible alternative hypothesis explaining these observations may be that the 
conversion to resistance occurs more easily in non-B2 strains or in isolates 
harbouring fewer virulence factors (Johnson et al., 2005b). 
In order to elucidate this question, Johnson et al. performed the molecular 
analysis of 40 diverse wild-type and reference E. coli. The isolates were submitted to 
selective passages on antimicrobial- supplemented agar plate, to induce 
spontaneous transition to nalidixic acid or ciprofloxacin resistance (Johnson, 
Johnston, Kuskowski, Colodner, & Raz, 2005a). They reported that this transition 
occurred independently of strain characteristics, including phylogenetic group, 
collection of origin, and virulence profile, and, in addition, it was accompanied by 
negligible alterations in the inferred phylogenetic group or virulence genetic content 
of the strains. In view of these results, the authors hypothesise that resistant strains 
may be acquired from an external selection source. The strains reservoir could be 
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food animals which carry a susceptible source population exhibiting the same low 
virulence and non-group-B2 profile, similar to resistant human clinical isolates. This 
would explain the inverted relation between resistance and virulence. Therefore, this 
study contradicts the theories that defend the direct loss of virulence genes during 
the acquisition of resistance, and the higher capacity of acquisition of resistance 
among non-B2 strains (Vila et al., 2002).  
4.3. Resistance to sulfamethoxazole-trimethoprim and to 
aminoglycosides 
The relation between resistance to sulfamethoxazole-trimethoprim and virulence has 
also been studied. Resistance to this combination of agents is associated with 
borderline or moderate shifts away from B2 phylogroup (Houdouin et al., 2006; 
Johnson et al., 2005b; Moreno et al., 2006). In fact, resistant strains have been 
shown to be mainly associated with phylogenetic group D (Houdouin et al., 2006; 
Moreno et al., 2006). Differences were also observed in the prevalence of virulence 
genes considering the resistance phenotype. Genes papGIII (Johnson et al., 2005b); 
iroN (Horcajada et al., 2005); sfa/focDE, hlyA and fyuA (Moreno et al., 2006); as well 
as malx (Horcajada et al., 2005; Johnson et al., 2005b; Moreno et al., 2006), were 
shown to be statistically significant less prevalent among resistant isolates. In 
opposition, afa/dra, iutA, traT, which are often associated with plasmids (Johnson et 
al., 2005b); as well as bmaE and gafD (Horcajada et al., 2005), were found to be 
significantly more prevalent among isolates resistant to this antimicrobial 
combination.  
Considering the virulence scores of the isolates, contradictory findings have 
been reported, as on one hand Johnson et al. reported that no net changes were 
observed in the virulence scores of resistant isolates compared to the susceptible 
ones (Johnson et al., 2005b); and on the other, Moreno et al. reported that the 
aggregate virulence scores of  sulfamethoxazole-trimethoprim- susceptible isolates 
were significantly higher (Moreno et al., 2005).    
Contrarily to the other antibiotics referred before, the relation between 
resistance to aminoglycosides and virulence is still largely unknown.  Resistance to 
gentamicin in B2 E. coli isolates, was reported to be associated with a reduction in 
the prevalence of fimH and an increase in iutA prevalence, in comparison to 
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susceptible isolates (Horcajada et al., 2005). Nonetheless no further studies were 
performed that supported this observation. 
5. Objectives 
The interplay between resistance and virulence is a complex phenomenon which 
seems to depend on diverse factors. Moreover, several contradictory evidences have 
been reported, which make this matter even more complicated. Studies focusing on 
this relation among Enterobacteriaceae have been mainly performed in E. coli 
strains, disregarding other clinically important pathogens, including Klebsiella spp. 
that is emerging in the nosocomial setting. Additionally, the presence of the different 
pathogenicity islands, which are important virulence gene clusters that may be 
responsible for enhancing the virulence potential of bacteria, are generally not 
considered. 
With the worldwide dissemination of resistance, and facing the possibility of the 
emergence of strains simultaneous highly virulent and resistant, it is therefore crucial 
to elucidate if resistance can be accompanied of more virulence, or if a trade-off 
between these characteristics is verified.  
Therefore, the main objective of this study is to understand the relation 
between virulence and resistance in E. coli and Klebsiella spp. from clinical and non-
clinical sources, by investigating the distribution of virulence factors; determining their 
resistance profile, and characterizing the plasmids and resistance determinants 
carried by the strains. This will allow understanding if resistant strains, both from 
clinical and non-clinical origins, also carry more virulence determinants, and to 
ascertain if the use of antibiotics may also be selecting for more virulent strains. 
Additionally, we also aim to assess if there is a significant fitness cost in the cell, 
associated to the maintenance of pathogenicity islands and a plasmid carrying  
blaCTX-M-15.  
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Extraintestinal pathogenic Escherichia coli (ExPEC) strains cause infections such as 
urinary tract infections, septicaemia, and meningitis. Knowledge of the phylogeny of 
the strains contributes to the recognition of their virulence potential and clinical 
outcome. ExPEC virulence factors are often clustered in pathogenicity-associated 
islands (PAIs) (Diard et al., 2010). Pathogenic ExPEC strains belong to the B2 and, 
to a lesser extent, D phylogenetic groups, whereas commensal isolates are assigned 
to groups A and B1. The triplex PCR method is often used to assess phylogenetic 
groups (Clermont et al., 2000). The accuracy with which this method assigns strains 
to their correct multilocus sequence typing (MLST)-based phylogroups is good 
(Gordon, Clermont, Tolley, & Denamur, 2008). 
As part of a project investigating antimicrobial resistance, virulence, and 
phylogeny, we used this method (Clermont et al., 2000) to determine the phylogroup 
of E. coli isolates collected at a university hospital. E. coli strain HUC270 was isolated 
in 2007 from the urine of a 52-year-old man hospitalized in a medical ward. The 
antimicrobial susceptibility testing was performed with the Vitek 2 Advanced Expert 
System (AES) (bioMérieux, France). Eight PAIs were screened by a multiplex PCR 
(Sabaté, Moreno, Pérez, Andreu, & Prats, 2006). The amplification products were 
sequenced (Macrogen). MLST was used to determine the sequence type (Wirth et 
al., 2006). 
E. coli HUC270 was resistant only to ampicillin and cephalothin, being 
susceptible to amoxicillin-clavulanic acid, piperacillin- tazobactam, cefotaxime, 
ceftazidime, levofloxacin, ciprofloxacin, gentamicin, trimethoprim-sulfamethoxazole, 
and nitrofurantoin. An inverted relationship between the presence of virulence factors 
and susceptibility to quinolones has been reported in uropathogenic E. coli, which 
may suggest a possible association of E. coli HUC270 with a virulent phylogenetic 
group like B2 (Moreno et al., 2006). The majority of uropathogenic strains belonging 
to the B2 phylogroup contain three or more PAIs (Sabaté et al., 2006). Indeed, E. coli 
HUC270 encoded different virulence determinants in PAIs: in PAI III536, S-fimbriae 
and an iron siderophore system; in PAI IV536, the yersiniabactin siderophore system; 
and in PAI IICFT073, P-fimbriae and iron-regulated genes. However, it was not possible 
to cluster the strain in the major phylogenetic groups or subgroups (Clermont et al., 
2000; Escobar-Páramo et al., 2004b). The chuA gene was not amplified, but the yjaA 
and DNA fragment tspE4.C2 genes were present in the genome (Figure 2.1). The 
result was reproducible and consistent for six colonies submitted to triplex PCR to 
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avoid the hypothesis of a mix of strains belonging to the A0 or A1 (Escobar-Páramo 
et al., 2004b) and B1 phylogroups. 
 
Figure 2.1 – Triplex PCR profiles specific for E. coli phylogenetic groups. Lanes 1 and 2, group A; 
lane 3, group B1; Lanes 4 and 5, group D; lanes 6 and 7, group B2; lane 8, E. coli HUC270 profile. 
Lane M contained 100bp marker. 
 According to the MLST scheme (MLST databases at the Environmental 
Research Institute [ERI], University College Cork), E. coli HUC270 revealed a new 
sequence type (ST2084), which was related to the B2 reference E. coli strain 
(ST127) by five housekeeping genes (adk, gyrB, icd, mdh, and recA). These findings 
suggested that this unusual genotype profile may be included in phylogroup B2 and 
not   considered   as   a   “hybrid”   strain   like   E. coli reference strain 70 (ECOR 70), in 
which some housekeeping genes exhibit nucleotide sequences shared by group A 
ECOR strains and some show sequences from B1 ECOR strains (Clermont et al., 
2000). 
To our knowledge, the combination of yjaA gene and DNA fragment tspE4.C2 
reported here has not been described previously. A study correlating phylogroup with 
MSLT results for 600 E. coli strains did not report this phylogenetic profile (Gordon et 
al., 2008), suggesting that it is uncommon. Also, it could not be assigned to one of 
the seven groups defined by Escobar-Páramo et al. (Escobar-Páramo et al., 2004b). 
On the basis of the results of PAI determination, MLST profile, and susceptibility to 
quinolones, we suggest that E. coli strains showing this combination of genes by the 
triplex PCR method should be assigned to the major phylogenetic group B2 and 
considered potentially pathogenic. 
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ABSTRACT 
This study aimed to characterize the relation between pathogenicity islands (PAIs), 
single virulence genes and resistance among uropathogenic Escherichia coli, 
evaluating the resistance plasmid carriage fitness cost related to PAIs. For 65 urinary 
E. coli antimicrobial susceptibility and ESBL-production were determined with Vitek 2 
AES. Phylogroup determination, detection of PAIs, virulence genes papAH, papC, 
sfa/foc, afa/dra, iutA, kpsM II, cnf1, eaeA, hlyA, stx1 and stx2; plasmid replicon typing 
and screening for plasmidic resistance determinants qnr,   aac(6’)-Ib-cr, qepA and 
blaCTX-M were done by PCR. Conjugation was performed between a donor carrying 
IncF, IncK and blaCTX-M-15, and receptors carrying one to six PAIs. The relative fitness 
of transconjugants was estimated by pairwise competition experiments. PAI IV536 
(68%), gene iutA (57%) and resistance to ampicillin were the most prevalent traits. 
PAI I536, PAI II536, PAI III536 and PAI IIJ96 were exclusively associated to susceptibility 
to amoxicillin-clavulanic acid, cefotaxime, ceftazidime, ciprofloxacin, gentamicin and 
trimethoprim-sulfamethoxazole and were more prevalent in strains susceptible to 
ampicillin and cephalothin. PAI IV536, PAI IICFT073 and PAI ICFT073 were more prevalent 
among resistance to amoxicillin-clavulanic acid, cephalothin, cefotaxime, ceftazidime, 
and gentamicin. An inverted relation was observed between the number of plasmids 
and number of PAIs carried. Transconjugants were obtained for receptors carrying 
three or less PAIs. The mean relative fitness rates obtained were 0.87 (two PAIs), 
1.00 (one PAI) and 1.09 (three PAIs). The interplay between resistance, PAIs 
carriage and fitness cost of plasmid acquisition could be considered PAI specific, and 
not necessarily associated to the number of PAIs.  
INTRODUCTION 
Uropathogenic Escherichia coli (UPEC) are the most frequent cause of community 
and hospital acquired urinary tract infections. They express several virulence factors 
that contribute to the efficient colonization and infection of the host urinary tract 
(Wiles et al., 2008), such as adhesins, siderophores and toxins. Some of these 
virulence determinants are usually encoded in chromosomal DNA segments known 
as pathogenicity islands (PAIs), which are mobile genetic elements that can be 
transferred horizontally, thus dramatically changing the phenotype of the receptor 
(Gal-Mor & Finlay, 2006; Hacker et al., 1997). 
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 The antimicrobial resistance reported in UPEC during the last decades has 
become a major concern. The acquisition of resistance genes through mobile genetic 
elements, such as plasmids, is the major force of the antimicrobial resistance 
dissemination, enhancing the survival capacity of bacteria under antibiotic pressure 
(Bennett, 2008). In the clinical management, it is usually accepted that resistance, 
especially multidrug resistance, equates the virulence of the strain. However, 
molecular studies indicated an inverted relationship between the distribution of 
virulence factors and antimicrobial resistance determinants, and particularly with 
quinolones (Johnson et al., 2003; Moreno et al., 2006; Piatti et al., 2008; Vila et al., 
2002). 
Phylogenetic analysis of extra-intestinal pathogenic E. coli (ExPEC) strains 
showed that they cluster into four main groups, in which virulent strains belong 
mainly to phylogroup B2 and, to a lesser extent, to group D, and most of the 
commensal strains belong to groups A and B1 (Clermont et al., 2000). Eventually, 
the less virulent strains maybe more prone to acquire resistance determinants, and 
this has been demonstrated for resistance to quinolones (Vila et al., 2002). However, 
this interplay between virulence and resistance has been reported for single genes 
and not for genes located in higher segments of DNA. To the best of our knowledge, 
the relation between the main pathogenicity islands detected in UPEC strains and 
antimicrobial resistance has not been addressed. We hypothesize that maintenance 
of PAIs and plasmids carrying resistance genes will impose a biological cost to the 
host cell. In fact, most of the studies show a fitness burden associated with the 
presence of resistant plasmids (Björkman & Andersson, 2000). Therefore, the main 
objectives of this study were to characterize the relation between the presence of 
virulence determinants, including PAIs, the antimicrobial resistance profile and the 
phylogenetic background in a collection of clinical E. coli isolated from urine samples 
in a University hospital. Additionally, we intended to evaluate the fitness cost 
conferred by the acquisition of a resistance plasmid in strains harboring different 
number of diverse PAIs. 
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MATERIALS AND METHODS 
Bacterial isolates and susceptibility testing 
A total of 65 non-duplicate E. coli isolates were collected from urine samples during 
November and December 2007, from different wards of the Coimbra Hospital and 
University Centre (CHUC), Portugal.  
The antimicrobial susceptibility profiles and the preliminary identification of 
ESBL-producing isolates were determined at the Service of Clinical Pathology using 
the Vitek 2 Advanced Expert System (BioMérieux, Marcy l´Etoile, France). The 
results were interpreted according Clinical and Laboratory Standards Institute 
guidelines (C.L.S.I., 2010). E. coli ATCC 25922 was used as a quality control strain. 
Phylogenetic analysis 
Determination of the major E. coli phylogenetic groups (A, B1, B2 and D) was 
performed by using a simple PCR-multiplex based technique which screens for chuA, 
yjaA and DNA fragment tspE4.C2 genes (Clermont et al., 2000; Mendonça et al., 
2011). 
Detection of pathogenicity island markers and virulence genes 
PAIs markers were detected using the Bronowski et al. method (Bronowski et al., 
2008), based in the technique described by Sabaté et al. (Sabaté et al., 2006). The 
method consists in three multiplex-PCR which allow the detection of eight PAIs, 
encoding different virulence genes: PAI I536,  α-haemolysin, CS12 fimbriae and F17-
like fimbrial adhesin; PAI II536,   α   -haemolysin and P-related fimbriae; PAI III536, S-
fimbriae and an iron siderophore system; PAI IV536, yersiniabactin siderophore 
system; PAI IJ96,  α  -haemolysin and P-fimbriae; PAI IIJ96,  α  -haemolysin, Prs-fimbriae 
and cytotoxic necrotising factor 1; PAI ICFT073,   α   -haemolysin, P-fimbriae and 
aerobactin; and finally PAI IICFT073 coding for P-fimbriae and iron-regulated genes.  
Other virulence genes that maybe present in ExPEC such as papAH, papC (P 
fimbriae structural subunit and assembly), sfa/foc (S and F1C fimbriae), afa/dra (Dr-
binding adhesins), iutA (aerobactin receptor), kpsM II (group 2 capsules) and cnf1 
(cytotoxic necrotizing factor 1) were screened by PCR (Johnson & Stell, 2000). 
Additionally, specific genes of intestinal pathogenic E. coli (IPEC), namely the 
Enterohemorrhagic E. coli associated virulence genes eaeA (intimin), hlyA (pore-
Chapter 3 
55 
 
forming cytolysin), stx1 and stx2 (shiga-like toxins) were also screened (Ram, 
Vajpayee, & Shanker, 2008). 
PCR products were purified using the QIAquick PCR Purification kit (QIAGEN, 
Izasa, Portugal), according to the manufacturer's instructions and amplicons were 
further sequenced at Macrogen, Amsterdam, Netherlands. 
Antimicrobial resistance determinants detection 
The blaCTX-M, blaTEM and blaSHV genes encoding for β-lactamases and the plasmid 
mediated quinolone resistance (PMQR) determinants aac(6’)-Ib-variant, qnrA, B and 
S, and qepA were screened with specific primers by PCR (Cattoir, Poirel, Rotimi, 
Soussy, & Nordmann, 2007; Ma et al., 2009; Mendonça, Leitão, Manageiro, Ferreira, 
& Caniça, 2007; Park, Robicsek, Jacoby, Sahm, & Hooper, 2006). All the amplicons 
were purified with ExoSAP-IT and further sequenced at Macrogen, Amsterdam, 
Netherlands. 
Plasmid Replicon typing 
Plasmid replicons were identified by a PCR-based replicon typing scheme described 
by Carattoli et al. (Carattoli et al., 2005), that consists of five different multiplex and 
three simplex, and allows the detection of the major replicon families in 
Enterobacteriaceae: HI2, HI1, I1-ϒ, X, L/M, N, FIA, FIB, FIC,W, Y, P, A/C, T, K and 
B/O. 
Biological fitness assessment 
Conjugation assays were used to transfer a plasmid carrying a resistance 
determinant gene into recipients with diverse number of PAIs. Strain Ec161B 
(Calhau, Ribeiro, Mendonça, & Da Silva, 2013) was used as a plasmid donor. E. coli 
strains with one to six PAIs were used as receptors: Ec396 (PAI IV536), Ec93 (PAI 
IV536, PAI IICFT073), Ec107 (PAI IV536, PAI ICFT073 and PAI IICFT073)  Ec 112 (PAI I536 , 
PAI II536,  PAI IV536 and PAI IIJ96), Ec270 (PAI I536 , PAI III536,  PAI IV536, PAI IICFT073 
and PAI IIJ96) and Ec91(PAI I536 , PAI II536,  PAI IV536, PAI ICFT073, PAI IICFT073 and PAI 
IIJ96). Briefly, donor and recipient strains were grown in Luria Bertani (LB) broth 
overnight and mating assays were performed in LB agar using 100 µl of receptor and 
50 µl of the donor, and incubated at 37ºC overnight. A suspension of the grown 
culture was made in 500 µl of physiological serum and 25 µl were dispersed into 
selective plates. The transconjugants were selected in LB agar plates containing 10 
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µg/ml of tetracycline plus 1 µg/ml of cefotaxime or 50 µg/ml of nalidixic acid plus 1 
µg/ml of cefotaxime, according to the receptor resistance profile. The acquisition of 
the plasmid was confirmed by PCR. 
The relative fitness (W) of plasmid-carrying transconjugants was estimated by 
pairwise competition experiments between the transconjugants and the receptor 
strain in S2-minimal medium for 24 h, as previously described (Ray et al., 2009), with 
the exception that 25 mg/ml glucose was added to the medium (Enne et al., 2005). 
Briefly, a single CFU was inoculated in the medium and incubated at 37 ºC overnight 
with good aeration (225 rpm) (Day -1). On the next day (Day 0), cultures were diluted 
1:10 in 0.9 % NaCl, and equal amount of each competitor was transferred into the 
medium. The initial cell density [A (0) and B (0)] was determined by plating different 
dilutions of the wild-type strain and the transconjugants in antibiotic-free LB and in LB 
supplemented with 1 µg/ml of cefotaxime, respectively. The competition culture was 
incubated at 37 ºC with agitation at 225 rpm. After 24 hrs, the competition assay was 
stopped (Day 1). The culture was diluted and different dilutions were plated in LB 
with antibiotic selection and without selection, to calculate the final density [A(1) and 
B(1)] of each competitor. Twelve to fifteen competition replicates were done for each 
transconjugant. 
The relative fitness (W) was calculated as the ratio of the Malthusian 
parameter of each competitor: WAB = MA/MB, where MA = ln [A(1)/A(0)], MB = ln 
[B(1)/B(0)], A or B(0) = estimated density of A or B at Day 0 (cells per ml), and A or 
B(1) = estimated density of A or B at Day 1 (cells per ml). 
Statistical analysis 
Chi-square test and t-test were applied using IBM SPSS statistics version 22.0. A 
P≤0.05   was   considered   statistically significant for the chi-square test and the 
variables considered statistically associated. 
RESULTS 
Strains origin and phylogeny 
E. coli strains were obtained from patients suffering from UTIs presenting ages from 
14 to 98 years, with the majority being isolated from female gender (72%). Fifty-
seven percent of the isolates were from nosocomial origin while the remaining 43% 
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were from community UTIs. The most prevalent phylogroup was B2 (46%) followed 
by group A (28 %), B1 (15%) and phylogenetic group D (11%) (Table 3.1). 
Table 3.1 – Prevalence of Pathogenicity Islands, virulence genes and plasmid groups in the different 
phylogroups. 
 Prevalence % (n) 
Phylogenetic groups  
 A 
(n=18) 
B1 
(n=10) 
B2 
(n=30) 
D 
(n=7) 
Pathogenicity islands     
PAI I536 0 (0) 0 (0) 20 (6) 0 (0) 
PAI II536 0 (0) 0 (0) 13 (4) 0 (0) 
PAI III536 0 (0) 0 (0) 7 (2) 0 (0) 
PAI IV536 39 (7) 10 (1) 100 (30) 86 (6) 
PAI ICFT073 0 (0) 0 (0) 80 (24) 43 (3) 
PAI IICFT073 0 (0) 0 (0) 90 (27) 14 (1) 
PAI IIJ96 0 (0) 0 (0) 20 (6) 0 (0) 
Virulence genes     
papAH 6 (1) 20 (2) 27 (8) 43 (3) 
papC 6 (1) 20 (2) 40 (12) 57 (4) 
afa/draBC 6 (1) 0 (0) 0 (0) 14 (1) 
sfa/focDE  11 (2) 10 (1) 20 (6) 0 (0) 
kpsMTII 22 (4) 40 (4) 73 (22) 57 (4) 
iutA 22 (4) 40 (4) 87 (26) 43 (3) 
cnf1  11 (2) 10 (1) 43 (13) 14 (1) 
eae  0 (0) 0 (0) 7 (2) 0 (0) 
stx1  6 (1) 0 (0) 3 (1) 0 (0) 
Plasmid Group         
IncF 78 (14) 70 (7) 90 (27) 100 (7) 
Inc K 83 (15) 90 (9) 43 (13) 14 (1) 
IncB/O 11 (2) 10 (1) 10 (3) 14 (1) 
IncHI 0 (0) 20 (2) 0 (0) 0 (0) 
IncI 28 (5) 30 (3) 13 (4) 43 (3) 
IncX 0 (0) 0 (0) 0 (0) 0 (0) 
IncL/M 0 (0) 0 (0) 0 (0) 0 (0) 
IncN 0 (0) 0 (0) 13 (4) 0 (0) 
IncW 22 (4) 30 (3) 7 (2) 14 (1) 
IncY 6 (1) 20 (2) 0 (0) 0 (0) 
IncP 22 (4) 10 (1) 0 (0) 29 (2) 
IncA/C 6 (1) 0 (0) 0 (0) 0 (0) 
IncT 0 (0) 0 (0) 0 (0) 0 (0) 
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Virulence characterization 
The pathogenicity islands most frequently detected were PAI IV536 (68%) followed by 
PAI IICFT073 (42%) and PAI ICFT073 (42%) (Table 3.1). PAI I536 and PAI IIJ96 were 
detected in 9% of the isolates , PAI II536 in 6% and PAI III536 in 3% (n=2). PAI IJ96 was 
not detected. PAI I536, PAI II536, PAI III536 and PAI IIJ96 were exclusively detected in 
phylogroup B2 and PAI IV536 was detected among all the phylogroups but was more 
prevalent among phylogroups B2 (100%) and D (86%). PAI ICFT073 and PAI IICFT073 
were only detected in phylogroups B2 and D (80% of B2 and 43% of group D 
isolates; and 90% of B2 and 14% of phylogroups D strains, respectively). 
All the virulence genes were identified among the isolates, with exception of 
hlyA and stx2 (Table1). The most frequently detected was iutA (57%), followed by 
kpsMTII (52%), papC (29%), cnf1 (26%) and papAH (22%). The least frequent were 
sfa/focDE (14%) and afa/dra, eae and stx1, each detected in 3% of the isolates.  The 
majority of the virulence genes were more frequently identified among B2 
phylogroup. Exceptions were genes papAH (43%), papC (57%) and afa/dra (14%), 
more prevalent among isolates from phylogenetic group D, and stx1 gene, detected 
in one isolate from phylogroup A and in other from B2 group.    
Phenotypic and genotypic resistance profile 
Resistance to ampicillin was the most frequent (74%) followed by ciprofloxacin 
(69%), cephalothin (57%) trimethoprim-sulfamethoxazole (48%), amoxicillin-
clavulanic acid (42%), and gentamicin (29%). Resistance to cefotaxime and 
ceftazidime were the least detected among isolates (19% each).  
The plasmidic resistance determinants, aac  (6’)-lb-cr (49%) and blaCTX-M (19%) 
were the most prevalent while qnrA and qnrS genes were only detected in 3% of the 
strains. The qnrB and qepA genes were not identified. Gene aac   (6’)-lb-cr was 
detected in 44% of strains resistant to ciprofloxacin. 
Phylogenetic background and virulence genes in relation to phenotypic 
resistance  
The distribution of the phylogroups and virulence traits among susceptible and 
resistant strains to different antibiotics are shown Table 3.2. Phylogroups A, B1 and 
D were more prevalent among susceptible isolates to amoxicillin-clavulanic acid, 
cefotaxime, ceftazidime and gentamicin, while group B2 was more prevalent in the 
resistant isolates. The reverse was observed for trimethoprim-sulfamethoxazole. 
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Phylogroups A, B1, and D were more prevalent in resistant isolates (42% vs 15%, 
23% vs 9% and 16% vs 6%, respectively) while isolates from phylogroup B2 were 
more susceptible (71% vs 19%).   
Considering resistance to ampicillin and ciprofloxacin, phylogenetic group A 
was more prevalent among resistant strains, compared to the susceptible isolates 
(31% vs 18% for ampicillin and 33% vs 15% for ciprofloxacin). The same was 
observed for phylogroup B1 (17% vs 12% and 20% vs 5%, respectively). On the 
opposite, phylogroups B2 (59% vs 42% for ampicillin and 55% vs 42% for 
ciprofloxacin) and D (12% vs 10% and 25% vs 4%, respectively) were more prevalent 
among susceptible strains. 
The majority of virulence genes were more prevalent among susceptible 
isolates (Table 3.2). Exceptions were observed for iutA, kpsMTII, afa/dra and eae 
genes:  iutA gene was more common in resistant strains except for trimethoprim-
sulfamethoxazole (71% of susceptible vs 42% of resistant); kpsMTII  was more 
frequent among resistant strains except for ciprofloxacin (60% in susceptible vs 49% 
in resistant) and trimethoprim-sulfamethoxazole (62% in susceptible vs 42% in 
resistant strains);  afa/dra was more prevalent among ampicillin resistant strains (4% 
vs 0%); and eae was most frequently detected among strains resistant to ampicillin 
(4% vs 0%), amoxicillin-clavulanic acid (4% vs 0%), cephalothin (5% vs 0%), 
ciprofloxacin (4% vs 0%), gentamicin (11% vs 0%) and displayed no differences 
between susceptible and resistant trimethoprim-sulfamethoxazole isolates.      
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Distribution of PAIs according to resistance profile 
Pathogenicity islands PAI I536, PAI II536, PAI III536 and PAI IIJ96 were exclusively found 
among strains susceptible for amoxicillin-clavulanic acid, cefotaxime, ceftazidime, 
ciprofloxacin, gentamicin and trimethoprim-sulfamethoxazole and were more 
prevalent in strains susceptible to ampicillin and cephalothin (Table 3.2). 
Nonetheless, only the absence of PAI I536, PAI II536 and PAI IIJ96 in isolates resistant to 
ciprofloxacin (p<0.001 each), and of PAI I536 and PAI IIJ96 in isolates resistant to 
trimethoprim-sulfamethoxazole (p=0.014 each) were considered statistically 
significant. The remaining PAIs detected were found both in resistant and susceptible 
isolates for all antibiotics studied. PAI ICFT073 was more prevalent in strains 
susceptible for ampicillin (52% vs 38%), ciprofloxacin (50% vs 38%) and 
trimethoprim-sulfamethoxazole (59% vs 23%, p= 0.003) and in strains resistant to 
amoxicillin-clavulanic acid (44%vs 40%), cefotaxime, (75% vs 34%, p=0.009) 
ceftazidime (75% vs 34%, p=0,029),  cephalothin (51% vs 27%) and gentamicin 
(63% vs 33%). PAI IICFT073 was more prevalent among isolates resistant to ampicillin 
(44% vs 41%), amoxicillin-clavulanic acid (56% vs 34%), cefotaxime, (92% vs 32%¸ 
p<0.001), ceftazidime (92% vs 32%, p<0.001), cephalothin (57% vs 35%, p= 0.002), 
ciprofloxacin (44% vs 40%) and gentamicin (74% vs 30% p=0.005) and in isolates 
susceptible to trimethoprim-sulfamethoxazole (65% vs 19% p<0.001).  
Finally PAI IV536 was more prevalent among isolates susceptible to ampicillin 
(82% vs 63%), ciprofloxacin (90% vs 58%, p=0.010) and trimethoprim-
sulfamethoxazole (85% vs 48%, p=0.001) and resistant to amoxicillin-clavulanic acid 
(70% VS 66%), cefotaxime, (92% vs 62%, p= 0.049), ceftazidime (92% vs 62%), 
cephalothin (76% vs 57%) and gentamicin (79% vs 63%) (Table 3.2). 
All isolates carried from none to six PAIs. Isolates resistant to amoxicillin-
clavulanic acid, cefotaxime, ceftazidime, ciprofloxacin, gentamicin, and trimethoprim/ 
sulfamethoxazole did not presented more than three PAIs (Table 3.2).  
Plasmid carriage and virulence markers  
The plasmid group most frequently detected was IncF (85%), followed by IncK (59%). 
IncX, IncL/M and IncT were not detected. IncHI was only detected in strains from 
phylogroups B1, IncN in phylogenetic group B2 and IncA/C was exclusively found in 
isolates from phylogroups A (Table 3.1). 
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The number of PAIs versus plasmids carriage is shown in Table 3.3. Strains 
carrying more than three plasmids contained three or less PAIs, while strains with 
three or less identified plasmids harbored from none to six PAIs (Table 3.3).  
Evaluation of the biological cost conferred by plasmid acquisition in 
transconjugants  
Considering the results obtained, which seem to indicate an inverted relation 
between the amount of plasmids and number of pathogenicity islands simultaneously 
carried in the same isolates, fitness studies were performed. Transconjugants 
carrying a plasmid were only obtained in three receptors harboring three or less 
PAIs. PCR reactions confirmed the presence of IncK and blaCTX-M-15 in the 
transconjugants.  The fitness cost of the same plasmid in the transconjugants was 
evaluated and the mean relative fitness ranged from 0.87 (CI 0.61-0.87) to strain 93 
(2 PAIs); 1.00 (CI 0.86-1.12) to strain 396 (1 PAI) and 1.09 (CI 1.09-1.29) for strain 
107 (3 PAIs).    
Table 3.3 – Distribution of isolates according to the number of PAIs and number of identified plasmids. 
 Prevalence % (n) 
Number of identified plasmids 
 
 ≤1 
(n=19) 
2 
 (n=26) 
3 
 (n=15) 
≥4 
(n=5) 
Number of Pathogenicity 
Islands     
0 10 (2) 39 (10) 47 (7) 40 (2) 
1 16 (3) 8 (2) 27 (4) 40 (2) 
2 16 (3) 19 (5) 0 (0) 0 (0) 
3 53 (10) 19 (5) 20 (3) 20 (1) 
4 0 (0) 4 (1) 0 (0) 0 (0) 
5 0 (0) 4 (1) 0 (0) 0 (0) 
6 5 (1) 8 (2) 7 (1) 0 (0) 
DISCUSSION 
E. coli is one of the most versatile bacterial species and the diversity of its lifestyles is 
achieved through a high degree of genomic plasticity, via gene loss or gain, through 
lateral gene transfer (Rasko et al., 2008). Pathogenicity islands are important mobile 
genetic elements which allow the simultaneous transmission of several virulence 
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determinants in one single horizontal gene transfer event, leading to important 
changes in the virulence phenotype of bacteria. Despite of the importance of PAIs in 
the bacterial genome, generally these elements have not been included in studies 
focusing in the interplay between resistance and virulence. Thus the main goal of this 
study was to investigate the association between the main PAIs found in UPEC, 
virulence genes, phylogenetic background and resistance, as well as evaluate the 
possible influence of the presence of PAIs in the acquisition of a resistance plasmid.  
A link between phylogeny and virulence has been previously reported in E. coli 
strains. The most virulent strains belong mainly to group B2, and in lesser extent to 
group D, while the commensal strains are mostly associated with groups A and B1 
(Clermont et al., 2000; Picard et al., 1999). In this UPEC collection, phylogroup B2 
was the most prevalent and was the only group in which PAI I536, PAI II536, PAI III536 
and PAI IIJ96 were detected. The remaining PAIs were also more prevalent among 
strains from this group. Sabaté et al. similarly reported the occurrence of PAI II536 and 
III536 only among B2 strains, and PAI I536 and IIJ96 among B2 and B1 strains (Sabaté 
et al., 2006). There is evidence that PAI II536 and PAI III536 are the most unstable 
islands, and thus more prone to be excised, which may explain the low prevalence 
found in this study (Middendorf et al., 2004). The fact that these PAIs have only been 
detected among B2 strains may lead us to speculate that this phylogroup possibly 
provides a genetic background which may somehow contribute to enhance the 
stability of this islands in the bacterial genome. In addition, the virulence genes 
detected were also more frequent in B2 phylogroup with the exception of papAH and 
papC and afa/dra, more common in phylogroup D, considered to be the second more 
virulent. Nonetheless the reduced number of strains from this phylogenetic group 
compared to the remaining phylogroups may be influencing the results, as this was 
the less prevalent group among our strains. The concentration of virulence factors 
within group B2 isolates is mainly due by a genetic background that allows numerous 
horizontal gene transfer events (Escobar-Páramo et al., 2004a). This may explain the 
higher prevalence of virulence factors and PAIs among this group. 
Genes eae and stx1 though rare, were detected among the isolates. This 
observation emphasizes the possible role of food reservoirs and foodborne 
transmission of E. coli and the development of UTIs (Vincent et al., 2010). 
The iutA gene, encoding the aerobactin receptor, part of a siderophore system 
was the most detected virulence gene. The production of aerobactin was shown to 
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facilitate the growth in urine (Johnson, Moseley, Roberts, & Stamm, 1988), a medium 
with limited iron conditions, in which siderophores may be extremely useful and 
constitute an important virulence factor in UTIs development. 
 The isolates presented high levels of resistance to aminopenicillins, third 
generation cephalosporins, aminoglycosides, and fluoroquinolones compared to the 
average rates of resistance reported in Portugal for the year of 2007 (EARSS, 2007 ). 
Resistance to third generation cephalosporins was associated to the production of 
CTX-M-15 beta-lactamase associated with phylogenetic group B2, which is in 
concordance with previous reports (Coque et al., 2008b; Karisik et al., 2008).  
Higher prevalence of phylogroup B2 was observed in strains susceptible to 
ampicillin, ciprofloxacin and trimethoprim/ sulfamethoxazole, which may account for 
the old paradigm of a tradeoff between resistance and virulence (Houdouin et al., 
2006; Johnson et al., 2005b; Johnson et al., 2003; Moreno et al., 2006; Piatti et al., 
2008). Nonetheless, considering resistance to ampicillin and ciprofloxacin, though the 
susceptible isolates   presented   higher   prevalence’s   of   B2   group   compared   to   the  
resistant ones, B2 was still the most prevalent phygroup among resistant strains. 
Thus, a shift towards non-B2 phylogroups was only observed for sulfamethoxazole-
trimethoprim. 
A positive relation was observed for phylogroup B2 and the most frequent 
PAIs, PAI IV536, PAI IICFT073 and PAI ICFT073 and resistance to amoxicillin-clavulanic 
acid, cephalothin, cefotaxime, ceftazidime, and gentamicin. It has been suggested 
that some plasmids, including from FIB replicon may be carriers of PAIs (Johnson & 
Nolan, 2009). PAI IV536, also known as the High Pathogenicity Island (HPI), may be 
transferred by a conjugative F plasmid (Schubert et al., 2009), and PAI II536 was also 
previously transferred using conjugation (Schneider et al., 2011). The higher 
prevalence of the most common islands, including PAI IV536, among strains resistant 
to antibiotics, which are mainly associated to plasmidic resistance mechanisms, may 
suggest that these islands may be using resistance plasmids to potentiate their 
dissemination. 
The remaining PAIs were only detected among strains susceptible to all the 
antibiotics tested, with the exception of ampicillin and cephalothin. For these 
antibiotics, although the PAIs were also present in resistant strains, they were more 
prevalent in susceptible strains. This confirms that the trade-off between resistance 
and virulence is also verified for the PAIs considered to be more unstable. Previous 
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studies have already demonstrated that the resistance to quinolones is associated to 
a lower prevalence of PAI IIJ96-like domains (Houdouin et al., 2006; Piatti et al., 
2008). 
The presence of virulence genes was generally more frequent among strains 
susceptible to the tested antibiotics, which was in agreement with previous studies, 
particularly with quinolone susceptible strains (Johnson & Stell, 2000; Moreno et al., 
2006; Piatti et al., 2008; Vila et al., 2002). Nonetheless this tendency was not 
observed for iutA, afa/dra and eae genes. This could be associated to the fact that 
these genes may be carried by plasmids which also contain resistance determinants.  
The results seemed to indicate an inverse tendency between the number of 
plasmids and the number of pathogenicity islands. This led us to the hypothesis that 
the presence of more PAIs may be a factor that could affect the acquisition of 
plasmids. The fact that we could not obtain transconjugants using strains with more 
than three PAIs as receptors seemed to confirm this hypothesis. Nonetheless, the in 
vitro fitness studies performed between transconjugants and the wild-type receptor 
indicated that, at least for strains harboring three or less PAIs, the carriage of higher 
number of islands was not directly associated to a higher fitness cost conferred by 
the acquisition of the plasmid. The absence of a clear fitness burden imposed by the 
initial acquisition of a resistance-encoding plasmid differs from most of the fitness 
studies, where it is associated with a biological cost (Dionisio, Conceição, Marques, 
Fernandes, & Gordo, 2005; Enne et al., 2005). Thus, other factors possibly related to 
the genetic background of bacteria may be responsible for this tendency. 
Nonetheless, the transconjugants were only carriers of the PAIs considered to be 
more prevalent, and as we have seen which seem to be positively associated to the 
presence of resistance mediated by plasmidic determinants, including to third 
generation cephalosporins. In fact, the combination of three PAIs carried by the 
transconjugant with a fitness advantage compared to the receptor strain has already 
been reported as being the prevalent combination of PAIs for clone ST131 (Calhau et 
al., 2013). Therefore, the trade-off between the plasmid number and the number of 
PAIs may be related to the presence or absence of specific PAIs rather than their 
number. 
This study confirms previous reports of the trade-off between resistance and 
virulence and provides new insights into the interplay between resistance and 
virulence encoded by pathogenicity islands. 
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ABSTRACT 
Escherichia coli ST131, is an important cause of multidrug-resistant infections. Thus, 
the aim of this study was to evaluate the concomitant presence of resistance 
plasmids and pathogenicity islands (PAIs) in ST131 E. coli. From 97 extra-intestinal 
E. coli characterized for antimicrobial susceptibility and extended-spectrum beta-
lactamase production, 16% of isolates were identified as CTX-M-15 producers. 
These strains were studied by PFGE, MLST and phylogroups, plasmid groups, PAIs 
and plasmid-mediated quinolone-resistance determinants. MLST identified one ST10 
strain from phylogroup A and the remaining isolates were ST131, from group B2. 
Despite the genetic variability, 64% of ST131 strains presented a profile composed 
by PAI IV536, PAI ICFT073 and PAI IICFT073, IncF plasmid, blaCTX-M-15 and aac(6’)-lb-cr 
genes. The prevalent virulence and resistance profile detected among the strains, 
may constitute an optimal combination of factors which allow E. coli ST131 to 
maintain both features becoming concomitantly virulent and extremely resistant. 
INTRODUCTION 
The high levels of resistance observed in Escherichia coli, a pathogen responsible for 
several infections in the human host, to several important antibiotics groups, such as 
cephalosporins and quinolones, have become a main concern. One of the most 
successful E. coli clone, ST131, has emerged as very important cause of multidrug-
resistant infections worldwide (Totsika et al., 2011). 
The E. coli ST131 clone has been usually   associated   with   resistance   to   β-
lactams, mostly due to the production of extended-spectrum beta-lactamase (ESBL) 
CTX-M-15, which confers resistance to penicillins, cephalosporins and monobactams 
except to cephamycins (Rogers, Sidjabat, & Paterson, 2011). Resistance to 
fluoroquinolones is also frequently found in E. coli ST131 clones, probably 
potentiated by the presence of plasmid-mediated quinolone resistance (PMQR), like 
qnr encoding   genes   or   aminoglycoside   modifying   enzyme   AAC(6’)-Ib-cr, usually 
present in ST131 strains (Rogers et al., 2011). These mobile resistance determinants 
(ESBLs and PMQRs), responsible for antimicrobial resistance, can be carried and 
disseminated through plasmids. In Enterobacteriaceae family, plasmids are gathered 
into major replicon families HI2, HI1, I1-ϒ, X, L/M, N, FIA, FIB, FIC, W, Y, P, A/C, T, 
K, B/O (Carattoli, 2009). 
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Additionally to the resistance capacities, E. coli ST131 strains have been 
described to harbor several virulence factors, contributing to the pathogenicity and 
invasion of the hosts. These determinants are generally involved in escaping the host 
immune system, adhesion, collection of nutrients under limited conditions and 
induction of inflammation, instigating the development of extraintestinal pathology. 
Virulence factors in this clone include toxins, adhesins, and siderophore systems 
among others (Rogers et al., 2011). Furthermore, the virulence factors can be carried 
and disseminated by horizontal gene transfer through pathogenicity islands (Sabaté 
et al., 2006). Although several virulence factors have been identified in E. coli ST131 
strains (Lavigne et al., 2012), the lack of pathogenicity islands could make it less 
virulent than other uropathogenic bacteria. 
Regardless of the general assumption that the acquisition of resistance may 
have a fitness cost which leads to decreased virulence, E. coli ST131 has proven to 
be able to maintain both features (Clark et al., 2010). Thus, the aim of this work was 
to evaluate the concomitant presence of plasmids as resistance determinants 
transporters and pathogenicity islands carrying several virulence factors in multidrug 
resistant ST131 E. coli clinical isolates.  
MATERIALS AND METHODS 
From a total group of 97 non-duplicate isolates of E. coli collected between 
November and December 2007 from different clinical samples and wards of the 
University Hospitals of Coimbra (HUC), located in the Centre region of Portugal, 
presumable ESBL producers were selected based in the antimicrobial susceptibility 
tests. ESBL production was further confirmed with the double disk synergy test using 
the antimicrobials disks of amoxicillin-clavulanic acid, cefotaxime, ceftazidime, 
cefepime and aztreonam (OXOID). Results interpretation was done according 
Clinical and Laboratory Standards Institute guidelines (C.L.S.I., 2010). E. coli ATCC 
25922 was used as a quality control strain. 
Initially, multi-locus sequence typing (MLST) was performed based in the 
University of College Cork (Cork, Ireland) scheme for E. coli (Wirth et al., 2006). To 
strengthen the phylogenetic relationship of the strains, pulsed-field gel 
electrophoresis (PFGE) was performed as previously described (Mendonça et al., 
2007), and PFGE images were analyzed with Bionumerics 6.6. Clustering was 
performed using the Dice band-based similarity coefficient, with a band position 
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tolerance of 1.0% and an optimization of 1.8. A cutoff value of 80% similarity was 
determined by the cluster cutoff method according to Bionumerics software. Isolates 
with a Dice band-based similarity coefficient value > 80% were assigned to the same 
cluster. 
In order to evaluate the presence of resistance determinants, PMQR and 
ESBL encoding genes (qnrA, B and S, aac[6’]-Ib-variant, qepA and blaCTX-M) were 
screened by PCR (Cattoir et al., 2007; Ma et al., 2009; Park et al., 2006). E. coli 
12HUC carrying the blaCTX-M-15 and aac(6’)-lb-cr determinants, Klebsiella 
pneumoniae5, carrying qnrA and qnrB, and the plasmid pSTV that carries qepA, 
were used as positive controls in PCR. Resulting PCR products were submitted to 
purification using the QIAquick PCR Purification kit (QIAGEN, Izasa, Portugal), 
according to the producer's instructions and were sequenced at Macrogen, South 
Korea.  
The detection of plasmid mediated resistance mechanisms implied the plasmid 
replicon typing. For this, a PCR-based replicon typing scheme described by Carattoli 
et al. detecting the principal incompatibility groups in enterobacteria: HI2, HI1, I1-ϒ, 
X, L/M, N, FIA, FIB, FIC,W, Y, P, A/C, T, K and B/O was performed (Carattoli et al., 
2005). When needed, plasmid extraction was performed using QIAGEN Plasmid Midi 
Kit. 
Finally, to evaluate the pathogenicity potential of these E. coli strains, 
pathogenicity island (PAI) markers were detected using the method of Sabaté et al. 
consisting in three multiplex-PCR which allow the detection of eight PAIs (Sabaté et 
al., 2006), reinforced by the determination of the major E. coli phylogenetic groups 
(A, B1, B2 and D), according to the  Clermont’s  method (Clermont et al., 2000). 
RESULTS AND DISCUSSION 
ST131 clone is a highly adapted E. coli with a genetic structure with several virulence 
and resistance genes which contribute to the efficient and global spread of this 
pathogen. The virtual omnipresence of ST131 E. coli strains, normally associated 
with CTX-M-15 ESBL production, impelled us to investigate the relationship between 
the presence of plasmids and PAIs within the cell. Thus, the present study aimed the 
investigation of the optimal relationship between these two mobile elements, within 
multidrug resistant ST131 E. coli strains presenting PMQRs and ESBL. 
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 From the total of 97 isolates, the co-analysis of the antibiogram performed by 
Vitek2Advanced Expert System and the double disk synergy results indicated the 
expression of ESBL in 15 strains, and suggested the production of CTX-M enzymes. 
This was further confirmed using PCR and sequencing techniques which identified 
the blaCTX-M-15 gene, whose expression was responsible for the ESBL phenotype in all 
strains. 
 In order to establish a phylogenetic relationship between the isolates, MLST 
was first executed, which allowed the identification of ST131 clone in 93% of the 
strains, all belonging to phylogroup B2. The remaining strain was integrated in the 
phylogenetic group A and presented a MLST corresponding to the ST10. ST131 has 
been mainly known as a worldwide extraintestinal pathogenic E. coli from phylogroup 
B2 with the capacity to acquire simultaneously virulence and resistance, thus having 
the capacity to cause severe antimicrobial-resistant infections  (Rogers, Sidjabat, & 
Paterson, 2011). This clone contradicts the hypothesis that bacteria displaying high 
levels of resistance have a high fitness cost which results in decreased pathogenic 
capacities (Clark et al., 2010). 
 In this study, despite of the genetic variability observed in the PFGE profiles 
for the ST131 isolates, it was possible to observe that 64% of the strains presented 
the same characteristics in terms of virulence and resistance determinants (Figure 
4.1). These strains presented one IncF plasmid, containing a blaCTX-M-15 and aac(6’)-
lb-cr genes and three PAIs (PAI IV536, PAI ICFT073 and PAI IICFT073). This may 
constitute a favorable and equilibrated combination of resistance and virulence 
factors for E. coli ST131 clones which may enhance its fitness and adaptation 
capacity, contributing to the dissemination of this clone.  
  
Chapter 4 
72 
 
 
 
 
 
 
 
  
Fi
gu
re
 4
.1
 –
 C
lo
na
l 
re
la
te
dn
es
s 
of
 s
tra
in
s 
an
d 
ch
ar
ac
te
riz
at
io
n 
of
 p
hy
lo
ge
ny
, 
vi
ru
le
nc
e 
an
d 
re
si
st
an
ce
 d
et
er
m
in
an
ts
, a
nd
 p
la
sm
id
 in
co
m
pa
tib
ilit
y 
gr
ou
ps
. 
 
St
ra
in
 
Ph
yl
og
en
et
ic
 
gr
ou
p 
M
LS
T 
PA
Is
 
Pl
as
m
id
s 
ES
BL
 
PM
QR
 
46
7 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
13
8 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
47
 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6 
F 
bla
C
TX
-M
-1
5 
qn
rS
, a
ac
(6
')-
lb
-c
r 
90
 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
30
5 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
15
5 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
89
B
 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6 
F,
 K
 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
85
 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
14
9 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F,
 K
 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
11
5 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F,
 I1
/Ig
 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
16
1 
B
 
A
 
ST
10
 
- 
F,
 K
 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
14
4 
A
 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
94
 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
37
8 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
10
4 
B2
 
ST
13
1 
PA
I I
I C
FT
07
3, 
P
AI
 IV
53
6, 
P
AI
 I C
FT
07
3 
F 
bla
C
TX
-M
-1
5 
aa
c(
6'
)-
lb
-c
r 
Chapter 4 
73 
 
 The resistance determinants blaCTX-M-15, and the aac(6’)-lb-cr enhance the 
survival of E. coli ST131 strains regarding the action of the main antibiotics used in 
clinical practice such as cephalosporins and quinolones. In fact, CTX-M-15 enzyme 
is now worldwide disseminated mostly by E. coli strains, and it has been previously 
detected among portuguese clinical strains (Mendonça et al., 2007). The association 
between blaCTX-M-15 and aac(6’)-lb-cr genes is common, because they are usually 
found in the same plasmid, namely in IncF and in IncI1 plasmids, since they share 
the same genetic platform (Carattoli, 2009). Actually, in all the strains we have 
detected one plasmid from the group IncF.  Moreover,  in  one  ST131  strain  an  IncI1/Iγ  
was also detected and in two ST131 strains and one ST10 isolate the IncK was also 
identified. After plasmid extraction we detected one plasmid carrying blaCTX-M-15, 
aac(6’)-lb-cr as well as PAI IV536 which was assigned by replicon typing to IncF 
group.  
Regardless of the high dissemination of blaCTX-M-15 associated to aac(6’)-lb-cr, 
the acquisition of the mobile element containing these determinants may have an 
implicated fitness cost. In fact Sandegren and colleagues have studied the fitness 
cost of the acquisition of a plasmid containing the multiresistance gene cassette 
associated with ST131 clone composed namely by these two resistance elements 
and found that it originated a reduction of 3-4% of exponential growth rate 
(Sandegren, Linkevicius, Lytsy, Melhus, & Andersson, 2012). 
 The virulence factors encoded in the prevalent combination of PAIs, PAI IV536, 
PAI ICFT073 and PAI IICFT073 include P-fimbriae, siderophore systems and hemolysin 
and may be responsible for the enhancement of the virulence potential of E. coli 
strains and thus the development of more invasive disease (Johnson, 1991; Sabaté 
et al., 2006). In fact, 80% of the strains were isolated from urinary tract, where P 
fimbriae mediates bacterial adherence to human epithelial cells through di-
galactoside-specific binding to the P-blood group antigens, which are present all over 
the urinary tract and enable ascending infection of the ureter and kidney (Johnson, 
1991). Furthermore, siderophores systems, as efficient methods to acquire iron, have 
been described to be essential to bacterial growth especially under limiting conditions 
such as the ones found in the urinary tract (Johnson, 1991). These virulence factors 
present in the detected islands increase the E. coli ST131 capacity to subsist in the 
host and ascend in the urinary tract and may therefore contribute to the survival of 
this clone and to the evolution of its pathogenesis. 
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 Regardless of the presence of PAIs carrying important virulent factors, we 
have not detected other islands which are present in more virulent uropathogenic 
strains. The results are supported by a genomic mapping performed by Lavigne and 
colleagues in which they have not detected typical extraintestinal PAIs such as PAI 
I536, PAI II536 and PAI III536 (Lavigne et al., 2012).  
 In conclusion, the E. coli ST131 clone despite not being an extremely virulent 
clone presents an efficient organization of virulence and resistance determinants. 
The predominant arrangement of virulence and resistance determinants found in the 
ST131 isolates may therefore constitute an optimal and balanced combination, 
providing important resistance and virulence capacities without having an excessive 
fitness cost to bacteria. This may allow the dissemination and survival of these clonal 
strains among the clinical and communitarian sets. 
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ABSTRACT 
Introduction: The main objective of the study was the molecular characterization of 
extended spectrum β-lactamases (ESBL) in Escherichia coli isolates collected from 
human and bovine samples in Oyo state, Nigeria. 
Methodology: Between August 2010-2011, 114 E. coli isolates were collected 
from hospitals (n = 57) and bovine (n = 57). PCR and sequencing were used for 
identification of ESBLs, upstream sequences, plasmid-mediated quinolone resistance 
(PMQR) genes and class 1 integrons. Plasmid incompatibility groups were identified 
among ESBL-positive isolates by PCR. Genetic relatedness was assessed by rep-
PCR and MLST. Transfer of ESBL determinants to the recipient strain E. coli J53 was 
performed by broth mating assays. 
Results: CTX-M-15 was the unique ESBL found in eight human isolates. Six 
CTX-M-15 producers also carry the aac(6’)-lb-cr gene and/or qnrB gene, and class 1 
integrons. FIA, FIB, H11, H12, F, Y and K were the plasmid replicon types found. 
CTX-M-15 and PMQR determinants were transferred by conjugation in two E. coli 
assigned by MLST to ST131 and ST2695, a new allele. 
Conclusions: The study highlights the dissemination ability of CTX-M-15 
associated with PMQR, and the presence of class 1 integrons, able to capture 
additional genes, justifying the urgent need of antimicrobial resistance surveillance in 
Nigeria. 
INTRODUCTION  
Extended-spectrum β-lactamases (ESBLs) are plasmid borne, and are harboured by 
Gram-negative bacteria. They can be divided into three major groups: TEM, SHV, 
and CTX-M types (Pitout & Laupland, 2008). ESBL-producing strains can increase 
morbidity and mortality rates, in part as a result of associated resistance to other 
antibiotic families, which limits therapeutic options and raises healthcare costs 
(Perez, Endimiani, Hujer, & Bonomo, 2007). Plasmid-mediated quinolone resistance 
genes (PMQRs) have been reported to be associated with ESBLs (and other β-
lactamases) (Robicsek, Jacoby, & Hooper, 2006a). Many reports have described and 
characterized ESBLs in Klebsiella spp. and Escherichia coli, including reports from 
African countries (Blomberg et al., 2005; Gangoué-Piéboji et al., 2005). However, few 
reports on the prevalence of ESBL and PMQR determinants in both human and 
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bovine isolates in Nigeria have been documented. A recent study reported high rates 
of resistance to quinolones in association with β-lactams among E. coli isolates from 
healthy animals in Nigeria (Fortini, Fashae, García-Fernández, Villa, & Carattoli, 
2011). Thus, the objectives of this study were to determine the prevalence of ESBL in 
E. coli clinical isolates from human and bovine origins collected in Oyo state, Nigeria, 
to perform their molecular characterizations, and to assess their potential 
dissemination. 
MATERIALS AND METHODS 
Bacterial isolates  
Between August 2010 and August 2011, 57 E. coli isolates were collected from 
different inpatients from four hospitals located in Oyo state, Nigeria: two tertiary care 
hospitals (University College Hospital Ibadan and Bowen Teaching Hospital 
Ogbomoso), and two secondary hospitals (Oluyoro Catholic Hospital Ibadan and 
General Hospital Adeoyo Ibadan). During the same period, 57 E. coli isolates were 
also isolated from fecal samples of different healthy bovine animals from diverse 
farms at slaughter in Oyo state, Nigeria. Farms from three different locations (Ibadan, 
Ogbomoso, and Iseyin) were included in the study.  
Susceptibility testing and phenotypic ESBL detection  
Susceptibility testing for 12 antibiotics was performed using the Kirby-Bauer method. 
Results were interpreted using Clinical Laboratory and Standards Institute criteria 
(C.L.S.I., 2010). The double disk synergy test was used to screen the production of 
ESBLs in all isolates (Jarlier, Nicolas, Fournier, & Philippon, 1988).  
Identification of ESBL genes and upstream sequences, PMQR genes, and class 
1 integrons  
PCR was used to screen for blaTEM, blaCTX-M, and blaSHV types of β-lactamases using 
specific primers (Mendonça et al., 2007) in presumptive ESBL producers. E coli 
39FFC (blaTEM), E. coli 144FFC (blaCTX-M), and Klebsiella pneumoniae 339FFC 
(blaSHV) were used as positive controls. PCR products were purified with Exosap IT 
(Affymetrix, Santa Clara, USA), and sequenced in both strands (Macrogen, Seoul, 
Korea). Nucleotide sequences were analysed with BioEdit software, and database 
searches were performed using the National Center for Biotechnology Information 
website (www.ncbi.nlm.nih.gov).  
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All isolates were screened by multiplex PCR for the most common qnr genes: 
qnrA, qnrB, and qnrS (Cattoir et al., 2007). Two simplex PCRs were carried out to 
detect aac(6’)-lb and qepA genes (Fortini et al., 2011; Park et al., 2006). Human 
isolates positive for the aac(6’)-lb gene were further analyzed by digestion with a 
BtsCI enzyme (New England Biolabs Ipswich, USA) to identify aac(6’)-lb-cr, which 
lacks the BtsCI restriction site present in the wild type gene (Park et al., 2006). 
ISEcp, Is26, and Is903 elements were investigated in the ESBL-positive isolates 
(Mendonça et al., 2007).  
Integrase gene, intI1, was screened by PCR in ESBL-positive and Qnr-positive 
isolates (Barlow, Pemberton, Desmarchelier, & Gobius, 2004). Isolates positive for 
intI1 were subjected to amplification with 5´-CS and 3´-CS primers (Lévesque, Piché, 
Larose, & Roy, 1995) to amplify the variable region of class 1 integrons. PCR 
products were purified and sequenced as previously described.  
Plasmid replicon typing  
Plasmid incompatibility groups were identified among positive ESBL isolates. The 
PCR-based Inc/rep typing method consists of five multiplex-PCRs recognizing three 
different replicon types and three simplex PCRs for K, F, and B/O replicon types 
(Carattoli et al., 2005).  
Conjugation experiments  
The transfer of ESBL determinants to the recipient strain E. coli J53 (sodium azide 
resistant) was performed by broth mating assays, at a bacterial cell ratio of 1:10. 
Overnight cultures were centrifuged, the sediment suspended in 50 μL of PBS buffer, 
and 20 μL were plated in duplicates of Luria-Bertani agar containing sodium azide 
(100 mg/L) and cefotaxime (1 mg/L). The antibiotic susceptibility profile was 
determined for transconjugants by the disk diffusion method. PCR amplification of the 
ESBL determinants and plasmid replicon types was also performed to confirm the 
transfer of resistance determinants and to identify the plasmid replicon type involved 
in the transfer of resistance, using the methodology described.  
Genetic relatedness and sequence typing by MLST  
The rep-PCR genomic fingerprinting method was performed on the ESBL producers 
to assess their genetic relatedness (Mohapatra, Broersma, & Mazumder, 2007). 
Multilocus sequence typing (MLST) analysis was performed (Wirth et al., 2006) on 
the two ESBL-positive strains that were successful on conjugation assays.   
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RESULTS 
Origin of bacterial isolates, antibiotic susceptibility, and phenotypic detection 
of ESBLs  
Of the isolates from human clinical samples, 34 were from urine, 10 were from high 
vaginal swabs, 9 were from stool, 3 were from sputum, and 1 was from an 
endocervical swab. The majority of the human samples (54%) were isolated from the 
University College Hospital (UCH), the first teaching hospital in Nigeria. Seventy-four 
percent of the bovine samples (n = 42) were obtained from farms in Ibadan, which is 
the capital city of Oyo state and the third-largest metropolitan area in Nigeria.  
Table 5.1 shows the susceptibility profiles obtained for the isolates. As shown, 
the bovine isolates were more susceptible to the antimicrobials tested than were the 
human isolates. ESBLs were only detected in the human E. coli isolates. ESBL-
positive strains were also resistant to gentamicin (87.5%), nalidixic acid (62.5%), and 
ciprofloxacin (50%), but susceptible to cefoxitin and imipenem (100%). The ESBL-
producing isolates were predominantly isolated from urine samples, followed by high 
vaginal swabs.  
Table 5.1 – Antibiotic susceptibility pattern of the human and bovine E. coli isolates. 
Human (%)                       Bovine (%) 
Antibiotics R I S R I S 
Amoxicillin 88 0 12 18 5 77 
Amoxicillin plus clavulanic acid 30 47 23 0 0 100 
Ceftazidime 9 4 88 0 2 98 
Cefotaxime 14 5 81 0 0 100 
Aztreonam 5 9 81 0 0 100 
Cefepime 0 4 97 0 0 100 
Imipenem 0 2 98 0 0 100 
Cefoxitine 0 0 100 0 0 100 
Nalidixic acid 47 4 49 4 0 97 
Ciprofloxacin 40 0 60 0 0 100 
Trimethoprim 83 0 18 25 0 75 
Gentamicin 46 0 54 0 0 100 
 
 
 
Chapter 5 
80 
 
Characterization of ESBL and PMQR  
Table 5.2 summarizes the molecular characterization of ESBL producers and a 
bovine isolate. CTX-M-15 enzyme was identified in eight human E. coli isolates, 
confirming the resistance phenotype. All isolates also carried the non-ESBL blaTEM-1. 
Two and six E. coli. blaCTX-M-15 producers showed the qnrB and aac(6’)-lb-cr-variant 
genes, respectively. Two isolates carried both the qnrB and aac   (6’)-lb-cr genes. A 
single bovine strain carried the qnrS gene. ESBLs and other PMQRs were not found 
in the bovine isolates.  
An ISEcp1 element was detected upstream of the blaCTX-M-15 gene. The IS26 
element was located in three of the ESBL producers, and one isolate had both the 
IS26 and IS903 elements.  
Rep-PCR identified three DNA fingerprint patterns among the blaCTX-M-15 
producers. They were from two hospitals in Oyo state; UCH had the highest number 
of isolates (n = 7). Most of the isolates shared a common fingerprinting pattern (data 
not shown).  
Plasmid identification  
Plasmids carrying the CTX-M-15 β-lactamase and the PMQRs determinants were 
assigned to the FIA, FIB, HI2, F, and K replicon types (Table 2). In the bovine strain, 
plasmids were assigned to the HII, FIB, and Y incompatibility groups.  
Conjugation assays  
Transfer by conjugation of the ESBL and PMQR phenotypes to E. coli J53 was 
successful for two out of the eight blaCTX-M-5-positive strains. The transconjugants 
showed resistance profiles identical to the donors. The blaTEM-1, blaCTX-M-15, aac(6’)-lb-
cr-variant, and qnrB genes were confirmed to be present in transconjugants. The 
transferred plasmids were assigned to the FIB and HI2 replicon types (Table 2). E. 
coli with conjugative plasmids belonged to different sequence types; H15, carrying 
aac(6’)-lb-cr, blaTEM-1, and blaCTX-M-15, was identified as ST131, while E. coli H1, 
harboring qnrB, aac(6’)-lb-cr-variant, blaTEM-1, and blaCTX-M-15, was assigned to 
ST2695, a new allele.  
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Characterization of class 1 integrons  
The intI1 gene was present in the qnrS-borne bovine strain (no gene cassettes 
inserted in the variable region) and in 87.5% of the human ESBL-positive isolates. 
Two different gene cassette arrays were identified in six ESBL-positive isolates: 
aadA1, encoding resistance to streptomycin and spectinomycin, and dfrA17-aadA5, 
encoding resistance to streptomycin/spectinomycin and trimethoprim (Table 2).  
DISCUSSION 
ESBLs, especially CTX-M-15 β-lactamase, usually located in conjugative plasmids, 
are disseminated worldwide. This study confirmed the presence of CTX-M-15 in 
human clinical isolates in Nigeria, though at a moderate prevalence. A strong 
association between ESBL production and quinolone resistance has been reported in 
Enterobacteriaceae (Perez et al., 2007). In this study, the resistance to nalidixic acid 
and ciprofloxacin shown by the CTX-M-15 producers could be linked partially to the 
simultaneous carriage of PMQRs. The aac(6’)-lb-cr-variant was shown to be 
prevalent; qnrB was found in two isolates. Five different plasmid replicon types (H12, 
FIA, FIB, F, and K) were identified, but only FIB, H12, and K were shown to 
conjugate. Both CTX-M-15 and TEM-1 determinants, as well as the qnrB and aac(6’)-
lb-cr-variant, could be transferred (Table 2), demonstrating the potential of co-
dissemination by horizontal gene transfer of resistance to β-lactams and quinolones. 
Recently, a study reported high rates of resistance to β-lactams and quinolones 
among Gram-negative isolates from different hospitals in Nigeria (Ogbolu, Daini, 
Ogunledun, Alli, & Webber, 2011), which may support our findings at a molecular 
level. 
Nevertheless, only two E. coli were able to conjugate; these belonged to 
distinct sequence types, as determined by MLST. ST131 was identified as carrying 
blaCTX-M-15 and aac(6’)-lb-cr. The first report recently made in West Africa of E. coli 
ST131 harboring blaCTX-M-15 and aac(6’)-lb-cr , found predominantly among hospital 
isolates, was from Lagos, Nigeria (Aibinu, Odugbemi, Koenig, & Ghebremedhin, 
2012). Our results support the dissemination of this strain in the country, since they 
were collected in a different state. The other blaCTX-M-15 E. coli, harboring the qnrB 
and aac(6’)-lb-cr genes, was assigned to ST2695, a new allele, not previously 
reported to be associated with CTX-M-15.  
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The IncF plasmidic family was the most common found in this study; it includes 
the F1A and F1B groups frequently reported to be associated with CTX-M and 
aac(6’)-lb-cr resistance genes (Carattoli et al., 2005). However, reports about the 
association of the qnrB with the plasmid replicon types found in this study are limited, 
as are reports about the qnrS association with HII, Y, and/or FIB plasmid types 
detected in bovine isolates. The lack of conjugative transfer of the CTX-M-15 
determinant (and PMQR associated genes) may indicate that in the other E. coli 
isolates, the resistance determinants were encoded on non-conjugative plasmids.  
Class 1 integrons coding for resistance to other antibiotic families were also 
associated with CTX-M-15 producers, though their genetic location was not 
investigated. However, this finding shows the higher ability of the strains to capture 
additional resistance genes.  
E. coli is commonly associated with urinary tract infections, and the majority of 
CTX-M-15 strains were found in urine, followed by high vaginal swab samples. 
Samples were mainly collected at the UCH. This may be due to the fact that most 
patients in this tertiary care hospital are referred from other hospitals, where they 
have been started on antibiotherapy. Also, in developing countries like Nigeria, 
resources are limited and antibiotics are indiscriminately used both in humans and 
animals, which could result in dissemination of ESBL producers.  
In contrast with other Nigerian reports (Ajayi, Oluyege, Olowe, & Famurewa, 
2011; Chah & Oboegbulem, 2007; Fortini et al., 2011), bovine E. coli isolates did not 
show considerable resistance, which may be attributed to less bovine antibiotic 
dosing in this geographic location. The predominant resistance rate was seen for 
tetracycline (44%), followed by trimethoprim (25%). Resistance to amoxicillin was 
detected in 23% of the strains, correlating with data obtained from reports on bacteria 
isolated from meat tables in the geographical location where the study was 
conducted (Ajayi et al., 2011).  
The use of cephalosporins and fluoroquinolones for prophylaxis and treatment 
of bovine animals is rare in Nigeria, which supports the high rates of susceptibility of 
E. coli bovine isolates. However, these resistance determinants may be selected by 
other drugs frequently used in food animals. Chah et al. (Chah & Oboegbulem, 2007) 
reported the wide use of ampicillin in poultry production in Nigeria, which may provide 
a selective pressure favouring the emergence of E. coli strains that carry plasmids 
with TEM-1/2 and ESBL determinants. These other food animals may serve as 
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reservoirs of ESBL-producing E. coli strains that could be transferred to humans and 
other animals. However, in this study, we could not find an association between E. 
coli from human and bovine origins.  
The study reports the prevalence of CTX-M-15 in human clinical Nigerian E. 
coli strains carrying genetic mobile elements such as conjugative plasmids and class 
1 integrons that can amplify the spread of resistance in the country, reinforcing the 
crucial need for antimicrobial surveillance in a country where over-the-counter 
antibiotic sales and indiscriminate use of antibiotic are common.  
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ABSTRACT 
Escherichia coli is simultaneously an indicator of water contamination and a human 
pathogen. This study aimed to characterize the virulence and resistance of 
Escherichia coli from municipal and hospital wastewater treatment plants (WWTPs) 
in central Portugal. From a total of 193 isolates showing reduced susceptibility to 
cefotaxime and/or nalidixic acid, twenty E. coli with genetically distinct fingerprint 
profiles were selected and characterized. Resistance to antimicrobials was 
determined using disc diffusion method. ESBL and PMQR genes, phylogroups, 
pathogenicity islands (PAIs) and virulence genes were screened by PCR. CTX-M 
producers were typed by multilocus sequence typing. Resistance to beta-lactams 
was associated to the presence of blaTEM, blaSHV, blaCTX-M-15 and blaCTX-M-32. Plasmid-
mediated quinolone resistance was associated to qnrA, qnrS and aac(6’)-Ib-cr. 
Aminoglycosides resistance and multidrug resistant phenotype were also detected.   
PAI IV536, PAI IICFT073, PAI II536 and PAI ICFT073, and uropathogenic genes iutA, papAH 
and sfa/foc were detected. The concerning clinical ST131 clone carrying  blaCTX-M-15, 
blaTEM-type, qnrS and aac(6’)-lb-cr; IncF and IncP plasmids, and virulence factors PAI 
IV536, PAI ICFT073, PAI IICFT073, iutA, sfa/foc and papAH was identified  in the effluent of 
a hospital plant. WWTPs contribute to the dissemination of virulent and resistant 
bacteria into water ecosystems, constituting an environmental and public health risk.  
INTRODUCTION 
Escherichia coli is mutually a biological indicator of water treatment safety, as well as 
an important human pathogen responsible for several diseases (Edberg, Rice, Karlin, 
& Allen, 2000; Kaper et al., 2004). E. coli presents several virulence and antimicrobial 
resistance genes which contribute to its success as human pathogen (Pitout, 2012). 
These genes may be disseminated by mobile genetic elements such as 
pathogenicity islands, carriers of virulence factors, or plasmids with genes coding for 
both resistance and virulence determinants (Carattoli, 2009; Hacker et al., 1997). 
Water constitutes a good matrix for the lateral transfer of mobile genetic elements 
(Taylor, Verner-Jeffreys, & Baker-Austin, 2011) which are responsible for the 
dissemination of virulence or resistance traits between bacteria from different 
sources, contributing to the modification of the natural bacterial ecosystems 
(Baquero, Martínez, & Canton, 2008). 
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Currently, the inverse relation between antimicrobial resistance and virulence 
has been of consensus (Moreno et al., 2006). However, recently it has been showed 
that these two features may co-exist in the same genotype perpetuating the bacterial 
lineage and highlighting the concern due to its dissemination (Colomer-Lluch et al., 
2013; Dolejska et al., 2011). 
Wastewater treatment plants (WWTP) are designed to significantly reduce the 
biological contamination of water. Nevertheless, studies report resistant bacteria in 
effluents of treated water, and suggested that the conditions in WWTPs favor the 
proliferation of antibiotic resistant bacteria and the exchange of genetic elements 
(Dolejska et al., 2011; Korzeniewska, Korzeniewska, & Harnisz, 2013; Moura, 
Henriques, Ribeiro, & Correia, 2007). The emergence and dissemination of 
antimicrobial resistant bacteria has led to an increasing concern on potential 
environmental and public health risks. Moreover, the carriage of specific virulence 
genes, especially those located in mobile genetic elements, are important to evaluate 
the public health risks.  
The main objectives of this study were to characterize the virulence and 
antimicrobial resistance profiles of E. coli collected in waters from municipal and 
hospital WWTPs from central Portugal and to screen for the presence of mobile 
genetic elements. 
MATERIALS AND METHODS 
Bacterial isolates 
Between April and May 2011, water samples were collected from four hospitals and 
three municipal WWTPs located in the central region of Portugal:  
- University hospital: reference hospital for the central region of Portugal. A 
large hospital harboring 1456 beds, with an extended set of medical specialties and 
clinical services, as well as a center of research, serving a population of 
approximately 430,000 inhabitants; 
- General hospital: medium-sized hospital with thirteen main wards and 
composed by 350 beds. It serves a population of approximately 369,000 inhabitants. 
- Pediatric hospital: small reference hospital in the center of Portugal that 
supports pediatric units. It is composed by nine mainwards and 110 beds serving a 
population of about 90,000 inhabitants. 
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- Maternity: small hospital with 96 beds and three main wards- gynecology, 
obstetrics and neonatology, not including the baby unit. It serves a population of 
approximately 507,000 women. 
- Municipal WWTP1: serves 14,000 population equivalent. 
- Municipal WWTP2: serves a 213,000 population equivalent. It receives urban 
wastewaters which include domestic wastewaters and hospital effluents (namely from 
the four mentioned hospitals). 
- Municipal WWTP3: serves 1,500 population equivalent. 
Municipal WWTP sampling was performed at the entrance and exit of the 
station at two occasions and Hospital samples were collected on three different dates 
at the exit of the station. Wastewater samples (250mL) were collected in amber glass 
bottles   and   further   vacuum   filtered   through   1.0   μm   glass   microfiber   filters   (GF/C,  
Whatman,  UK),   followed  by  0.45  μm  nylon  membrane   filters   (Whatman,  UK).     The  
filters were placed in MacConkey Agar supplemented with 0.5 mg/L of cefotaxime or 
10 mg/L of nalidixic acid. A bacterial suspension was prepared with the inoculum and 
cultured in MacConkey Agar. A maximum of eight presumptive colonies of E. coli per 
plate were further cultured in Eosin Methylene Blue Agar (EMB), and lactose 
fermenter colonies with a green metallic sheen were selected. The citrate test was 
used to distinguish E. coli from Citrobacter spp. The identification was confirmed 
using a PCR-based technique with specific primers set targeting uidA gene (Heijnen 
& Medema, 2006). 
The genetic relationship was evaluated by BOX-PCR (Versalovic, Schneider, 
de Bruijn, & Lupski, 1994), and only non-duplicate isolates were further analyzed. 
Susceptibility  testing  and  phenotypic  extended  spectrum  β-lactamase 
detection 
The antimicrobial susceptibility profile for ampicillin (10µg), amoxicillin- clavulanic 
acid (20/10µg), cefoxitin (30µg), cefotaxime (30µg), ceftazidime (30µg), nalidixic acid 
(30µg), ciprofloxacin (10µg) and gentamicin (10µg) was determined using a disc 
diffusion test (OXOID). Extended spectrum β-lactamase (ESBL) producers were 
detected with the double disk synergy test (Jarlier, Nicolas, Fournier & Philippon, 
1988). The methods were performed and the results were interpreted based on the 
Clinical and Laboratory Standards Institute guidelines (CLSI, 2010). Multidrug 
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resistance was defined as acquired non-susceptibility to at least one agent in three or 
more antimicrobial categories (Magiorakos et al., 2012). 
Antimicrobial resistance determinants detection 
The blaCTX-M, blaTEM and blaSHV genes coding for β-lactamases and plasmid mediated 
quinolone resistance (PMQR) determinants qnrA, B and S, and qepA were screened 
with specific primers by PCR (Cattoir et al., 2007; Ma et al., 2009; Mendonça et al., 
2007).  For the samples with positive result for the screening of blaCTX-M, the full gene 
was further amplified using previously described primers (Conceição et al., 2005) and 
amplicons were purified with ExoSAP-IT (Affymetrix, USB products). The whole 
genes were sequenced at Macrogen, Amsterdam, Netherlands. 
aac(6’)-Ib  was screened by PCR and isolates positive for the aac(6’)-lb gene 
were further digested with BtsCI enzyme (New England Biolabs) to identify aac(6’)-lb-
cr which lacks the BtsCI restriction site present in the wild type gene (Park et al., 
2006).    
Plasmid Replicon typing 
Plasmid replicon identification was performed according to the PCR-based replicon 
typing scheme (Carattoli et al., 2005), detecting the main replicon families in 
Enterobacteriaceae. 
Detection of pathogenicity islands and other virulence markers 
Pathogenicity island (PAI) markers were screened according to the Bronowski  et al. 
scheme (Bronowski et al., 2008), based on the technique first described by Sabaté et 
al. (Sabaté et al., 2006). This method allows the detection of eight PAIs, encoding 
several virulence determinants: PAI I536, PAI II536, PAI III536, PAI IV536, PAI IJ96, PAI 
IIJ96; PAI ICFT073, and finally PAI IICFT073 (Sabaté et al., 2006). 
Other virulence genes that maybe present in extraintestinal E. coli (ExPEC) 
such as papAH, papC (P fimbriae structural subunit and assembly), sfa/foc (S and 
F1C fimbriae), afa/dra (Dr-binding adhesins), iutA (aerobactin receptor), kpsM II 
(group 2 capsules) and cnf1 (cytotoxic necrotizing factor 1) were screened by PCR 
(Johnson & Stell, 2000), as well as the Enterohemorrhagic E. coli associated 
virulence genes eaeA (intimin), hlyA (pore-forming cytolysin), stx 1 and 2 (shiga-like 
toxins) (Ram et al., 2008). 
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Phylogenetic analysis 
The determination of E. coli major phylogroups (A, B1, B2 and D) was performed with 
a PCR-multiplex detecting chuA, yjaA and DNA fragment tspE4.C2 genes (Clermont 
et al., 2000; Mendonça et al., 2011).  
Multilocus sequence typing (MLST) 
MLST of the CTX-M producers was performed based on the PCR amplification and 
sequencing of seven housekeeping genes, adk, fumC, gyrB, icd, mdh, purA and 
recA, according to the University of College Cork (Cork, Ireland) scheme for E. coli 
(http://mlst.ucc.ie/mlst/dbs/Ecoli). 
RESULTS 
Bacterial isolates 
A total of 193 presumably E. coli with reduced susceptibility to cefotaxime and/or 
nalidixic acid were obtained from WWTPs. The majority of the isolates showed an 
identical genetic profile and only twenty isolates with distinct profiles were selected 
(non-duplicate isolates) and further characterized for resistance and virulence profiles 
(Table 1). Fourteen of the non-duplicate isolates were from municipal WWTPs, while 
the remaining six were recovered from hospital water samples. The municipal 
isolates were recovered from WWTP2 (n=7), followed by WWTP3 (n=4) and WWTP1 
(n=3). Isolate W4 and W12 were detected in both the affluent and effluent of the 
respective WWTPs, and in addition W12 isolate was detected in two different 
sampling occasions. From the hospital WWTPs, three strains were recovered from 
the general hospital, two from the Maternity hospital and one from the University 
Hospital. E. coli isolates with reduced susceptibility to CTX or NAL were not detected 
in the outflow of the Pediatric hospital. 
Resistance profile characterization 
The majority of the isolates were resistant to nalidixic acid (85%), followed by 
resistance to ampicillin (50%), amoxicillin-clavulanic acid (35%), cefoxitin (35%), 
cefotaxime (35%), ciprofloxacin (30%), ceftazidime (25%) and gentamicin (15%). 
Strains W4 and W5 from Municipal WWTP1 were susceptible to all the antibiotics 
tested, and strains W3 from the University hospital, strain W16 from the General 
Hospital and strain W7 from the Municipal WWTP2 were multidrug resistant. Among 
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the antimicrobial resistance determinants screened, blaTEM was the most detected 
(n=7) followed by qnrA (n=3), qnrS (n=2) and blaCTX-M (n=2). The studied resistance 
determinants were not detected in nine isolates. 
Only two strains carried blaCTX-M genes: blaCTX-M-15 (W3) collected from the 
University hospital outflow and blaCTX-M-32 (W15) from the Municipal WWTP3 inflow 
water. Isolate W3 was assigned by MLST to ST131 and isolate W15 to ST34. The 
strain W3 ST131 was multidrug resistant and showed the higher diversity of 
plasmidic determinants, carrying blaCTX-M-15, blaTEM-type, qnrS and aac(6’)-lb-cr. 
The main plasmid groups detected in Enterobacteriaceae family members 
were   also   investigated.   Four   plasmid   groups:   IncF,   IncK,   IncI1/Iγ   and   IncP   were  
detected. IncF was the most prevalent group (n=11) found in both hospital and 
municipal WWTPs waters, while in 25% of the isolates no plasmid was identified. 
Virulence profile description 
The pathogenicity island more frequently detected was PAI IV536 (n=13) followed by 
PAI IICFT073 (n=5), PAI ICFT073 (n=2) and PAI II536 (n=1). PAI I536, PAI III536, PAI IJ96 and 
PAI IIJ96 were not detected. PAI IV536 and PAI IICFT073 were more prevalent in 
municipal isolates. PAI II536 was exclusively detected in a strain from a municipal 
WWTP. Different combinations of pathogenicity islands were identified (Table 6.1). 
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Considering individual virulence genes, the most frequently detected was iutA 
(n=13), followed by papAH (n=2), more common among hospital isolates sfa/foc and 
eaeA were less prevalent, each of them being detected in one isolate; the former 
found in a hospital source and eaeA detected in a municipal WWTP. The genes 
afa/dra, kpsM II, cnf, hlyA, stx1 and 2 were not detected. The most prevalent 
phylogenetic group was group A (n=7) followed by B2 (n=5), and finally B1 and D 
(n=4, each). Strains from phylogroup B2 from both municipal and hospital WWTPs 
carried more virulence factors, including the ST131 isolate (Table 1). All the other 
isolates presented virulence determinants regardless of the phylogroup, with the 
exception of W17 and W8 from phylogroup A, and W5 from phylogroup B1.  
Discussion 
This study aimed to characterize the virulence and resistance profiles of E. coli 
selected from municipal and hospital WWTPs from a central region of Portugal, 
evaluating the possibility of environmental dissemination of pathogenic and/or 
resistant bacteria from these sources. Several studies indicate the potential 
dissemination of resistant and/or virulent bacteria from WWTPs into the environment 
(Biswal, Mazza, Masson, Gehr, & Frigon, 2014; Chagas et al., 2011; Colomer-Lluch 
et al., 2013; Dolejska et al., 2011; Jakobsen et al., 2008; Sabaté et al., 2008). 
Nonetheless, only one study concomitantly studied virulence factors and resistance 
determinants in hospital WWTPs (Jakobsen et al., 2008), and it only focused on 
gentamicin resistance determinants and in single virulence factors. Here, we 
extended the study to the identification of PAIs, clusters of virulence genes with the 
potential to be mobile. 
E. coli strains showed resistance to important groups of antibiotics such as 
beta-lactams, quinolones, and aminoglycosides, with multidrug resistance being 
detected in both municipal and hospital strains, indicating that WWTPs may be 
responsible for the introduction of multidrug resistant bacteria into the environment. 
In the Portuguese Mondego river, where the effluents of the studied WWTPs are 
discharged, several types of antibiotics, including fluoroquinolones, were recently 
detected (Santos et al., 2013), which may exert a selective pressure in the 
dissemination of resistant bacteria in environmental waters (Kümmerer & Henninger, 
2003). Plasmidic resistance determinants are important vehicles of transmission of 
resistance genes. Several resistance determinants were detected in this study, 
including blaTEM,  blaSHV, blaCTX-M-15 and blaCTX-M-32, responsible for resistance to 
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several beta-lactams, as well as PMQR genes, including qnrA, qnrS and aac(6’)-Ib-
cr. Different beta-lactamase genes were already detected, including blaCTX-M-group 1, 
blaCTX-M-group 9, blaSHV and blaTEM genes, in hospital and municipal effluents 
(Korzeniewska & Harnisz, 2013; Korzeniewska et al., 2013). In addition, CTX-M-15 
and CTX-M-32 producers were already detected in river waters in Portugal, with 
unknown origin, indicating that these determinants may be spreading among water 
systems (Tacão, Correia, & Henriques, 2012). 
Several virulence factors responsible for enhancing the pathogenic potential of 
bacteria have been detected in E. coli (Johnson, 1991; Johnson & Stell, 2000), and 
some of them are clustered in pathogenicity islands, mobile genetic platforms 
capable of dissemination throughout horizontal gene transfer (Hacker et al., 1997). 
Virulence profiles were characterized in the isolates. Results show that PAI IV536 was 
the most prevalent island, likewise other studies performed in clinical samples and in 
waters from several origins, but none of them from WWTPs (Mendonça, Ramalho, 
Vieira, & Da Silva, 2012; Sabaté et al., 2006). The association of PAI IV536 to 
virulence is controversial, as some studies indicate that this island contributes to the 
virulence of EXPEC (Schubert, Picard, Gouriou, Heesemann, & Denamur, 2002) but 
other authors suggest that this is rather a fitness element (Oelschlaeger, Dobrindt, & 
Hacker, 2002). Several Uropathogenic E. coli (UPEC) virulence genes were identified 
in the isolates, including iutA, involved in the uptake of iron, papAH coding for P-
Fimbriae associated to pyelonephritis (Dowling, Roberts, & Kaack, 1987; Källenius et 
al., 1981) and sfa/foc encoding S-Fimbriae/F1C fimbriae, involved in urinary 
infections, neonatal sepsis as well as meningitis (Antão et al., 2009). In addition, eae 
usually detected in Enteropathogenic (EPEC) and Enterohemorragic E. coli (EHEC) 
was also detected in a municipal isolate. This fact may be related to the possible 
association of animal farms to the municipal WWTP where W12 isolate was detected, 
as ruminants are known to be important reservoirs of E. coli carrying intimin gene 
(Blanco et al., 2005). This isolate also carried other virulence determinants and was 
detected in both the affluent and effluent of the WWTP in different collection dates 
indicating that WWTPs are not only inefficient on the elimination of virulent bacteria, 
but are also contributing to the dissemination of strains carrying virulence- associated 
genes in the environment. 
Phylogenetic background of the strains was studied as an indicator of the 
virulence potential of the isolates. E. coli strains have been grouped into four different 
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phylogroups (A, B1, B2, and D) according to their virulence features. Virulent extra-
intestinal strains belong mainly to group B2 and, to a lesser extent, to group D, while 
commensal strains belong to groups A and B1(Clermont et al., 2000). Despite group 
A and B1 are considered less virulent, strains from these phylogroups harboring 
virulence factors were detected in both municipal and hospital isolates. This 
observation may indicate that even the considered less virulent bacteria may be 
enhancing their virulent potential, possibly due to horizontal gene transfer of 
virulence traits.  
In this study the international clone E. coli ST131 was detected in the effluent 
of a hospital. The ST131 isolate carried several pathogenic factors including PAI 
IV536, PAI ICFT073, PAI IICFT073, iutA, sfa/foc and papAH as well as resistance 
determinants blaCTX-M-15, blaTEM, qnrS, and aac(6’)-lb-cr and the IncF plasmid, a 
conjugative plasmid which can easily be spread to other bacteria and known for 
dissemination of blaCTX-M-15 and aac(6’)-Ib-cr (Carattoli, 2009; Partridge, Zong, & 
Iredell, 2011). ST131 displays both resistance and virulence features which 
contribute to the success of this international clone, which today is one of the most 
adapted and efficient human pathogens (Johnson, Johnston, Clabots, Kuskowski, & 
Castanheira, 2010a; Johnson et al., 2010b). This clone was previously detected in 
the effluent of a municipal WWTP in the Czech Republic (Dolejska et al., 2011) and 
in the influent of a WWTP in Catalonia, Spain (Colomer-Lluch et al., 2013). But to our 
knowledge, this is the first finding in hospital WWTPs, highlighting the crucial need of 
monitoring the efficiency of hospital WWTPs. 
The dissemination of bacteria carrying both resistance and virulence 
determinants, such as ST131, constitutes an important threat to public health and to 
the environment. Resistant or pathogenic isolates when in contact with 
autochthonous bacteria may be responsible for the dissemination of resistance and 
virulence determinants among natural ecosystems by horizontal gene transfer. 
Conclusions 
WWTPs constitute a potential mechanism of propagation of resistant and pathogenic 
bacteria from sewage of diverse origin, into the environment, and may thus contribute 
to the environmental dissemination of virulence and resistance determinants which 
constitutes an important public health concern. 
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ABSTRACT  
Klebsiella spp. are nosocomial opportunistic pathogens often resistant to multiple 
antibiotics. The virulence of resistant strains is barely known. Thus, the interplay 
between resistance and virulence in K. pneumoniae and K. oxytoca was investigated. 
Resistance   phenotype,   presence   of   β-lactamases and plasmid-mediated quinolone 
resistant genes and plasmid replicon typing were determined and the carriage of 
virulence genes and pathogenicity islands identified. Only two PAIs were detected, 
PAI IV536 and PAI IICFT073. Carriage of PAI IICFT073 by K. oxytoca was firstly reported. 
This PAI was statistically associated to resistance to cephalothin, cefotaxime, 
ceftazidime, ciprofloxacin and gentamicin, while in K. pneumoniae PAI IV536 was 
statistically associated to resistance to gentamicin and sulfamethoxazole-
trimethoprim (SXT). In general, higher prevalence of virulence factors was detected 
among strains resistant to ciprofloxacin and gentamicin and, to a lesser extent, to 
cefotaxime and SXT in K. pneumoniae. Similarly, in K. oxytoca, higher prevalence of 
virulence genes was generally observed among strains resistant to SXT. This study 
confirms that virulence and resistance are compatible features among Klebsiella spp. 
INTRODUCTION 
Klebsiella spp. are opportunistic pathogens mostly associated with nosocomial 
infections including pneumonia, septicaemia, soft tissue and urinary tract infections. 
Antibiotic β-lactams have been the choice for treating Klebsiella spp. infections. 
Nonetheless, the use of these antibiotics has become problematic because of the 
emergence of diverse classes of β-lactamases among clinical Klebsiella spp. isolates 
(Broberg et al., 2014; Lowe et al., 2012). 
Several virulence factors are carried by K. pneumoniae strains, including 
capsule, lipopolysaccharide, siderophore systems, and fimbrial and non-fimbrial 
adhesins (Brisse et al., 2009). Pathogenicity islands (PAIs), large DNA fragments 
carrying several virulence factors with the ability to disseminate by horizontal gene 
transfer, and usually present in uropathogenic Escherichia coli, have also been 
detected in K. pneumoniae strains (Calhau, Boaventura, Ribeiro, Mendonça, & da 
Silva, 2014).  
The studies focusing on the interplay between resistance and virulence in 
Klebsiella spp. are scarce. One reported that in K. pneumoniae a significant high 
proportion of strains expressing type 1 and type 3 fimbrial adhesins were detected 
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among extended-spectrum beta-lactamases (ESBL) producers (Sahly et al., 2008). 
Recently, virulence genes irp2, mrkD and fimH were more frequently found in K. 
pneumoniae KPC-producers (de Cássia Andrade Melo et al., 2014). These studies 
suggest that some virulence genes might be associated with specific resistance 
determinants. 
Thus, the main objective of this work was to assess the relation between 
virulence genes and PAIs, and the resistance profile of Klebsiella spp. clinical 
isolates.  
Materials and Methods 
A total of 42 K. pneumoniae and K. oxytoca isolates were collected during 2007 from 
different wards of the Coimbra University Hospital Centre (CHUC), Portugal.  
Identification and susceptibility testing were performed by using Vitek 2 
Advanced Expert System (BioMérieux, Marcy l´Etoile, France).  
PAIs markers were screened according to the Bronowski et al. method 
(Bronowski et al., 2008). Virulence factors allS, rmpA, the capsular antigen genes K1, 
K2, K5, K20, K54, and K57, adhesin genes fimH, mrkD and cf29A; and kfu, uge, 
wabG and ureA genes were detected as described elsewhere (Brisse et al., 2009). 
Plasmid replicon typing was performed using a PCR-based replicon typing (Carattoli 
et al., 2005). Statistical tests were performed using IBM SPSS statistics version 22.0. 
A  P≤0.05  was  considered  statistically  significant.   
Results and Discussion 
From the 42 isolates, 33 were identified as K. pneumoniae and nine were K. oxytoca. 
Isolates were mainly collected from urine (50%) and blood (14%). 
All the isolates were resistant to ampicillin. Resistance to cephalothin was the 
second most prevalent (45%) followed by amoxicillin-clavulanic acid (41%), 
cefotaxime, ceftazidime and sulfamethoxazole-trimethoprim (SXT) (all of them with 
38%). Resistance to ciprofloxacin was observed in 24% of the isolates.  
The majority of studies on Klebsiella spp. virulence are mainly performed with 
K. pneumoniae strains, not considering the opportunist pathogen K. oxytoca. The 
strains studied are often from pyogenic liver abscess, disregarding other clinical 
sources that have become more important due to the increase isolation of multidrug 
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resistant Klebsiella spp. strains. In addition, the presence of PAIs usually associated 
with uropathogenic E. coli (UPEC) is generally not considered. 
The ureA gene was detected in all the isolates in accordance to previous 
findings (Brisse et al., 2009) and mrkD, encoding type 3 fimbriae, was the second 
most prevalent (88%). The genes rmpA, cf29A and the capsular antigen genes K1, 
K5, K20, K54, and K57 were not detected. The allS gene, involved in allantoin 
metabolism and associated with liver infection caused by K. pneumoniae (Chou et 
al., 2004), was found in six isolates, four of which were from urinary samples. In fact, 
it is known that allantoin is one of the products of the metabolism of uric acid (Kim et 
al., 2009), and thus it is excreted in the urine. Klebsiella spp. may thus be using 
allantoin as a nitrogen energy source, and therefore, allS gene may be considered an 
important virulence factor on urinary tract infections.  
In this study, only two PAIs were detected, PAI IV536 and PAI IICFT073, which 
have been previously reported in K. pneumoniae (Calhau et al., 2014). PAI IV536 was 
detected in eleven (33%) K. pneumoniae strains and PAI IICFT073 was exclusively 
detected in six (66%) K. oxytoca strains. To our knowledge, this is the first report of 
the carriage of this PAI among K. oxytoca strains. 
So far, the knowledge of the relation between resistance and virulence traits in 
Klebsiella spp. compared to UPEC is limited. The prevalence of the different 
virulence genes was compared between resistant and susceptible isolates from K. 
pneumoniae and K. oxytoca, and results are shown in Table 7.1 and Table 7.2, 
respectively. 
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For the majority of K. pneumoniae strains, resistance to ciprofloxacin, 
gentamicin and SXT, was associated to higher prevalence of the virulence genes. 
Exceptions were gene alls, more prevalent among strains susceptible to these 
antibiotics, and additionally, wabG which was also more prevalent in strains 
susceptible to SXT. Statistically significant differences were only observed for 
resistance to ciprofloxacin and gene kfu, encoding Klebsiella ferric iron uptake (38% 
in resistant vs 4% in susceptible, p= 0.012); resistance to gentamicin and kfu (60% in 
resistant vs 4% in susceptible, p<0.001) and PAI IV536 (80% in resistant vs 25% in 
susceptible, p= 0.016); and finally resistance to SXT and PAI IV536 (58% in resistant 
vs 19% in susceptible, p=0.021). For the beta-lactams, the distribution depended on 
the genes and specific antibiotics, however, in the majority of cases a higher 
tendency of carriage of virulence genes was detected among resistant strains. 
Statistically significant differences were only observed for the gene kfu and 
resistance to cefotaxime (33% in resistant vs 4% in susceptible, p=0.022) and 
ceftazidime (30% in resistant and 4% in susceptible, p= 0.038).  
Overall, for Klebsiella spp. an inverted relation between resistance and 
virulence does not seem to be verified. Contrarily to the observed for E. coli, 
particularly in quinolones, where a trade-off between resistance and virulence has 
been reported (Vila et al., 2002), in K. pneumoniae the opposite seems to occur. In 
fact, a higher prevalence of the virulence factors was detected among resistance to 
ciprofloxacin and gentamicin and at a lesser extent to cefotaxime and SXT. 
In the case of K. oxytoca, strains resistant to SXT presented more prevalence 
of virulence genes. Noteworthy, the gene mrkD, encoding type 3 fimbria, was the 
only one in which a higher prevalence was detected in strains susceptible to SXT 
compared with resistant strains. Considering resistance to cephalothin, cefotaxime, 
ceftazidime and ciprofloxacin, higher prevalence of genes allS, fimH (encoding type 1 
fimbria), and PAI IICTF073 were detected in resistant isolates compared to the 
susceptible counterparts. In contrast, genes mrkD, uge (encoding uridine phosphate 
galacturonate), and wabG (encoding glucosyltransferase) were more prevalent 
among susceptible isolates. Additionally, the genes allS, mrkD and PAI IICFTO73 were 
more prevalent among isolates resistant to gentamicin, while fimH, uge and wabG 
were more prevalent among isolates susceptible to this antibiotic. Despite of the 
differences observed, only the relation between PAI IICFT073 and resistance to 
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cephalothin (p= 0.023), cefotaxime (p= 0.023), ceftazidime (p= 0.023), ciprofloxacin 
(p= 0.023) and gentamicin (p= 0.018) were considered statistically significant.  
Similarly to the observed for K. pneumoniae, in K. oxytoca, higher prevalence 
of virulence genes were generally observed in SXT resistant strains. Nonetheless, for 
the remaining antibiotics the tendency observed for the genes prevalence was 
dependent on the antibiotic and virulence gene considered. 
Furthermore, the presence of PAIs among Klebsiella spp. was generally more 
prevalent among resistant strains indicating a possible relation between these 
elements and antimicrobial resistance. Previously, PAI IV536 has been reported to be 
carried in a resistance plasmid in E. coli (Calhau et al., 2013).    
This study reports for the first time the carriage of PAI IICFT073 among K. 
oxytoca and demonstrates that in a general way, among Klebsiella spp., virulence 
and resistance features seem to be compatible. Furthermore, resistance to SXT in 
Klebsiella spp. seems to be associated with more virulence factors, thus could be 
consider as a possible indicator of pathogenity among these species.  
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ABSTRACT  
The objective was to characterize virulence markers and β-lactam resistance in 
Klebsiella pneumoniae isolates from renal transplant patients and to evaluate their 
genetic relatedness. Two main genetic lineages were detected: one carried blaCTX-M-
15 not associated to IncFIIA plasmid replicon, which was found on the other lineage 
not expressing CTX-M-type enzyme. PAI III536 and PAI IICFT073 were detected for the 
first time in K. pneumoniae in one clone, while the siderophore kfu was carried by the 
other, with only PAI IV536. The molecular data indicates colonization before 
admission, and fuels the discussion on implementation of antibiotherapy before 
surgery. 
TEXT 
Urinary tract infection (UTI) constitutes the most common infection among renal 
transplant patients. Klebsiella pneumoniae has been increasingly isolated and it has 
assumed clinical relevance in some hospitals due to the emergence of multidrug-
resistant strains. Antimicrobial resistance limits therapeutic options, increasing the 
rates of treatment failure and infection-related mortality, also extending 
hospitalization and health-care related costs. K. pneumoniae strains producing 
extended-spectrum beta-lactamases (ESBLs) have been reported in renal transplant 
units. However, in contrast with antimicrobial resistance, little is known about the 
virulence traits of K. pneumoniae strains isolated from these particular patients. For 
example, pathogenicity islands (PAIs) have been extensively described in urinary 
pathogenic Escherichia coli (UPEC) (Kao, Stucker, Warren, & Mobley, 1997; 
Middendorf et al., 2004; Sabaté et al., 2006), but to our knowledge, only PAI IV536 
has been identified so far in K. pneumoniae. 
In 2011, an outbreak of multidrug resistant K. pneumoniae isolates was 
identified at the University hospital among renal transplant patients, raising the 
hypothesis of an emergent clone and its possible dissemination among wards. The 
goal of this study was to evaluate the clonal relatedness of these isolates, and to 
characterize at molecular level the virulence features and antimicrobial resistance of 
the isolates.  
From May until July of 2011, 25 K. pneumoniae isolates were collected from 22 
inpatients submitted to a renal transplant at Coimbra University Hospital a tertiary 
care 1,200 bed hospital. Identification and susceptibility testing was performed by 
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using Vitek 2 System (BioMérieux). ESBL production was additionally confirmed by 
using the double disk synergy test. The genetic relatedness of K. pneumoniae 
isolates was analyzed by pulsed-field gel electrophoresis (PFGE), as previously 
described (Mendonça, Ferreira, Louro, & Caniça, 2009). A cutoff value of 80% 
similarity was determined by the cluster cutoff method according to Bionumerics 
software. Isolates with a Dice band-based similarity coefficient value > 80% were 
considered to belong to the same clone. The blaCTX-M, blaSHV and blaTEM determinants 
were screend and sequenced at Stabvida, Portugal. PAIs markers were screened 
using the Bronowski et al. method (Bronowski et al., 2008). Other virulence factors 
such as allS, rmpA gene, the capsular antigen genes K1, K2, K5, K20, K54, and K57, 
adhesin genes fimH coding for type 1 fimbriae, mrkD coding for type 3 fimbriae and 
cf29A coding for non fimbrial adhesin CF29K; and kfu, uge, wabG and urea were 
detected as described elsewhere (Brisse et al., 2009). Plasmid replicon typing was 
performed using a PCR-based scheme described by Carattoli et al. (Carattoli et al., 
2005). 
The majority of isolates were collected from urine (76%), 12% from blood and 
12% from exsudates. All the isolates were resistant to ampicillin and cefotaxime. High 
frequency levels of resistance were also observed for ceftazidime (96%), 
ciprofloxacin (96%), levofloxacin (96%), trimethoprim-sulfamethoxazole (96%), and 
gentamicin (88%). They were susceptible to meropenem and ertapenem. KPC 
enzymes has already been found in Lisbon, Portugal (Machado et al., 2010). Isolates 
presented the usual blaSHV gene, and 68% produced CTX-M-15 and TEM-1b beta-
lactamases. The plasmid replicon Inc FIIA was the unique type identified, detected in 
32% of the isolates. In Portugal, previous studies reported the presence of blaCTX-M-15 
in K. pneumoniae (Conceição et al., 2005; Mendonça et al., 2009), but to our 
knowledge, this is the first study made in renal transplant patients. IncFII, IncA/C, 
IncL/M, IncL1 plasmids are frequently found in Enterobacteria and associated with 
ESBL dissemination (Carattoli, 2011). However, we could not associate FIIA replicon 
type with CTX-M-15 gene. This suggests the presence of other plasmids or a 
chromosomal location, and that some lineages of K. pneumoniae are evolving to 
maintain specific antimicrobial determinants. Recently, CTX-M-15 gene was found 
integrated in K. pneumoniae chromosome (Coelho et al., 2010). 
So far, the extent of knowledge of the virulence traits content in K. pneumoniae 
compared to uropathogenic E. coli is limited. The biological basis of the clone 
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lineages for divergent clinical behavior is unclear. However, it likely involves great 
differences in disease-relevant traits, i.e., specific virulence factors. PAI IV536 was 
found in 64% of the isolates. PAI III536 and PAI IICFT073 were detected simultaneously 
in 36% of the isolates. PAI I536, PAI II536, PAI IJ96, PAI IIJ96 and PAI ICFT073 were not 
detected. PAIs are well described in E. coli uropathogenic strains (Bronowski et al., 
2008; Sabaté et al., 2006). However, the presence of these clusters virulence genes 
are not so well known in Klebsiella spp., including in isolates associated with urinary 
infections. To our knowledge, with the exception of PAI IV536, (Koczura & Kaznowski, 
2003), the presence of PAIs in K. pneumoniae strains has not been investigated. 
The virulence encoding-genes fimH, mrkD, uge, wabG and ureA were detected 
in all the isolates, while kfu was detected in 64% of the isolates. alls, rmpA, and 
cf29A genes and the capsular genes K1, K2, K5, K20, K54 and K57 were not 
detected.  
The analysis of PFGE data revealed the identification of four clusters at >80% 
degree of genetic similarity (Figure 8.1).  
 
Figure 8.1 – Dendrogram based on the band-based coefficient of similarity of PFGE profiles. 
Coefficient value >80% were considered to belong to the same clone. 
Five isolates did not group at this cut-off. Clusters I and II were related at a 
72% degree of similarity, while clusters III and IV grouped together at 76%. Table 8.1 
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shows the antimicrobial profiles of the main clusters with the E-lactamase resistance 
determinants and the virulence genes identified. 
 The isolates seemed to have distinct origins. Indeed, some patients could be 
colonized before admission to the hospital, since they were submitted to 
hemodialysis elsewhere, or they were transferred from regional hospitals. Thus, the 
screen for colonization and the knowledge of clinical history on the admission to the 
tertiary care hospital may be helpful to prevent and manage further infections. 
Moreover, the emergence of multidrug resistant strains in renal transplant recipients 
fuels the discussion on whether antibiotherapy should be implemented before the 
transplant. Molecular characterization of bacterial populations can give insight on the 
sources and modes of transmission of microrganisms which is useful to improve or 
design infection control strategies. 
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1. General Discussion  
Along with the worldwide increase of resistance and the growing importance of 
bacterial virulence, questions related to the association between resistance and 
virulence started to arise: Are resistant strains also more virulent? Is there a trade-off 
between resistance and virulence? This study aimed to understand the relation 
between virulence and resistance in E. coli and Klebsiella spp. as important human 
pathogens. Diverse origins of strains were considered, including clinical isolates from 
Portugal and from a country with a different use of antibiotics (Nigeria), and 
wastewater treatment plants isolates, and the variety of their virulence and resistance 
determinants was characterized.  
The phylogenetic group of E. coli is used in the characterization of isolates, as 
an indicator of the pathogenic potential of bacteria. The genetic characterization of 
clinical E. coli strains, allowed the finding of a new profile of genes, which was not 
previously reported or even considered in the method of Clermont et al. (Clermont et 
al., 2000). Chapter 2 describes this new profile and characterizes the virulence and 
resistance characteristics of the strain. After the publication of this unusual 
yjaA/TspE4.C2 profile, Skjot-Rasmussen et al. also reported the identification of this 
profile in four isolates: two from human  samples (urine and blood), one from pig and 
one from broiler chicken meat (Skjot-Rasmussen, Jakobsen, Olsen, Frimodt-Moller, 
& Hammerum, 2013). The identification of this unusual PCR profile partially 
contributed to the development of new strategies to identify the phylogroup of the 
strains. Doumith et al. developed an updated version of the original multiplex PCR 
based on this and other reports, and facing the observation of the existence of 
polymorphic regions in the annealing sites of the primers previously described by 
Clermont et al. (Doumith, Day, Hope, Wain, & Woodford, 2012). Furthermore, 
Clermont et al. published a revision of the original method, introducing an extended 
quadruplex method which identified eight E. coli phylogroups: A, B1, B2, C, D, E, F 
belonging to E. coli sensu stricto, and the eighth which was Escherichia cryptic clade 
I (Clermont, Christenson, Denamur, & Gordon, 2013). 
Aiming to understand the relation between virulence and resistance in E. coli, 
a collection of UPEC isolates was characterized for phylogroup, virulence genes, 
PAIs, antimicrobial resistance profile and resistance determinants (Chapter 3). 
Conjugation assays and fitness studies were performed to understand if the carriage 
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of PAIs would influence the fitness cost of the cell by a resistance plasmid 
acquisition.  
Pathogenicity islands PAI I536, PAI II536, PAI III536 and PAI IIJ96, were found to 
be associated to phylogroup B2. The exclusive detection of these PAIs among B2 
strains may be related to the fact that generally higher concentrations of virulence 
factors have been reported among the phylogroup B2 (Picard, Garcia et al. 1999).  
Two main theories may explain the higher concentrations of virulence factors 
in this phylogroup: the occurrence of a particular compatibility between virulence 
genes and genetic background of phylogroup B2; or as result of the interaction 
between chance and timing (Johnson and Kuskowski 2000). The first theory defends 
that a specific genetic background may be required for the acquisition of virulence 
genes and that phylogroup B2 may have genetic characteristics that are suitable for 
the acquisition and or maintenance of these traits, leading to the emergence of a 
virulent clone (Picard, Garcia et al. 1999, Johnson and Kuskowski 2000). Or in 
addition, the occurrence of adaptive mutations among the B2 phylogroup may help to 
compensate the acquisition of virulence genes contributing to their maintenance in 
the lineage, although the bacteria initially may not have been receptive to these 
exogenous genes (Johnson and Kuskowski 2000).  
Another theory claims that there is no particular affinity between phylogroups 
B2 and virulence genes, and that these genes may have been acquired randomly by 
a B2 ancestor, and were further vertically inherited by the majority of the members 
during clonal expansion. The acquisition of these virulence traits may also be so 
recent that the evolutionary time has not yet been sufficient for these traits to diffuse 
to the remaining groups (Johnson and Kuskowski 2000). 
Additionally, among strains carrying these non- frequent PAIs, PAI I536, PAI 
II536, PAI III536 and PAI IIJ96, a trade-off between virulence and resistance was 
observed. The carriage of these islands was generally found to be associated with 
susceptibility to antibiotics. In fact, this trade-off seems to be verified for the majority 
of the virulence genes, as higher prevalence of these determinants are verified 
among susceptible isolates compared to the resistant ones. This trade-off does not 
seem to be associated with a depletion of B2 phylogroup, as in this study, this group 
was generally more prevalent among resistant isolates when compared to the 
susceptible counterparts. Exceptions were observed for resistance to ampicillin, 
ciprofloxacin and sulfamethoxazole-trimethoprim, however a shift towards non-B2 
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phylogroups was only observed for sulfamethoxazole-trimethoprim. Considering 
resistance to ampicillin and ciprofloxacin, though the susceptible isolates presented 
higher   prevalence’s   of   B2   group   compared   to   the   resistant   ones,   B2   was   still   the  
most prevalent phylogroup among resistant strains. This observation is supported by 
the study performed by Johnson and colleagues, in which they report that non-B2 
strains didn’t have higher capacity to acquire resistance (Johnson et al., 2005a). 
These authors also suggest that the inverted relation between resistance and 
virulence is related to the importation of resistant strains from an external selection 
reservoir, such as food animals, carrying a susceptible source population exhibiting 
the same low virulence and non-group-B2 profile similar to resistant human clinical 
isolates.  
On the other hand, a positive relation was observed for the most frequent PAIs 
(PAI IV536, PAI ICFT073 and PAI IICFT073) and resistance to amoxicillin-clavulanic acid, 
cephalothin, cefotaxime, ceftazidime and gentamicin. This association between these 
islands and resistance associated with plasmidic determinants may be indicative that 
these PAIs may be using resistance plasmids to enhance their dissemination.  
Although an inverted relation between the number of the plasmids identified 
and the number of PAIs carried by the isolates seemed to occur, the experiments 
demonstrated that this relation was not fully verified. Conjugation assays were used 
to transfer a resistance plasmid carrying a blaCTX-M-15. Fitness studies indicated that 
the carriage of a higher number of PAIs didn’t implicate a direct rise in the fitness 
cost of the acquisition of the resistance plasmid, at least in strains harboring until 
three PAIs. Nonetheless, conjugation was not successful in strains harboring more 
than three PAIs, including the less commonly detected (Chapter 3).  It is important to 
notice that the best fitness value was obtained for the transconjugant which harbored 
the plasmid carrying blaCTX-M-15 and the combination of three PAIs (PAI IV536, PAI 
ICFT073 and PAI IICFT073). This supports the previous observation that this combination 
of PAIs and blaCTX-M-15 were more prevalent among the ST131 isolates (Chapter 4), 
and therefore is another indicator that this can constitute an optimal combination of 
virulence and resistance features.  
A wide variety of plasmid types were found to be carried by the UPEC isolates. 
IncF and IncK were the most common. aac  (6’)-lb-cr was frequently found among the 
isolates and, in addition, blaCTX-M-15, qnrA and qnrS resistance determinants were 
also detected.  
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The genetic relation between CTX-M-15 producers was investigated, strains 
were characterized and the sequence type (ST) was determined (Chapter 4). With 
the exception of one isolate belonging to ST10, the remaining isolates were assigned 
to ST131. 
Regardless of the genetic variability, the majority of ST131 strains were found 
to present a profile composed by PAI IV536, PAI ICFT073 and PAI IICFT073, IncF plasmid, 
blaCTX-M-15 and aac(6’)-lb-cr genes. This prevalent virulence and resistance profile 
may constitute an optimal combination of factors which allow E. coli ST131 to 
maintain both features, becoming concomitantly virulent and extremely resistant.  
In fact, despite of the apparent trade-off between virulence and resistance, 
particularly concerning quinolones, E. coli ST131 is an example of a clonal group that 
contradicts this tendency, as it combines resistance and virulence genes, and this 
feature may be contributing to its successful dissemination worldwide (Johnson et al., 
2010a). Contrarily to other ExPEC isolates from phylogroup B2, ST131 isolates are 
commonly producers of ESBLs, including CTX-M-15, and the great majority are also 
resistant to fluoroquinolones (Nicolas-Chanoine et al., 2014). In addition, ST131 E. 
coli isolates are considered to be truly pathogenic, not only because of the diversity 
of infections they cause either in community or hospital settings, but also because of 
the wide number of virulence-associated genes they carry. 
The wide distribution of clone ST131 and its success as a human pathogen 
may in part be explained by the co-selection of resistance genes including blaCTX-M, 
and virulence genes. IncF group, widely detected among ST131 clone has been 
associated with the dissemination of both virulence and resistance genes (Beceiro, 
Tomás, & Bou, 2013). During this study, an IncF plasmid which carried blaCTX-M-15, 
aac(6’)-lb-cr and PAI IV536 was identified in a ST131 isolate from a urine sample. 
Antibiotic selective pressure and acquisition of plasmid that co-carry virulence factors 
and resistance determinants seem to be the key for the equilibrium of this important 
human pathogen, which is, nowadays, worldwide disseminated.  
A human E. coli isolate ST131 was also identified from a high vaginal swab 
from Nigeria. This strain, similarly to the ST131 isolates detected among the 
Portuguese collection studied, was multidrug resistant and also presented blaCTX-M-15 
and aac(6’)-lb-cr genes, and a IncFIB replicon (which in this case was shown to be 
conjugative). Resembling the Portuguese ESBL producers, the Nigerian ESBL 
producers carried mainly IncF plasmids and in some cases also carried IncK 
Chapter 9 
 
116 
 
plasmids. In addition, they carried IncHI plasmids not detected among the 
Portuguese ESBL producers. The PMQR genes detected were also similar except 
that qnrB was only detected among the Nigerian isolates. Once again it was shown 
that although there are regional differences among the isolates, clone ST131, IncF 
plasmids and blaCTX-M-15 are widely and successfully disseminated worldwide.  
The dissemination of resistance and virulence determinants by horizontal gene 
transfer may contribute to the emergence of more virulent and resistant bacteria. This 
concern is not only valid for the clinical setting but also to the environment. WWTPs 
are a focus of concentration of sewage from several origins, and therefore, a place 
where bacteria from different sources and with different characteristics become in 
contact with each other. Considering that water may be a good matrix for horizontal 
gene transfer, if the treatments performed in the WWTPs  are unable to remove 
potentially pathogenic and/or resistant bacteria from water, they will be disseminated 
into the environment constituting a threat, not only to public health but also to the 
natural ecosystems.  
E. coli from municipal and hospital WWTPs were characterized to understand 
if bacteria carrying resistant and virulence traits are being disseminated into the 
environment (Chapter 6).  
Likewise in the clinical studies of both Portuguese and Nigerian ESBL 
producers, ST131 clone was also detected in the effluent of a hospital WWTP. This 
isolate was multidrug resistant and carried the prevalent combination of resistance 
determinants and PAIs previously referred. In addition, it also presented blaTEM, qnrS, 
iutA, sfa/foc and papAH genes. Other isolates containing several resistance and 
virulence determinants were also detected. Nonetheless, this isolate from ST131 
clone was the one which presented simultaneously more virulence and resistance 
determinants and, thus, was the one constituting a higher risk for public and 
environmental health.  
Despite of the high diversity of bacterial sources that converge into the 
WWTPs, when compared to the Portuguese clinical isolates, these E. coli generally 
present fewer variety of plasmid types, resistance determinants and virulence factors. 
Nonetheless, the observed presence of strains carrying potentially disseminative 
elements at the effluent of the WWTPs, those of them persisting along the treatment 
station for several days, constitutes a real threat. Dissemination of these virulence 
and resistance determinants between bacteria may lead to the appearance of more 
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virulent and/or resistant bacteria including among natural ecosystems. Therefore, it is 
important to re-think the treatments used in WWTPs and increase the efficiency on 
the removal of potentially pathogenic bacteria from wastewaters. Perhaps a higher 
control would be needed for particular species including E. coli, and, thus, the 
number of allowed colonies from this species in microbiological control should be 
reduced. 
E. coli is known to be an important pathogen among Enterobacteriaceae 
family. Nonetheless, K. pneumoniae and at a lesser extent K. oxytoca are also 
important human pathogens, particularly in nosocomial infections. Their clinical 
importance is increasing, not only because of the enhancement of resistance among 
these species, but also to the fact that they are being more frequently identified as 
causative agents of several types of infections. However, studies on these species 
are generally focused in resistance, and investigations on virulence are scarce. To 
understand the relation between virulence and resistance in these species the 
characteristics of two distinct populations were studied.  
The relation between virulence and resistance was evaluated for K. 
pneumoniae and K. oxytoca from several clinical samples (Chapter 7).  
The presence of PAI IICFT073, frequently found among the E. coli isolates, and 
also detected in the K. pneumoniae strains from the renal transplant patients 
(Chapter 8), was firstly identified among K. oxytoca in this study. The presence of this 
island in this species confirms the dissemination of uropathogenic associated PAIs 
within the genus Klebsiella.  
A statistically significant relation between PAI IV536 and resistance to 
gentamicin and sulfamethoxazole- trimethoprim in K. pneumoniae was observed. 
Furthermore, PAI IICFT073 was significantly associated with resistance to cephalothin, 
cefotaxime, ceftazidime, ciprofloxacin, and gentamicin in K. oxytoca. The co-carriage 
of pathogenicity islands in resistance plasmids may be one possible explanation for 
these observations, which could constitute one of the research line emerging from 
this work. 
Among the clinical syndromes caused by K. pneumoniae, pyogenic liver 
abscess is a serious condition which can lead to extra-hepatic complications. This 
explains why many of the virulence studies focus on K. pneumoniae from this source. 
Several virulence determinants have been associated with this condition including 
alls, involved in the allantoin metabolism (Chou et al., 2004). In this study, this gene 
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was prevalently detected among strains from urinary infections. This may indicate 
that this virulence factor generally involved in PLA may also be an important 
urovirulence determinant. In fact, allantoin is found in human urine as a product of 
uric acid metabolism, and therefore the possibility of using this substance as an 
energy source may also constitute an advantage for bacterial growth among urine. 
To really understand the pathogenic potential and the possible role of the different 
virulence factors among Klebsiella spp. further studies should expand the range of 
clinical samples studied.  
Contrarily to the observed in E. coli, where a trade-off between virulence and 
resistance seems to occur, has in our strains the majority of the genes were more 
prevalent among susceptible isolates, this is generally not verified in Klebsiella spp. 
In fact, in K. pneumonia, higher prevalence of virulence factors was detected among 
isolates resistant to ciprofloxacin and gentamicin and at a lesser extent to cefotaxime 
and sulfamethoxazole/ trimethoprim. Furthermore, higher prevalence of virulence 
genes was observed in resistance to sulfamethoxazole-trimethoprim in K. oxytoca. 
Nonetheless, for this species, in the remaining antibiotics, the prevalence was more 
balanced, as about half of the virulence genes were more prevalent among resistant 
strains, while the others were more prevalent on susceptible strains. These results 
suggest that the interplay between resistance and virulence are largely influenced by 
the genus and species, the virulence factor, as well as the resistance phenotype. 
Finally, a set of K. pneumoniae isolates from renal transplant patients, all of 
them ESBL producers, were characterized. The genetic relatedness was also 
assessed to understand if an outbreak was occurring (Chapter 8). Uropathogenic 
associated PAIs are commonly found among E. coli strains (Bronowski et al., 2008; 
Sabaté et al., 2006). Nonetheless, these elements are generally not investigated in 
K. pneumoniae. For the first time, the islands PAI IICFT073 and PAI III536 were reported 
among K. pneumoniae. Previously, only PAI IV536 had been identified in this specie 
(Koczura & Kaznowski, 2003). The identification of these mobile genetic elements in 
isolates from different genus, indicates that PAIs may be disseminating among 
Enterobacteriaceae members. The presence of PAI III536, one of the most unstable 
PAIs in E. coli (Middendorf et al., 2004), among K. pneumoniae strains may be 
suggestive that they may provide a favourable genetic background for the acquisition 
or maintenance of this island. In fact, while in our E. coli clinical strains this PAI was 
only detected in isolates susceptible to ciprofloxacin, in this case the carriers of this 
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island were resistant to ciprofloxacin. This indicates that resistance to ciprofloxacin in 
K. pneumoniae is not incompatible with the presence of PAI III536. The relation 
between resistance and the presence of certain virulence determinants seems 
therefore to be species- related.  
Likewise among E. coli, in K. pneumoniae ESBL producers from renal 
transplant patients, blaCTX-M-15 was also prevalent. Nonetheless, while in E. coli 
strains this determinant was generally associated with IncF plasmids, in K. 
pneumoniae producing CTX-M-15, none of the replicon types circulating among 
Enterobacteriaceae were detected. Therefore, either the gene encoding these 
enzymes was integrated in the chromosome of K. pneumoniae or other plasmid 
types, not identified by the Caratolli et al.  scheme, are circulating among this 
species. 
In addition to the characterization of K. pneumoniae strains, the genetic study 
of these isolates allowed to understand that the isolates had different origins. This 
excluded the possibility of an outbreak caused by a single internal clone 
disseminating among the Renal Transplant Unit. This information was very important 
to the hospital, and highlighted the importance of the screening for colonization of 
patients before admission in these units to prevent further infections, and 
dissemination of resistant strains. As these patients are generally 
immunocompromised hosts, the dissemination of potentially pathogenic and resistant 
bacteria in these units may even be fatal. 
2. Concluding Remarks  
Overall, this PhD dissertation provides new insights in the knowledge of the relation 
between virulence and resistance among E. coli and Klebsiella spp. This relation 
seems to be complex and dependent on several factors including genus and species, 
individual virulence factor and resistance phenotype. While in some virulence factors 
there seems to be a trade-off between virulence and resistance, particularly in E. coli, 
others seem to be positively related to resistance.  
Therefore, it is important not only to conduct other studies in other virulence 
factors but also consider other emerging resistance phenotypes, including resistance 
to carbapenems that, nowadays, start to emerge in our country. Furthermore, genetic 
relatedness studies should also be performed between strains from human and 
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animal origin. This would allow understanding if the trade-off observed for some 
virulence factors and resistance determinants is really verified, or if it is related to the 
importation of less virulent but more resistant strains from animal origin. 
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